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GENERAL INTRODUCTION
1
Introduction
Stroke is a disorder of the central nervous system of vascular origin. In the Netherlands, 
an estimated 0.26% of the whole population (41.000 persons) suffer from a first stroke 
each year,1 and a 27% increase in this incidence rate is expected until 2020 as a 
consequence of aging of the population.2 The majority of persons in the chronic stage 
(> 6 months) after stroke suffer from sensorimotor and cognitive impairments that 
restrict the capacity to perform activities of daily living such as walking. The walking 
pattern of persons in the chronic phase of stroke is typically characterized by a loss of 
selective motor control and by synergistic mass action of muscles.3 Impaired ankle 
dorsiflexion during the swing phase of gait, called ‘drop foot’, is often part of this 
movement pattern and hampers adequate foot lift.3 Reduced hip and knee flexion 
further complicate adequate foot clearance. To overcome the risk of foot drag and 
consequent stumbling and tripping, patients often develop compensatory strategies, 
including pelvic tilt, lower-limb circumduction, and trunk lateral flexion at the cost of 
gait speed, balance and energy consumption. Therefore, interventions to correct the 
drop foot are warranted.
Orthoses for stroke-related drop foot 
Drop foot is conventionally corrected by means of an ankle-foot orthosis (AFO). AFOs 
are produced with different materials and in various designs. All AFOs have in common 
that they support the foot in a more or less neutral position during the swing phase of 
gait, promote heel strike at initial contact and provide medial-lateral ankle stability 
during the stance phase of gait.4 As a functional disadvantage of AFOs, active ankle 
stability for balance correcting movements is reduced. Furthermore, AFOs reduce 
push-off in terminal stance by hindering ankle plantar flexion. 
Functional electrical stimulation of the common peroneal nerve (FES) provides an 
alternative treatment method for drop foot. With FES, muscles that dorsiflex and evert 
the ankle joint are artificially activated during the swing phase of gait. As early as 1961, 
Liberson et al5 reported the use of peroneal FES in persons with hemiplegia. However, 
technical and ergonomic problems have limited the use of FES in clinical settings for 
several decades. Only since recent technical advances, the clinical application of 
peroneal FES has grown rapidly in the stroke population. 
The use of FES is limited to a subset of persons with stroke-related drop foot. First, the 
use of FES is restricted to persons who demonstrate sufficient medio-lateral ankle 
stability during the stance phase of gait because no stimulation is provided in this 
12
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phase. People with equinovarus tendency at the affected ankle during the stance phase 
of gait may be at risk of ankle inversion with FES alone. Secondly, the mobility of the 
affected ankle should permit a neutral (plantigrade) position to be able to sufficiently 
profit from FES. Thirdly, it has been reported that people may develop allergic skin 
reactions at the electrode sites of surface-based FES devices.6-9 For these people, 
surface-based FES may not be the first choice, but implantable FES systems may prove 
to be a solution for them. Finally, FES devices need maintenance, such as daily charging, 
proper doing on and off, and turning on and off over the day. This makes FES less 
appropriate for persons with severe cognitive disability. 
FES has several theoretical advantages over the use of an AFO. First, foot lift provided by 
muscle force, as with FES, is active in nature, in contrast to the passive foot lift by means 
of an AFO. This active foot elevation may involve several beneficial physiological 
mechanisms. For example, a flexion reflex of the whole lower limb may be facilitated by 
activation of the tibial anterior muscle, as has been demonstrated in spinal cord injured 
persons.10 In addition, spasticity of the antagonistic calf11 or quadriceps muscle12 might 
be inhibited with FES. Both mechanisms may contribute to an improvement of the 
movement of the whole lower limb, particularly during the swing phase. A second 
advantage of FES over AFO is that FES allows free ankle movement during the stance 
phase of gait. This may promote the use of residual balance correcting movements and, 
thus, improve stance stability. Furthermore, the free ankle mobility permits active ankle 
plantar flexion at push-off in the case of preserved calf muscle strength. An increased 
push-off power facilitates the initiation of knee flexion at pre-swing and, with this, swing 
phase knee flexion.13 In conclusion, both the active nature of FES and the free ankle 
mobility support some of the presumed effects of FES beyond foot lift alone, i.e. FES 
may improve the movement pattern of the entire lower limb, particularly during the 
swing phase of gait. 
All these advantages relate to improvements in walking while stimulation is used: so 
called ‘orthotic’ effects of FES.14 In addition to these orthotic (or neuro-prosthetic) 
effects, therapeutic (or ‘carry-over’) effects have been reported15-17 that relate to 
functional gains without stimulation due to long-term FES use. Adaptive changes in 
peripheral structures, like muscle hypertrophy, may underlie such therapeutic effects. 
However, also structures and functions of the central nervous system may be modified 
by repetitive and active daily-life movements with the use of orthotic FES.18 Therefore, 
brain plasticity and associated motor relearning may also contribute to the therapeutic 
effects of FES. This hypothesis is supported by an improved corticospinal connectivity 
that has been demonstrated after long-term FES use.19 The current project did not seek 
to evaluate the therapeutic effects of FES but focused on the orthotic effects.
13
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Literature on the orthotic effects of peroneal FES
In order to be able to make a well-considered choice between AFO and FES, knowledge 
of the potential benefits of both devices is essential for persons post stroke who suffer 
from a drop foot. The effects of AFOs on gait capacity have been widely studied. 
Systematic literature reviews4, 20 suggested positive effects of an AFO on walking 
velocity, efficiency and the gait pattern. However, the evidence for such effects is only 
limited21 and in addition, the clinical relevance and significance of changes on daily 
functioning for the population at large remain largely unresolved.4, 22 This limited 
evidence of the effectiveness of AFOs might be explained by the large variation in 
patient populations, AFOs and study designs among studies.23 Regarding the orthotic 
effects of FES on gait in persons post stroke, two literature reviews have been published.8, 
14 In the most recent review,8 the available evidence for walking improvements with FES 
has been evaluated systematically. The researchers concluded that there is a positive 
effect of FES on gait speed. Interestingly, this benefit is not equally perceived by the 
users.7, 9 There is increasing evidence in several fields of health care that users’ perception 
is an important factor for optimal clinical decision making.24 The primary benefits of FES 
as perceived by the users are reduced effort of walking,9 improved safety and 
independency of gait,24 more confidence in walking on slopes and uneven terrain,7 and 
reduced risk of tripping.9 Thus, the effort and safety of walking might be more important 
outcomes for the users than merely the speed of walking. 
In the current project, a systematic literature search was conducted to get an overview 
of outcome measures that have been used to evaluate gait improvements while using 
FES in persons with stroke-related drop foot. The second aim of this search was to 
evaluate whether these measures quantified the gait improvements with FES as 
perceived by the users. The search was performed twice: in 2007, shortly after the start 
of this PhD project, and in 2012, at the end of the project. Sources for the literature 
search were: Medline, CINAHL and the Cochrane Controlled Trial Register. MeSH 
keywords used were: stroke, hemiplegia, transcutaneous electric nerve stimulation, 
electric stimulation therapy, lower extremity, leg, gait, and walking. The studies that met 
the following criteria were included: (1) mono- or bipolar FES of the common peroneal 
nerve had to be evaluated concerning the walking capacity in stroke patients with a 
drop foot; (2) walking with FES had to be evaluated in comparison with either another 
or no orthotic device; (3) the article had to be published in English. 
Table 1.1 lists the publications that were identified. A total of 27 publications fulfilled the 
selection criteria of which 12 papers were published in the period from 2007 (including 
the papers that resulted from this PhD project). The search demonstrated gait speed as 
the primary outcome (see Table 1.1), which is in line with previous reviews that evaluated 
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the effectiveness of FES on gait capacity.8, 14, 16 Consistent with a previous review,8 it can 
be concluded that a positive orthotic effect of FES on walking speed is conceivable 
when compared with walking without any device. However, in general, persons 
suffering from a drop foot have the choice between FES or an AFO, while walking 
without any device is no option. Hence, FES should be contrasted to a conventional 
device, such as an AFO, rather than to walking without any device in order to add to 
usual care and to support clinical decision making. Regrettably, studies that have 
compared FES with an AFO are scarce and yield inconclusive results.7, 25, 26 In response to 
the question of whether gait speed may reflect the benefits of FES as perceived by the 
users, it was already argued that gait speed itself is not the most important perceived 
benefit of FES.7, 9 Therefore, gait speed does not reflect users’ perception directly, but it 
may do so indirectly. Gait speed is a generic outcome measure that captures several 
other gait parameters.47, 48 An increase in walking speed may, thus, reflect an improvement 
of other aspects of gait, among which the safety of walking. 
The literature search indicated that the Physiological Cost Index (PCI), a measure of 
energy consumption, is used as another outcome measure in the evaluation of FES. This 
measure may better reflect the effort of walking as perceived by the users. Consistent 
with the perception of the users, most studies have suggested a positive effect of FES 
on PCI.6, 7, 27, 28, 31, 35 However, the number of studies that has evaluated this outcome is 
limited and the positive effects could not be confirmed by all studies.17 In addition, the 
effects of FES on PCI have only been contrasted to walking without any device and not 
to walking with an AFO. Therefore, and in line with previous research,8 it can be 
concluded that FES may have a positive effect on PCI, but that further research is 
required to evaluate this more comprehensively. 
A third group of outcome parameters focused on the gait pattern with FES and consisted 
of spatiotemporal and kinematic parameters during comfortable walking. In recent 
years, a growing body of literature has been published on this topic.7, 26, 32 Concerning 
spatiotemporal parameters, an improved symmetry, a shorter double support time 
duration26 and reduced variability of gait7, 32 have been reported when walking with FES. 
Different studies support the notion that the dynamic stability while walking may 
improve with FES.7, 26, 32 This notion may support FES users in their perception of improved 
stability and safety of gait. Further work needs to be done to establish the additional 
value of FES over AFOs with respect to the dynamic stability of walking and to verify an 
improved safety of gait as a consequence. With regard to kinematic gait parameters, the 
search showed that FES indeed improves ankle kinematics during walking,26, 30, 31, 33, 39, 41 
although this has been contrasted to an AFO in only one study.26 Knowledge about the 
orthotic effects of FES on the kinematics of gait is valuable for the understanding of its 
working mechanisms. Hip and knee kinematics while walking with FES have been 
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quantified in two studies26, 41 and both reported no effect of FES on knee or hip 
movements. Interestingly, improvement of the whole hemiparetic gait pattern with FES 
has been reported by earlier research on the basis of observational judgments.5, 31, 34, 45 
Although the strength of such qualitative assessments is limited, these studies still 
support the idea that the working mechanism of peroneal FES may reach beyond foot 
elevation alone.
In conclusion, the current literature provides evidence of orthotic effects of peroneal 
FES on walking speed compared with walking without any device. However, compared 
with an AFO, the literature is limited and inconclusive about the superiority of FES. 
Particularly this information may be supportive in clinical decision making between 
AFO and FES in persons with a stroke-related drop foot. A second void in the literature 
is that the available studies have focused on outcomes related to comfortable walking, 
which does not value users’ perception. FES users perceive improved gait confidence as 
an important additional value of FES. To underscore this benefit, users refer to their 
experiences in highly demanding situations rather than to comfortable walking. In such 
demanding situations, people must use their full gait capacity in order not to fall. Gains 
with respect to gait capacity under difficult circumstances may not be revealed by 
outcome measures that focus on comfortable walking alone. Thus, more challenging 
tests are needed to evaluate gait at the very limits of the individual’s capacity.49 Such 
tests may reveal benefits of FES with regard to the safety of gait that remain unnoticed 
when merely assessing comfortable walking. 
Adaptability of gait in persons post stroke
For persons post stroke, the safety of gait appears to be an important aspect of 
consideration in their choice for an orthotic device. Indeed, the safety of gait in persons 
post stroke is compromised as indicated by high fall rates,50-53 even in persons who are 
well-recovered from stroke and live an active life in the community.52 Community 
walking involves gait adjustments to environmental constraints, like a change in the 
walking surface, a branch that is blown up by the wind, or the sudden appearance of a 
playing child or animal. The capacity to adjust gait – gait adaptability – is an important 
prerequisite for safe community ambulation. Indeed, gait adaptability has been shown 
to be a key determinant of fall risk in healthy elderly.54 Most commonly, studies that 
evaluate the adaptability of gait use obstacle avoidance paradigms that challenge the 
participant to use his/her full gait capacity.53 The number of studies that evaluated the 
ability to negotiate obstacles in persons post stroke is limited.55-57 Although the evidence 
from these studies suggest that gait adaptability is compromised after stroke, the 
underlying deficits in movement control remain unknown. Several factors may 
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contribute to the reduced capacity to adjust gait to environmental changes. First, there 
may be a time delay in the adaptation of the step, as the disability is greatest under time 
pressure.55, 58 Second, an aberrant movement execution of the avoiding stride may play 
a role, leading to errors in the avoidance maneuver. So far, it is unknown which deficits 
in muscle control contribute most to the reduced gait adaptability after stroke. Third, 
persons post stroke often mention that walking in complex situations requires their full 
attention in order not to fall. Thus, online gait adaptation may be associated with higher 
attentional demands in persons post stroke than in non-disabled persons. As a result, 
higher attentional demands during gait adaptations may lead to an increased fall risk in 
persons post stroke while performing dual tasks. Lastly, tripping may more often lead to 
a fall in persons with stroke when recovery reactions following the trip are inadequate. 
Hence, not only a reduced capacity to avoid an obstacle but also a diminished capacity 
to restore steady gait after a disruption of the gait pattern may contribute to the 
increased fall risk in persons post stroke. 
FES users have reported an improved stability and safety of gait,7, 9, 24 and in addition, FES 
may be particularly beneficial for complex gait, as walking on an uneven surface.29 The 
question is, therefore, relevant whether this benefit may be related to a better gait 
adaptability with FES. It was already hypothesized that FES might improve the movement 
pattern of the whole lower limb in persons post stroke, particularly during the swing 
phase. Reduction of the pathological synergism during the swing movement may 
increase motor selectivity and lead to improved gait adaptability to environmental 
challenges. Therefore, in this thesis, the hypothesis is tested that FES contributes to safer 
walking, not only due to improved foot clearance, but also to an increased capacity to 
adapt gait to environmental changes. 
Thesis aims and outline 
This thesis consists of two parts. Each part will address one main topic related to gait in 
persons in the chronic phase after stroke. These topics are (1) online gait adaptations 
and underlying motor control after stroke, (2) the effects of peroneal FES compared with 
an AFO on gait adaptability in persons with stroke-related drop foot.
Part I: Online gait adaptations and underlying motor control after stroke
Part I investigates the capacity to adapt gait to environmental changes in persons post 
stroke. To this aim, the gait adaptability is compared between community-dwelling 
persons in the chronic phase after stroke and healthy controls. All participants walk on 
a treadmill and have to adapt the ongoing stride to avoid an obstacle that is suddenly 
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released in front of one foot. With this paradigm, the participants are tested at the limits 
of their capacity using standardized conditions, rendering it suitable to assess a wide 
range of capacities and to study underlying deficits in motor control at the same time. 
Part I is built up of 3 chapters, each of which addresses a unique research question by 
using the same study setup:
1. (a) Is the capacity to adapt gait to sudden environmental changes reduced in persons 
post stroke compared with healthy controls? (b) Which deficits in neuromuscular control 
underlie the expected disability in persons post stroke?
Chapter 2 studies the (in)capacity to adapt gait to environmental changes in persons 
post stroke compared with healthy controls. Thirty obstacle avoidance trials are 
performed by each of the 25 participants in both groups. Gait adaptability is quantified 
by the success rate. Deficits in muscle responses underlying any disability are identified 
and interrelated with kinematic and spatiotemporal characteristics of the avoidance 
maneuvers. We expect that (a) the online gait adaptability is reduced in persons post 
stroke and (b) delayed and weak muscle responses contribute to this presumed reduced 
gait adaptability.
2. Are gait adaptations associated with higher attentional demands in persons post stroke 
than in healthy controls?
Chapter 3 assesses the attentional demands of online gait adaptations in persons post 
stroke and healthy controls. A subset of 8 patients and 8 healthy controls from the study 
reported in chapter 2 is included. Eighteen obstacle avoidance trials are performed by 
the participants in each of two conditions: with and without a concurrent cognitive 
task. Dual-task costs on both the motor and the cognitive task are assessed and 
compared between the groups. Higher dual-task costs on both tasks are hypothesized 
for persons post stroke compared with controls. 
3. Is the capacity to restore steady gait after a step modification reduced in persons post 
stroke compared with healthy controls?
Chapter 4 investigates the capacity to restore steady gait after a step modification in 
persons post stroke compared with healthy controls. To this end, the restoration of gait 
after crossing the obstacle is compared between 20 persons post stroke and 20 healthy 
controls, who all perform 30 obstacle avoidance trials. Deviations in step length and 
time as well as hip flexion and extension excursions of 11 post-crossing steps are 
analyzed. More persistent deviations are expected in the stroke group. 
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Part II: the effects of peroneal FES compared with an AFO on gait adaptability 
in persons with stroke-related drop foot
Part II compares the potential surplus value of peroneal FES over an AFO for the 
treatment of stroke-related drop foot. This part describes a study in 26 community-
dwelling persons in the chronic phase of stroke. All participants were used to an AFO 
and were provided with a surface-based FES device (NESS L300®) during the study. Data 
retrieved from repeated measurements during the 8-week study protocol are analyzed 
using a within-subject design in order to address a specific research question in each of 
the chapters of part II.
4. Is transcutaneous stimulation of the common peroneal nerve superior to an ankle-foot 
orthosis regarding patients’ satisfaction and walking performance in persons post stroke 
with a drop foot? 
In Chapter 5, the satisfaction of the participants with FES and their AFO is assessed. In 
addition, the effects of FES and AFO on daily life performance are quantified using the 
10-meter comfortable walking speed test and by measuring the level of physical activity 
using a pedometer. The participants are expected to benefit from a transfer to peroneal 
FES, as reflected by improved satisfaction and gait performance parameters with FES 
compared with an AFO.
5. Is transcutaneous stimulation of the common peroneal nerve superior to an ankle-foot 
orthosis regarding gait adaptability?
Chapter 6 reports on the effects of FES and AFO with respect to the capacity to avoid a 
sudden obstacle. To this aim, the same obstacle avoidance setup as reported in part I is 
used to test walking with FES and AFO in week 2 and 8 of the study protocol. The 
obstacle avoidance capacity is regarded as an ecologically valid measure of gait 
adaptability. We test the hypothesis that gait adaptability is better with FES than with 
AFO. 
6. (a) What aspects of functional superiority of peroneal FES over AFO can be distinguished 
in the case of an excellent responder? (b) Can the gait pattern with FES in such an 
excellent responder shed light on the potential working mechanisms underlying this 
superiority?
Chapter 7 presents one of the participants of the study who was an extraordinarily 
good responder to peroneal FES. In this participant, the effects of both FES and AFO are 
assessed at a functional level, regarding comfortable walking speed and obstacle 
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avoidance capacity. In order to reveal the potential working mechanisms of FES in this 
person, hip, knee and ankle kinematics are assessed while walking with FES, with an 
AFO, and without any device. 
In Chapter 8, the research conducted in this PhD thesis is summarized and discussed. 
The potentials of the obstacle avoidance paradigm for the stroke population are 
evaluated, the clinical implications and working mechanisms of the superiority of 
peroneal FES over AFO are explored and directions for future research are emphasized.
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Abstract
Background. Safe community ambulation requires the capacity to adapt gait to 
environmental changes on short notice. A reduced gait adaptability may contribute to 
an increased fall risk. 
Objective. This study investigated gait adaptability in community-dwelling persons post 
stroke and sought to understand some of the mechanisms underlying the expected 
loss of gait adaptability. 
Methods. Participants were 25 post-stroke persons (Functional Ambulation Categories 
score 5) and 25 healthy controls of similar age. During treadmill walking, 30 obstacles 
were suddenly dropped in front of the affected (post-stroke persons) or left (controls) 
leg. The participants had to avoid the obstacle by either lengthening or shortening the 
ongoing stride. The obstacle avoidance success rates were determined. Furthermore, 
the electromyographic (EMG) activity of bilateral biceps femoris, rectus femoris, tibialis 
anterior and gastrocnemius medialis muscles were recorded as well as concomitant 
knee and hip angle courses and spatial characteristics of the avoiding stride. 
Results. Post-stroke persons demonstrated markedly decreased obstacle avoidance success 
rates, most prominently under time pressure. Furthermore, they showed delayed and 
reduced EMG responses, smaller joint angle deviations from unperturbed walking, and 
smaller horizontal margins from the foot to the obstacle. 
Conclusions. Even in persons who were only mildly affected by stroke, gait adaptability 
may be reduced, which may place them at risk of falling. Delayed and decreased muscle 
responses were identified as one possible mechanism with diminished ability to adapt 
the length of the avoiding stride. Rehabilitation interventions could focus on these 
impairments.
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Introduction
People in the chronic phase of stroke are at an increased risk of falling compared to 
healthy age-matched peers.53 This high risk is evident even among well-recovered com-
munity-dwelling individuals.52 For independent and safe community ambulation, it is 
particularly important to be capable of adapting the gait pattern to environmental 
demands and constraints, as confirmed by reports of an increased fall risk in people 
with reduced gait adaptability.54 
It has been shown that gait adaptability is reduced in people with stroke55, 56, 59. People 
with stroke demonstrated deficits in visually55 or auditory59, 60 evoked online step 
adjustment. In good walkers, current clinical tests usually fail to demonstrate these 
more subtle gait impairments. Hence, gait adaptability tests that challenge people at 
the limits of their capacity may uncover problems that otherwise remain unnoticed in 
common observational clinical evaluation.
Although there is strong evidence that gait adaptability is compromised after stroke, 
the underlying mechanisms are still largely unknown. Deficits in movement execution 
were demonstrated when people with stroke had to approach and cross an obstacle 
that was positioned several strides ahead.61 However, deficits in step adaptations 
became even more prominent when they had to be executed under time pressure.55, 58 
Therefore, a delay in the commencement of the adaptation most likely further reduces 
their gait adaptability. Indeed, in healthy older individuals, both decreased response 
amplitudes and delayed reaction times have been associated with reduced gait 
adaptability.62 
It is important to elucidate the mechanisms underlying reduced gait adaptability after 
stroke, because this knowledge adds to our understanding of the problems that these 
people experience while walking in the community and may provide targets for 
intervention. Hence, in the current study, we aimed to study gait adaptability in com-
munity-dwelling people with stroke. In particular, we aimed to address some of the 
mechanisms underlying the expected decrease in gait adaptability. A time-constrained 
obstacle avoidance paradigm on the treadmill has often been used to evaluate gait 
adaptability54, 55, 63-66 and may predict falls in daily life.54 Moreover, treadmill walking is 
considered a valid method for detecting motor control deficits post stroke.67 Therefore, 
the present study compared the ability to avoid sudden obstacles during treadmill 
walking between post-stroke persons and healthy control subjects. We used electromy-
ography (EMG) to investigate muscle response times and amplitudes and we explored 
the relationship of EMG with kinematic and spatial characteristics of the avoidance 
maneuver.
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Methods
Participants
The experimental group consisted of 25 persons with hemiparesis at least 6 months post 
stroke. The data of this group were collected as part of a study comparing functional 
electrical stimulation (FES) of the peroneal nerve with an ankle-foot orthosis (AFO),36, 37 so 
all participants demonstrated stroke-related foot drop during gait. In addition, candidates 
had to be able to walk independently without a walking aid for more than 10 minutes on 
even and uneven surfaces (Functional Ambulation Categories score 547) and to walk 
comfortably on the treadmill without handrail support at 2 km/h or faster. Exclusion 
criteria that were relevant for the current study were visual impairments and an impaired 
understanding of instructions. Other FES-related exclusion criteria were a demand-type 
pacemaker, pregnancy, psychological disorders (depression or psychosis) and, related to 
the paretic limb, less than 30 degrees of passive ankle motion, inability to load the heel 
while standing upright, severe hypertonia of the calf (Modified Ashworth Scale scores 
4-568), skin lesions at the electrode sites and inability to stimulate the peroneal nerve. The 
following clinical measures were obtained: muscle tone of the knee and ankle muscles 
(Modified Ashworth Scale68), lower-extremity muscle strength (Motricity Index69), lower-
extremity motor selectivity (Fugl-Meyer Assessment70), balance (Berg Balance Scale71), and 
comfortable walking speed. For the control group, we recruited 25 healthy participants of 
similar age. All participants gave written informed consent. The experimental protocol 
was approved by the regional medical-ethical committee. 
Experimental setup 
The participants with stroke walked on a treadmill with their AFO at either 2 or 3 km/h, 
depending on their individual walking capacity (Figure 2.1a). The controls walked at 
both 2 and 3 km/h. We post-hoc ‘matched’ controls to the persons with stroke and only 
analyzed the series performed at the same speed. All participants wore comfortable 
shoes and a safety harness that did not support any body weight. Just above the 
treadmill, an obstacle (length, width and height: 40, 30 and 1.5 cm, respectively) was 
held by an electromagnet.72,73 The participants were instructed to maintain a sagittal 
distance of about 10 cm between the hanging obstacle and the avoiding foot at the 
moment of foot strike (Figure 2.1a).
Three reflective markers were attached at the most anterior, posterior and lateral part of 
each shoe, and one additional marker was placed at the front edge of the obstacle. A 
6-camera 3D motion analysis system (Vicon Motion Systems, Vicon-UK, Oxford, United 
Kingdom) recorded the marker positions at 100 Hz. Foot marker data were processed in 
real time to determine the instant and position of foot strike. Computer algorithms used 
this information to trigger obstacle release unexpectedly (after 5-15 unperturbed 
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Figure 2.1  The obstacle avoidance task.
 
(a) Schematic diagram of the experimental setup. (b) Schematic diagram of the avoidance strategies: 
Short Stride Strategy (SSS): an additional shortened stride is performed before the actual crossing stride. 
Long Stride Strategy (LSS): the stride is lengthened to cross the obstacle.
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strides) in one of three phases of the gait cycle: mid-stance, stance-swing transition, and 
mid-swing. Later instants of obstacle release reduced the time available to respond to 
the obstacle and, consequently, increased the level of difficulty of the trial. The three 
phases of obstacle release corresponded with available response times (ART) of 450-600, 
300-450 and 150-300 ms, respectively. ART was defined as the time span between 
obstacle release and the moment that the toe would have crossed the front edge of the 
obstacle in case of an unaltered walking pattern.
The obstacle always fell in front of the affected leg of the persons post stroke and the 
left leg of the controls, which will be referred to as the ‘avoiding leg’. Participants were 
instructed to avoid stepping on the obstacle, while stepping aside with the avoiding leg 
was not allowed. The other leg, called the ‘stance leg’, was not obstructed by the 
obstacle. Contact of the foot with the obstacle and steps beside the obstacle with the 
avoiding leg were classified as failures, which was judged by two assessors. In the case 
of any uncertainty, we checked the marker position data and video recordings of the 
respective trial to underscore a final decision. At the beginning of each session, the 
participants got time to familiarize with treadmill walking and, in addition, they 
performed 5 practice obstacle avoidance trials. Subsequently, they performed 30 
experimental obstacle avoidance trials in which the instants of obstacle release 
(mid-stance, stance-swing transition and mid-swing) were randomly distributed over 
the trials. Total walking time was approximately 20 minutes and breaks were permitted 
whenever needed.
Electromyographic (EMG) recordings were made of bilateral biceps femoris (BF), rectus 
femoris (RF), tibialis anterior (TA) and medial head of gastrocnemius (GM) muscles. We 
used self-adhesive electrodes (Tyco Arbo ECG, Brainclinics Diagnostics, Nijmegen, The 
Netherlands) that were attached according to SENIAM guidelines.74 Furthermore, flex-
ion-extension movements of the hips and knees were measured with goniometers 
(Biometrics SG150 and SG110/A; Biometrics Ltd, Ladysmith; VA 22501, USA). EMG and 
goniometer signals were recorded synchronously with the marker data at a sample rate 
of 1000 Hz. 
Data processing 
Individual avoidance success rates were calculated for each of the ART categories. From 
the marker data it was determined for each trial whether the subject had avoided the 
obstacle by shortening (short stride strategy; SSS) or by lengthening (long stride 
strategy; LSS) the ongoing stride (Figure 2.1b). The LSS is generally used at long ARTs, 
whereas the SSS is used at short ARTs.75, 76 In 5.1% of the trials, a strategy was applied that 
could not be classified as either SSS or LSS. These trials were discarded from the analysis. 
For each ART category, the proportions of LSS and SSS trials were computed. 
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Spatial outcomes included the distance from the toe to the obstacle (toe distance) for 
SSS trials, from the obstacle to the heel (heel distance) for LSS trials, and the amount of 
stride shortening (SSS) or lengthening (LSS), defined as the deviation from the mean 
control stride length (i.e. length of the stride prior to obstacle release for each trial; 
averaged over all 30 trials).
Goniometer data were low pass filtered (6 Hz; zero lag, fourth order Butterworth). 
Subsequently, we determined the maximum hip and knee flexion angles during the 
swing phase of the avoiding leg, and the maximum hip extension angles during the 
stance phase of the stance leg. Outcomes were computed for each trial as the deviation 
from the mean control stride (i.e. averaged over 30 trials) and were averaged within 
each subject over all SSS and LSS trials.
The EMG signals were band-pass filtered (20-450 Hz; zero lag, fourth order Butterworth), 
full-wave rectified and low-pass filtered (25 Hz; zero lag, fourth order Butterworth). For 
each muscle and each participant we calculated the average (±2SD) trajectory over the 
30 control strides. Muscle onsets were detected by a computer algorithm with visual 
inspection as a control. Onset was defined as the moment at which the EMG activity of 
Figure 2.2   Example of EMG onset detection in a control subject.
The solid trace represents an example of left biceps femoris response (BF-avoid) to obstacle release (from 
foot strike to foot strike of the avoiding stride). This BF-avoid trace is superimposed on a grey area 
representing the EMG activity of this muscle during unperturbed gait (i.e. mean ± 2 SD of control strides).
The thin vertical solid line gives the start of BF-avoid deviation from this area (muscle onset). Muscle onset 
latency is the time difference between muscle onset and obstacle release. Arrow a indicates the 100 
ms-period over which the ‘initial’ response amplitude was computed. Arrow b indicates the period of the 
avoiding stride over which the ‘late’ response amplitude was computed. FS = foot strike; FS avoid = foot 
strike of the avoiding stride; FS control = foot strike of the control stride.
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the perturbed step exceeded the mean plus 2 SDs of the control strides at the respective 
instant of the step cycle for at least 30 ms (Figure 2.2). Onset latency was the time 
between obstacle release and muscle onset. We calculated the EMG amplitudes over 
the initial 100 ms following response onset (Figure 2.2, arrow a), because we expected 
that this time period would be essential to successful performance due to the 
time-critical nature of the avoidance task. In addition, we calculated the ‘late’ response 
amplitudes from 100 ms after response onset until foot strike (Figure 2.2, arrow b). For 
both initial and late muscle response amplitudes, the extra amplitude (i.e. additional to 
the average control stride) was normalized to the mean control amplitude of the 
corresponding phase of the stride.
 
Statistical analysis 
First, success rates and the proportions of LSS and SSS were compared between the 
groups by means of a 2-way ANOVA with ART (150-300, 300-450, 450-600) as a within- 
and Group as a between-subjects factor. All trials, irrespective of successfulness, were 
further analyzed. Spatial outcomes were compared between the groups with Student 
t-tests. Further, we subjected each of the kinematic outcomes to a 2-way ANOVA 
(Strategy by Group). 
EMG onset latencies and initial response amplitudes were subjected to a 2-way ANOVA 
with Muscle (8 levels) as a within- and Group as a between-subjects factor. In this analysis, 
the results were collapsed over both avoidance strategies, because the activation 
sequence was not different between LSS and SSS (Strategy × Muscle on onset latencies, 
p = .275), nor were there any differential effects of strategy between the groups (Strategy 
× Group × Muscle, p ≥ .302). In contrast, late response amplitudes were compared 
between the groups by means of 2-way ANOVAs for SSS and LSS trials, separately. The 
significance level in these analyses was adjusted to.025% to correct for multiple testing. 
Post-hoc analyses were performed using Student t-tests with Bonferroni correction for 
multiple comparisons. For all primary tests, the (uncorrected) alpha level was set at .05.
Results
Participants
Table 2.1 summarizes the characteristics of the participants. The groups did not differ in 
age, gender, weight or body height. All but one participant with stroke wore an 
ankle-foot orthosis (AFO) to correct drop foot. In one participant, a trip occurred during 
one of the assessments. This single obstacle avoidance trial was excluded from the 
analysis.
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Obstacle avoidance success rates and avoidance strategy
The controls hardly ever touched the obstacle (average success rate 96.9 ±1.0 %), 
whereas the people with stroke were successful in merely 30.3 ±4.7 % of the trials (Group 
main effect, F(1,48) = 192.02, p < .001, η
p
2 = .80; Figure 2.3). The difference in success rates 
increased with increasing time pressure (Group × ART, (F(2,96) = 15.38, p < .001,η
p
2 = .243). 
The strategy used to avoid the obstacle was not different between the participants with 
stroke and controls (Group main and interaction effects, F < 1.98, p > .143), and ART was 
not different between the groups, neither for LSS (t(42) = 0.76; p = .452) nor for SSS (t(46) 
= 1.08; p = .285). The strategy used depended on ART, with the SSS being more prevalent 
at shorter ART (F(2,96) = 88.53, p < .001, η
p
2 = .65; Figure 2.3). 
Spatial characteristics
In Table 2.2, spatial characteristics of the avoidance maneuver are shown. In SSS, 
participants with stroke decreased their pre-crossing stride length to a lesser extent 
than controls (t(46) = 7.228, p < .001). Consequently, in successful trials their toe distances 
were significantly shorter (t(36) = 2.710, p = .010). In LSS, they demonstrated less stride 
Table 2.1  Characteristics of the participants 
Stroke (n=25) Control (n=25)
Mean age, years (range) 51 (21-68) 51 (23-72)
Sex, male/female, n 20 / 5 18 / 7
Mean body weight, kg (range)  82.6 (53-131) 73.8 (49-98)
Mean body height, m (range)  1.76 (1.53-1.89) 175 (1.60-1.90)
Mean time post stroke, months (range) 41.4 (7-105) NA
Hemisphere of stroke, left/right, n 15 / 10 NA
Type of stroke, infarction/haemorrhage, n 19 / 6 NA
Median Modified Ashworth Score (0-5)a (range)
Knee flexors / extensors 0 (0-4) / 0 (0-2) NA
Ankle plantar / dorsal flexors 0 (0-3) / 0 (0-1) NA
Median lower-extremity Motricity Index (0-100)a (range) 64 (27-83) NA
Median lower-extremity FMA (%) (range)a 68 (21-93) NA
Median Berg Balance Scale (0-56) (range) 53 (41-56) NA
Mean comfortable walking speed, m/s (range) 1.07 (0.67-1.67) 1.35 (1.03-1.60)
a Scores of the paretic body side; FMA = Fugl Meyer Assessment (% of full recovery); NA= not applicable. 
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lengthening (t(42) = 5.463, p < .001), and heel distances in successful trials tended to be 
smaller compared to the control subjects (t(39) = 1.864, p = .07). Averaged over all trials, 
the participants with stroke showed negative values for both heel and toe distances, 
indicating that the foot landed on the obstacle in the majority of the trials. 
Figure 2.3   Obstacle avoidance success rates and strategies. 
(a) Obstacle avoidance success rates (mean (CI)) for each of the available response time (ART) categories. 
(b) Rates of obstacle avoidance strategy (mean (CI)), for each of the groups and ART-categories. All 
outcomes for the stroke group are shown in black and for the controls in grey. The long stride strategy 
(LSS) is shown in solid lines and the short stride strategy (SSS) in dotted lines. Significant main effects are 
indicated for Group (plus-sign) and ART (asterisks). In case of a significant Group by ART interaction, 
significant post-hoc effects between the groups are indicated with a circle.
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Kinematics
Bilateral joint angle courses of the hips and knees are shown in Figure 2.4. In SSS, the 
knee of the avoiding leg landed in a more flexed position at foot strike compared to 
unperturbed walking. This phenomenon was more prominent in the controls (+28.2 
±1.5o) than in the stroke group (+4.5 ±1.2o, p < .001). Furthermore, maximum hip flexion 
became less, again more prominently in the controls (−4.2 ±0.5o) than in the stroke 
group (−0.3 ±0.8o, p < .001). As for the stance leg, the hip was less extended in late 
stance compared to unperturbed walking. The 7.0 ±0.5o decrease in hip extension 
angles in the controls was larger than in the participants with stroke (4.1 ±0.8o, p = .004).
In LSS, knee flexion angles during the swing phase increased in the avoiding leg 
compared to unperturbed walking, which tended to be more pronounced in the 
controls (+12.6 ±10.7o) than in stroke group (+4.8 ±2.2o, p = .036). In the stance leg, the 
knee was more flexed during the stance phase, which was more pronounced in the 
controls (+8.6 ±1.8o) than in the participants with stroke (+3.7 ±1.0o, p = .018). 
EMG muscle responses
In the healthy controls, the first response to the obstacle was consistently observed in 
BF-avoid and RF-stance (Figure 2.5b). These muscles also demonstrated the highest 
rates of occurrence (Figure 2.5a) and the largest response amplitudes (Figure 2.5c). 
Responses in the other muscles followed after ~30-80 ms in a variable sequence. 
Table 2.2  Spatial characteristics of the obstacle avoidance parameters (mean (SD))
Stroke Control
Control stride length (m) 0.81 (0.12) 0.90 (0.11)*
Stride shortening in SSS (m) 0.11 (0.10) 0.30 (0.08)**
Stride lengthening in LSS (m) 0.29 (0.10) 0.44 (0.09)**
SSS toe distance of successful trials (m) 0.09 (0.06) 0.15 (0.07)*
SSS toe distance of all trials (m) -0.06 (0.08) 0.14 (0.07)**
LSS heel distance of successful trials (m) 0.04 (0.03) 0.07 (0.06)
LSS heel distance of all trials (m) -0.09 (0.10) 0.07 (0.07)**
SSS: short stride strategy; LSS: long stride strategy; the asterisks indicate significant differences between 
the groups (*p < .05, **p < .001).
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Figure 2.4   Bilateral joint angle courses (hip, knee) from foot strike to foot strike of 
the avoiding leg during control strides
The mean individual trajectories were averaged over the healthy controls (left) and stroke group (right). 
Arrows indicate the mean increase or decrease in maximum joint angles (degrees) during SSS and LSS, 
compared to the control stride. Increases or decreases that differed significantly between the groups are 
indicated with an asterisk. Grey horizontal bars indicate the stance phase of the leg. The time span within 
which an obstacle may be dropped is depicted as a shaded area for each of the windows. The extension 
‘-avoid’ to the joints indicates the leg in front of which an obstacle was dropped, which was the affected leg 
for the stroke group and the left leg for the controls. The other leg is indicated with the extension ‘-stance’.
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Figure 2.5   EMG muscle responses to the obstacle (mean +CI)
(a) Percentage of trials in which an EMG onset could be detected. (b) Onset latencies, the time span 
between the moment of obstacle release and start of EMG deviation from control stride during 
unperturbed gait. (c) Response amplitudes computed over a time span of 100 ms following EMG onset. (d 
and e) Response amplitudes computed between EMG onset and subsequent foot strike for SSS (d) and 
LSS (e). Response amplitudes were normalized with respect to the average (over 30 strides) amplitude in 
the corresponding phase of the step cycle during unperturbed gait. Values represent the amount of 
additional EMG activity compared to unperturbed gait. BF: Biceps Femoris, RF: Rectus Femoris, TA: Tibialis 
Anterior, GM: Medial head of Gastrocnemius . ‘Avoid’: muscle of the avoiding leg; ‘Stance’: muscle of the 
stance leg. The Bonferroni corrected level of significance in post-hoc t-tests was .006 (a-c) and .003 (d-e). 
Significant differences between the groups are indicated with asterisks.
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In persons with stroke, the number of trials in which an EMG onset could be detected 
was generally lower and the activation sequence was less consistent than in controls. 
The onsets of particularly BF-avoid, RF-stance and GM-avoid were delayed in the stroke 
group compared to the controls by 41, 39 and 36 ms, respectively, without significant 
delays in the other muscles (BF-avoid (mean ± standard deviation) 194 ±32 vs. 154 ±19 
ms; RF-stance 206 ±26 vs. 167 ±21 ms; GM-avoid 226 ±43 vs. 191 ±29 ms for stroke and 
control group, respectively; Group × Muscle, F(5.46,256.77) = 4.99, p < .001, η
p
2 = .096). 
The initial response amplitudes (in the first 100 ms from onset; Figure 2.5c) were lower 
for persons with stroke, particularly in BF-avoid (328 ±143 % vs. 1754 ±1042 % for stroke 
and control group, respectively) and RF-stance (226 ±197 % vs. 1115 ±871 %). Significantly 
lower amplitudes were also observed in GM-avoid (361 ±274 % vs. 994 ±826 %) and 
BF-stance (309 ±182 % vs. 755 ±482 %; Group × Muscle, F(3.44,161.67) = 17.86, p< .001, 
η
p
2 = .275). 
Late response amplitudes were analyzed for SSS and LSS, separately. In SSS ( Figure 
2.5d), most muscles demonstrating lower initial response amplitudes in the stroke 
group also showed significantly lower late response amplitudes (i.e. BF-avoid, RF-stance 
and BF-stance; Group × Muscle, F(2.01,80.34) = 5.55, p = .005, η
p
2 = .122). In contrast, late 
response amplitudes in TA-avoid tended to be larger in the stroke group (with 390 ±460 
%) than in the controls (156 ±160 %; p= .007). 
Late response amplitudes in LSS (Figure 2.5d) were also lower for BF-avoid and RF-stance 
in the participants with stroke compared to the controls (BF-avoid 71 ±103 % vs. 363 
±261 %; RF-stance 104 ±83 % vs. 535 ±648 %, respectively; Group × Muscle, F(1.97,66.8) = 
6.81, p = .002, η
p
2 = .167). In contrast and similar to the results for late response amplitudes 
in SSS, the stroke group demonstrated larger TA-avoid amplitudes (308 ±456 %) 
compared to controls (84 ±104 %; p = .012). This effect, however, was not significant due 
to the corrected alpha level. 
Discussion
The present study demonstrated that people post stroke had major difficulties avoiding 
obstacles while walking, particularly when there was little time to execute the stride 
adjustment. This reduced gait adaptability confirms earlier reports of obstacle avoidance 
problems in people with stroke.7 In addition, this study identified some of the underlying 
motor impairments that explain the frequently observed obstacle contacts. People with 
stroke demonstrated delayed and reduced EMG responses, smaller changes in hip and 
knee joint angles (compared to unperturbed walking) and smaller horizontal margins of 
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the foot to the obstacle. In contrast to the study of Den Otter and co-workers,55 we 
found no between-group differences concerning the avoidance strategies used. Hence, 
the decreased success rates in the participants with stroke were probably not related to 
the application of inappropriate avoidance strategies.
The SSS was predominantly applied in the most difficult trials (i.e. with short ARTs; Figure 
2.3b). The stride shortening was achieved by a quick deceleration of the forward swing 
of the avoiding leg such that the hip was flexed less and the knee at foot contact was 
flexed more than in normal gait. However, in the people with stroke, these changes in 
joint angles were less pronounced than in the controls. This was most likely due to their 
BF-avoid delayed onsets and decreased activation levels (both initial and late response 
amplitudes). As a result, they often failed to sufficiently shorten their stride and landed 
on the obstacle with the toes (Table 2.2). With respect to the lower-leg muscles, the 
controls presumably activated their GM-avoid early and at high amplitudes in 
preparation for weight bearing on the forefoot, as the stride shortening (with 
considerable knee flexion) often resulted in a forefoot landing at initial contact. In 
contrast, the people with stroke landed on the obstacle with their toes in most SSS-trials, 
with the knee almost as extended as in the control strides. The use of an AFO may have 
prevented them from using a strategy with ankle plantar flexion and knee flexion. These 
participants may have attempted to avoid the obstacle by activating TA-avoid to hold 
the forefoot above the obstacle, while keeping the heel on the treadmill surface. In this 
perspective, the larger TA-avoid amplitudes in the stroke group may be regarded as a 
compensatory strategy for the delayed and decreased activity of BF-avoid. Nevertheless, 
this compensation was unsuccessful in the vast majority of trials, which is probably due 
to insufficient strength of the TA muscle on the affected side. In addition, the AFO may 
have hampered ankle dorsiflexion beyond 90 degrees. 
With respect to the stance leg during SSS, between-group differences in EMG onsets 
and amplitudes were most pronounced in RF. The knee extensor moment generated by 
this muscle may contribute to the deceleration of walking.77 In SSS, deceleration of 
walking would save time to make the additional stride in front of the obstacle. Hence, 
the delayed RF-stance onsets and reduced amplitudes (both initial and late) in the 
stroke group may indicate that they decelerate walking less effectively than controls. 
Ground reaction forces, however, are needed to provide conclusive evidence on the 
consequences of the RF-stance deficits in the persons with stroke. 
The LSS was most frequently applied in the easier trials, with longer ARTs. In contrast to 
SSS, foot contact was postponed in LSS, and the foot was positioned after the obstacle. 
The increase in knee flexion angles that was observed during the obstacle crossing 
swing phase was less prominent in the participants with stroke than in the controls, 
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which is likely related to their decreased BF-avoid amplitudes. High TA-avoid response 
amplitudes in the participants with stroke might be interpreted as part of a flexion 
synergy. Synergistic leg flexion may have assisted foot clearance with respect to the 
obstacle, where selective knee flexion failed. Furthermore, in order to lengthen the 
crossing stride, additional extensor activity has to be provided by the stance leg. This is 
presumably reflected in the large late response amplitudes of BF-stance, generating 
large hip extension moments.77 In the participants with stroke, BF-stance response 
amplitudes tended to be smaller than in controls, which may have reduced trunk 
progression, which is in line with earlier reports.78 This may have contributed to 
decreased79 and often insufficient stride lengthening leading to more frequent landing 
of the heel on the rear end of the obstacle. 
In spite of the clear kinematic differences between LSS and SSS, the muscle activation 
sequence was similar for both strategies, with BF-avoid and RF-stance being activated 
first and at high amplitudes. This observation is in agreement with previous research 
reporting an early and a later class of responses in order to adjust an ongoing movement 
of the arm80 or leg.81 The early, automatic response was modifiable in size but not in 
direction, whereas the later response changed the direction of movement according to 
the subjects’ intention. In line with this reasoning, the initial responses in the current 
study may be interpreted as a fast, generic ‘safety’ response to the obstacle in order to 
retract the swing limb (BF-avoid) and slow down the ongoing hip extension of the 
stance limb (RF-stance). In contrast, the late muscle responses in the current study may 
be strategy-specific. 
In the present study, the people with stroke demonstrated delayed responses to the 
obstacle, particularly in those muscles that are considered to be the prime movers. 
Previous research has also reported delayed onsets of step adjustments in people with 
stroke in response to a displacement of the stepping target.58 It has been suggested that 
in healthy people these online step adjustments represent a special class of reflex-like 
responses that are faster than voluntary reactions66 and may, therefore, be under 
automatic rather than cognitive control.66, 81, 82 In this perspective, the delayed responses 
in the people with stroke suggest that they use different neural pathways for online 
step adjustments, which might involve cognitive control. This suggestion is supported 
by the observation that people with stroke needed disproportionate amounts of 
attention during obstacle crossing.83
In the control group, we observed similar early onset latencies for the left and right leg 
(i.e. BF-avoid and RF-stance). It suggests that the first, generic reaction to an obstacle 
involves bilateral coordinated responses, rather than independently organized unilateral 
responses. Particularly these primary responses were bilaterally delayed in the people 
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with stroke. This finding may explain why the capacity to avoid sudden obstacles seems 
to be affected in people with stroke irrespective of whether the paretic or the 
non-paretic leg is used as the lead limb.55 As a consequence, unilateral damage to the 
pathways involved in the avoidance response may necessitate people with stroke to 
resort to different (slower) neural circuits for the control of both legs. 
A limitation of this study is that all but one participant in the stroke group wore an AFO, 
which complicated the interpretation of the TA-avoid and GM-avoid activity. Future 
studies should evaluate the ankle kinematics in persons with stroke who are not 
dependent on the use of an orthosis. Second, all post-stroke participants in this study 
were community walkers, which limits the generalizability to persons with poorer gait 
capacity. Nevertheless, our conclusions are pertinent because online step adjustments 
are particularly important for community-dwelling subjects. Third, we did not have 
brain images of our participants to identify the exact location of the brain lesions. 
Such knowledge might have been informative with regard to the neural pathways 
involved in the step adjustments. Finally, the findings on RF-stance activity call for 
further research including measurement of ground reaction forces during online gait 
adjustments. 
Implications of the study
The current study explored the capacity of people with stroke to adapt an ongoing 
stride in response to a sudden obstacle. The results confirm previous research55 that, 
even in people who were only mildly affected by stroke, gait adaptability is reduced, 
most prominently under time pressure. Some of the underlying impairments seem to 
involve both delayed and reduced activity of the prime movers, which coincides with 
essential kinematic changes that explain why participants with stroke are less able to 
adequately adjust their stride length in response to a sudden obstacle. This reduced 
gait adaptability may place people with stroke at a high risk of falling. Gait adaptability 
may improve with time-critical obstacle training, e.g. on a treadmill with visual objects 
projected on the belt84 and, in post-stroke drop foot, with functional electrical 
stimulation.37 Future research is needed to evaluate whether such training translates to 
safer community ambulation. 
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Abstract
The objective of the present study was to examine the attentional demands of gait 
adaptations required to walk over irregular terrain in community-dwelling people with 
chronic stroke. Eight community ambulators (> 6 months post-stroke, aged 57 ±15 
years) and eight age-matched healthy controls participated in the study. As the primary 
motor task, participants walked on a treadmill while they quickly reacted to a sudden 
obstacle in front of the affected (in the stroke group) or left (in healthy controls) leg. The 
secondary, cognitive task was an auditory Stroop task. Outcomes were avoidance 
success rate and muscle reaction times of the biceps and rectus femoris (motor task), 
and a composite score of accuracy and verbal reaction time (cognitive task). Success 
rates did not differ between single- and dual-task conditions in either group, while 
muscle reaction times deteriorated equally during the dual task in both groups. 
However, compared with the Stroop scores just before and after obstacle crossing, the 
scores while crossing the obstacle deteriorated more in the stroke group than in the 
controls (p = .012). The higher dual-task costs on the Stroop task reflect greater 
attentional demands during walking and crossing obstacles. The absence of dual-task 
effects on obstacle avoidance performance suggests that the people with stroke used 
a “posture-first strategy”. The results imply that common daily life tasks such as obstacle 
crossing while walking require disproportionate attention even in well-recovered 
people with stroke. 
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Introduction
Following acute stroke, two out of three patients are unable to walk independently. 
Although approximately 66% of the patients that could not walk initially regain 
independent walking ability, a large number of people with chronic stroke continue to 
experience significant gait deficits.85 In general, gait deficits result in increased 
attentional demands in order to maintain stability and prevent stumbling or falling.86
Increased attentional demands of walking can have important consequences, as in daily 
life we frequently walk over irregular terrain, while simultaneously negotiating obstacles 
and having a conversation. The common way to assess the attentional demands of 
walking is to add a secondary cognitive task, and compare the performance between 
the single- and dual-task conditions.87 The assumption underlying these dual-task 
paradigms is that the attentional demands of the two tasks combined exceed the total 
attentional capacity,88 demonstrated by deteriorated performance on the primary or 
secondary task, or on both. Thus, larger decrements in motor and/or cognitive task 
performance reflect greater attentional demands. 
In elderly populations, larger dual-task interference in gait tasks is associated with an 
increased fall risk.89-91 In people with stroke, there is no conclusive evidence yet for 
increased attentional demands during (complex) walking compared to age-matched 
healthy controls.92-94 This is surprising since even well-recovered people with stroke 
often complain of the fact that walking over uneven terrain and in complex environments 
requires full attention in order not to fall. 
The absence of conclusive evidence for increased attentional demands of walking in 
people with stroke may be explained by the methods used. In all prior dual-task 
experiments, the gait task involved walking over even terrain, for instance an institution’s 
hallway. As these situations do not impose a serious threat to balance maintenance, the 
gait task may be too easy to simulate the challenges of daily life.95 Furthermore, in 
previous studies,94, 96, 97 the secondary cognitive tasks did not impose major temporal 
constraints on, for instance, the number of answers to be given within a specific time. 
As a result, participants may have shifted their attention between the tasks rather than 
paying attention to both tasks simultaneously. This strategy may have enabled them to 
operate within the limits of their attentional capacity and maintain adequate 
performance. Lastly, dual-task effects may have remained undetected because the 
performance on the secondary task was either left out of consideration, or was reported 
in terms of rather crude outcome measures (e.g. number of errors).92-94 To fully capture 
the dual-task interference, it is necessary to precisely measure dual-task costs on both 
the primary and secondary task. 
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In the present study, we aimed to objectify the attentional demands of gait adaptations 
required to negotiate irregular or cluttered terrain in people with stroke. To this aim we 
conducted a dual-task experiment in community ambulators able to walk independently 
over even and uneven surfaces. They had to avoid obstacles during walking while 
concurrently responding to a secondary, cognitive task. As the cognitive task we used the 
auditory Stroop paradigm, a time-critical task requiring continuous attention, which has 
previously been able to elicit dual-task costs even in healthy young adults.73 This 
methodology enabled us to substantially stress the attentional capacity and minimize the 
possibility to switch attention between tasks. We hypothesized that people with stroke 
would demonstrate greater dual-task costs during obstacle crossing than healthy subjects.
Methods 
Subjects
Eight community ambulators with chronic (> 6 months post-onset) stroke (five men, 
aged 57 ±15 years) and eight age- and sex-matched healthy controls (aged 54 ±15 years) 
participated in the experiment. More detailed characteristics of the stroke group are 
presented in Table 3.1. 
People with stroke were recruited from a larger sample that had previously participated 
in a study on the effect of transcutaneous peroneal stimulation.36 All subjects suffered 
from a drop foot and regularly used an ankle-foot orthosis. To be included, they had to 
be able to walk independently without walking aid for more than 10 minutes on all 
surfaces (Functional Ambulation Categories 547), and had to have a score ≥ 50 on the 
Berg Balance Scale.98 Exclusion criteria were a range of ankle motion < 30 degrees, 
inability to load the heel while standing with an extended knee, severe hypertonia of 
the calf (Modified Ashworth Scale scores 4 and 5) at the affected body side, or any 
impairment that could interfere with the ability to carry out the cognitive task, e.g. 
aphasia. The regional medical ethical committee approved the experimental protocol 
and all subjects gave their written informed consent.
Obstacle avoidance task
During the obstacle avoidance task participants walked on a treadmill while wearing 
their own comfortable low-heeled shoes, at a constant velocity of 2 or 3 km/h, dependent 
on the walking abilities of the stroke subjects.66 The velocity of healthy subjects was 
matched to the velocity of the stroke subjects. For safety reasons, all subjects wore a 
harness attached to a ceiling-mounted rail. A wooden obstacle (40 cm × 30 cm × 1.5 
cm) was placed under a bridge just above the treadmill in front of the affected (in the 
stroke group) or left (in controls) leg of the subjects (Figure 3.1B). 
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Three reflective markers were placed on the heel, the hallux and lateral malleolus of 
each foot. Using a 6-camera 3D motion analysis system (Vicon), movement of the feet 
was recorded (sample frequency 100 Hz). These signals were processed online in order 
to detect heel strikes. Based on this information, the computer triggered the obstacle to 
be released at different, pre-set phases of the step cycle. As a consequence, the instant 
of obstacle release was unexpected. Participants were instructed to cross the obstacle 
without touching it or placing the crossing foot beside the obstacle. Failures in obstacle 
crossing were noted and checked after the measurement using video recordings. 
Muscle activation of the biceps femoris of the crossing leg and the rectus femoris of the 
contralateral (supporting) leg were recorded, because the first responses to the obstacle 
are observed in these muscles.62, 63 Electromyography (EMG) electrodes were placed on 
the bellies of the muscles according to SENIAM guidelines (sample frequency 1000 Hz).99 
Auditory Stroop task
We chose the auditory Stroop task as the secondary, cognitive task.100 In this task, 
subjects listened to the words “high” or “low” spoken at a high or low pitch, presented 
through headphones (Sennheiser) with an interstimulus-interval of 2 s. Subjects were 
instructed to respond as fast as possible by verbally indicating the pitch of the stimulus. 
For instance, the word “high” was presented at a high (congruent, correct response is 
‘high’) or a low pitch (incongruent, correct response is ‘low’), which introduced two 
difficulty levels depending on congruency. 
Stroop stimulus signals were recorded at a sample frequency of 1000 Hz. Responses of 
the subjects were recorded by the microphone attached to the headphone at the same 
sample frequency (1000 Hz). Accuracy of the verbal responses was checked after the 
experiment using the video camera. 
Procedure
Each measurement started with 20 Stroop stimuli to practice the task. Subsequently, the 
subjects performed a series of 40 Stroop stimuli while seated (seated Stroop). Then, all 
subjects familiarized with treadmill walking followed by 1.5 minutes of unperturbed 
walking with a concurrent Stroop task (dual-task unperturbed walking). Subsequently, 
subjects performed five familiarization trials of the obstacle avoidance task. Thereafter, 
18 obstacle trials were collected without the Stroop task (single-task obstacle avoidance), 
and 18 trials while responding simultaneously to the Stroop task (dual-task obstacle 
avoidance). Participants were instructed to keep up the performance of both tasks during 
the dual-task conditions.
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Figure 3.1   Schematic illustration of the four dual-task conditions.
(A) Unperturbed walking: the subject responded to the Stroop stimuli while walking on the treadmill 
without an obstacle present. (B) Pre-obstacle trial: the obstacle was placed in front of the subject and was 
about to fall. The pre-obstacle response was the response to the last Stroop stimulus before the obstacle 
was released. (C) Obstacle crossing: release of the obstacle on the treadmill. The obstacle response was 
defined as the response to the first Stroop stimulus after obstacle release. (D) Post-obstacle trial: the 
subject has just crossed the obstacle. The post-obstacle Stroop response was the response to the second 
Stroop stimulus after obstacle release.
 A
B
C 
D
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To eliminate possible sequence effects, half of the group started the avoidance trials in 
the single-task condition, whereas the other half started the avoidance trials in the 
dual-task condition. 
Data analysis
Obstacle avoidance trials were analyzed with regard to the time available to respond to 
the obstacle.73 Trials in which the available reaction time was too short (< 150 ms) or too 
long (> 600 ms) were excluded for all further analyses. 
For each participant, avoidance success rates for the single- and dual-task conditions 
were calculated as the number of successful trials divided by the total number of trials. 
With regard to the EMG data, signals were band-pass filtered (4th order Butterworth, 20 
- 450 Hz), rectified and subsequently low-pass filtered at 25 Hz. Mean EMG activity 
during unperturbed walking was calculated for rectus and biceps femoris from the 
strides preceding the obstacle release (reference strides). Muscle onset latencies were 
defined as the instant at which the EMG signal of the crossing stride deviated more than 
two standard deviations from the reference strides. Onsets were detected for all trials 
(failed and successful trials) by a computer algorithm and confirmed by visual inspection.
The stimulus and response signals of the Stroop task were rectified and low-pass filtered 
at 40 Hz. Onsets of the stimuli and the responses were visually inspected. Verbal reaction 
times were calculated by subtracting the onset of the stimulus from the onset of the 
response. To account for a speed-accuracy trade-off,101 verbal reaction time and accuracy 
were combined in a composite score (Eq. 3.1) .102
Composite score = 
accuracy (%)
verbal reaction time (s)
 (3.1)
Statistical analysis
For each participant, 5 composite scores on the Stroop task were calculated. The first 
composite score was calculated as the mean score over the 40 responses during the 
seated Stroop task, and the second composite score as the mean over all responses during 
dual-task unperturbed walking (Figure 3.1A). The third to fifth Stroop composite scores 
were retrieved from the dual-task obstacle avoidance condition and were computed as 
the mean scores over 18 trials. The third composite score was obtained from the 
pre-obstacle response, defined as the response to the last Stroop stimulus before the 
obstacle was released (Figure 3.1B). The fourth composite score was computed for the 
obstacle crossing response, defined as the response to the first Stroop stimulus after 
obstacle release (Figure 3.1C). The fifth composite score was obtained from the response 
to the subsequent Stroop stimulus (i.e. post-obstacle response; Figure 3.1D). 
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The effect of the addition of a secondary cognitive task on the avoidance success rate 
was analyzed using a 2 x 2 (group x task) repeated measures (RM-)ANOVA. To evaluate 
the effect of dual tasking on BF and RF reaction times, we conducted a 2 × 2 × 2 (group 
× task × muscle) RM-ANOVA. The effects of dual tasking on the Stroop performance 
were tested in a 2 × 4 × 2 (group × response × congruency) RM-ANOVA. The four 
response conditions that were distinguished were unperturbed walking, pre-obstacle, 
obstacle crossing and post-obstacle trials. Post hoc analyses were used for pair-wise 
comparisons when significant main effects were found and simple contrasts when 
interaction effects were found. Finally, to test whether seated Stroop composite scores 
differed from Stroop scores during unperturbed walking, a 2 × 2 × 2 (group × task × 
congruency) RM-ANOVA was conducted. For all main analyses, significance was 
accepted at p < .05. For post hoc comparisons, significance was accepted at p < .01.
Results
Dual-task effects on obstacle avoidance
There was no significant interaction effect of group × task (F(1,14)
 
= 2.419, p = .142), nor a 
main effect of task on the avoidance success rate (F(1,14)
 
= 2.419, p = .142), indicating that 
the addition of the Stroop task did not lead to more failures in either of the two groups 
(Figure 3.2). Further, a significant main effect of group indicated that the stroke group 
was generally less successful (mean ± standard deviation = 53 ±33%) in avoiding 
obstacles than the healthy subjects (99 ±1%, F(1,14)
 
= 15.42, p = .002).
Regarding the onset latencies of the muscles, there was no significant interaction effect 
of group × task (F(1,14)
 
= 0.50, p = .490), indicating that in the dual-task condition the 
stroke group did not deteriorate more than the healthy subjects (Figure 3.3). A significant 
main effect of task (F(1,14)
 
= 16.79, p = .001) indicated that the addition of the Stroop task 
resulted in delayed muscle onsets (19 ms in biceps femoris and 21 ms in rectus femoris). 
Furthermore, there was a main effect of group (F(1,14)
 
= 8.19, p = .013, Figure 3.3) showing 
36 ms later onsets of biceps femoris and 26 ms later onsets of rectus femoris activity for 
subjects with stroke compared to healthy subjects. No significant main or interaction 
effects of the factor muscle were identified (all p ≥ .174).
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Dual-task effects on the cognitive task
There was a significant group × response condition interaction effect (F(3,14)
 
= 4.11, p = .012, 
Figure 3.4) on the Stroop composite scores. Post hoc analysis showed that this interaction 
was restricted to the comparison between pre-obstacle and obstacle crossing responses 
(F(1,14)
 
= 10.42, p = .006) and between obstacle crossing and post-obstacle responses 
(F(1,14)
 
= 11.75, p = .004). Subjects with stroke lost 35% on the obstacle crossing responses 
compared to the pre-obstacle responses, whereas controls lost 17%. 
Analysis of the seated Stroop performance compared to unperturbed walking did not 
yield a significant interaction effect of group × task (F(1,14)
 
= 0.363, p = .556), nor a 
significant main effect of group (F(1,14)
 
= 0.127, p = .727). There was a main effect of 
congruency (F(1,14)
 
= 27.04, p < .001), with lower composite scores for incongruent 
compared to congruent Stroop stimuli, but there were no significant interaction effects 
with congruency (all p ≥ .382).
Figure 3.2   Means and 95% CI of avoidance success rates of the stroke group 
(black triangles) and the healthy subjects (grey circles).
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Discussion
This study examined the effect of a secondary cognitive task on the ability to avoid 
obstacles while walking on a treadmill in well-recovered people with chronic stroke. 
Whereas the subjects with stroke were less successful than controls in negotiating 
obstacles, and although they demonstrated delayed muscle responses in both the 
crossing and supporting leg, the addition of the Stroop task did not affect their obstacle 
avoidance performance or muscle response times more than in controls. Yet, the stroke 
group showed considerably greater loss on the cognitive task performance during 
obstacle crossing.
These results indicate that the subjects with stroke prioritized the obstacle crossing task 
over the Stroop task, despite the instruction to keep up their performance of both tasks. 
This seems to be an appropriate choice, often referred to as the ‘posture first’ strategy.87 
In daily life, prioritizing balance over other (less essential) tasks is usually the safest 
Figure 3.3   Onset latencies (means and 95% CI) of biceps femoris of the crossing 
leg (left panel) and rectus femoris of the contralateral (supporting) leg 
(right panel) for the stroke group (black triangles) and healthy controls 
(grey circles) in both single- and dual-task conditions.
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option. The clinical relevance of the posture first strategy is illustrated by the findings by 
Siu et al103 who reported that older adults with a history of falling experienced difficulties 
with prioritizing gait in dual-task situations. 
Interestingly, like the control subjects, the subjects with stroke did not deteriorate their 
Stroop task performance during unperturbed walking, pre-obstacle and post-obstacle 
trials compared to sitting. This indicates the specificity of the observed dual-task 
interference, which is restricted to the very instant of obstacle crossing. Because the 
walking speed was fixed, participants could not apply a strategy of reducing their gait 
velocity to deal with the dual-task demands, which was the most consistent finding in 
previous studies.86 It may be that in dual-task walking at a preferred speed, changes in 
gait velocity reflect what people would naturally do opposed to what they are capable 
of. The presently applied paradigm with a fixed gait speed most likely forced participants 
to exploit their maximum capacity. Hence, the presence of dual-task effects on the 
Stroop task only during obstacle crossing suggests that well-recovered people with 
Figure 3.4   Composite scores (means with 95% CI) on the Stroop task for the 
stroke group (black triangles) and healthy controls (grey circles) for  
the five response conditions.
*Significant group × response interaction effects (p < .01).
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stroke may not have major difficulties walking over even terrain while being engaged in 
an attention-demanding secondary task, but that they do experience problems during 
dual-task walking over irregular terrain which requires gait adaptations.
The absence of increased dual-task effects on the motor task in people with stroke is in 
line with the results of Canning et al,92 who did not find differential dual-task effects on 
gait speed or stride length between a stroke group and healthy controls. On the other 
hand, Haggard et al93 demonstrated that people with stroke adjusted their stride time 
significantly more than healthy subjects when concurrently responding to a cognitive 
task. Hyndman et al94 also observed increased dual-task effects of stroke, however only 
on walking time, not on stride length. Possibly, the type of cognitive task used, and 
consequently the attentional demands of the task, can account for these inconsistent results. 
A limitation of our study was the homogeneity of the stroke sample, all community 
ambulators, which limits generalization to a more severely affected stroke population. 
Nevertheless, in this well-recovered stroke group, decrements in dual-task performance 
could be demonstrated for a task that simulates obstacle avoidance during complex 
walking conditions encountered in daily life. Such decrements may even be greater in 
people with more pronounced balance and gait deficits. This remains to be investigated 
in future studies. Another limitation was that the small sample size of our study could 
have resulted in false negative findings. However, the means of the groups were close 
together when not significant, not exceeding 5%. Still, if a larger sample size would have 
yielded significant differences between groups, their clinical relevance difference would 
be questionable. Finally, we did not assess the cognitive status of the participants as a 
possible confounder in dual tasking. More specifically (prefrontal) executive functions 
have been proposed to be involved in allocating attention to different tasks at the same 
time.86 Indeed, in people with Parkinson’s disease104 and in Alzheimer’s disease,105 
executive deficits are associated with decrements in dual-task performance. It seems 
unlikely, however, that our participants suffered from such executive deficits, because 
their performance on the Stroop task, a well-established measure of executive functioning, 
was as good as in the healthy controls both while sitting and unperturbed walking. 
Our results demonstrate that well-recovered people with stroke need a disproportion-
ate amount of attention while walking and negotiating obstacles as a common task in 
everyday life. Yet, the extra attentional costs could be elicited only during obstacle 
crossing as opposed to unperturbed walking and pre- and post-obstacle trials. It may 
be that this increased dual-task interference makes people with stroke vulnerable to 
situations in which their gait is challenged and concurrent tasks demand attention at 
the same time. Future studies are necessary to further substantiate this notion and to 
relate dual-task performance to fall risk after stroke. 
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Abstract
Objective: To quantify the capacity to restore steady gait after a step modification in 
persons post stroke. 
Methods: Twenty persons in the chronic phase (>6 months) after stroke (aged 54.1 ±11 
years) and 20 healthy control participants of similar age were included. Participants 
were instructed to avoid obstacles that were suddenly released in front of the paretic 
(stroke) or left leg (control) while walking on a treadmill. Outcomes were success rates 
of obstacle avoidance as well as post-crossing step length, step time, hip flexion angle 
at foot strike, and peak hip extension of the steps measured within 10 seconds following 
obstacle release. 
Results: Success rates of obstacle avoidance were lower for persons post stroke and their 
first post-crossing step length and time (i.e., the non-paretic step) deviated more from 
steady gait than those of controls (i.e., the right step), with lower values for persons post 
stroke. These differences in step parameters were accompanied by changes in the 
magnitude of hip flexion angles at foot strike and peak hip extension excursions. 
Conclusions: Persons post stroke have reduced gait adaptability, as evidenced by lower 
success rates of obstacle avoidance as well as by an impaired capacity to restore steady 
gait after crossing an obstacle. The latter finding unveils the difficulty that persons post 
stroke have in incorporating step modifications in an ongoing gait. This is attributed to 
an asymmetry in propulsion generating capacity between paretic and non-paretic legs 
and to the induced postural imbalance after crossing the obstacle during single-support 
on the paretic leg.
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Introduction
Walking is a context-specific activity involving instant gait adjustments to a continually 
changing environment. Gait adjustments are essential when walking on uneven or 
cluttered terrain to secure adequate foot placement to local environmental features, like 
obstacles.106, 107 The capacity to modify gait to the environment is related to fall risk54 as 
most falls occur due to trips, slips, or misplaced steps.108 We use this capacity synonym 
to ‘gait adaptability’.
People in the chronic phase after stroke are at elevated risk of falling50-53 and even in 
well-recovered community-dwelling individuals fall rates are high, which may be 
attributed to impaired gait adaptability.55, 56, 59, 60, 109 For example, den Otter and 
colleagues55 found that persons post stroke were less successful in avoiding obstacles 
on short notice than healthy controls. Interestingly, the avoidance maneuver induced 
larger disturbances in the locomotor rhythm in severely affected persons post stroke 
than in controls and persons who were only mildly affected. While in controls and mildly 
affected persons the length and time of the post-crossing stride were almost instanta-
neously restored to steady gait values, this was clearly not the case for the severely 
affected persons, suggesting that the number of steps required to settle into steady gait 
after a step modification was considerably larger. Unfortunately, we do not know how 
much larger, because only a single post-crossing stride was analyzed.55 
These results expand our insight into gait adaptability in persons post stroke: not only is 
their capacity to avoid obstacles diminished, but ostensibly also their capacity to restore 
steady gait after crossing obstacles. A slower restoration of coordination after a 
perturbation reflects reduced coordinative stability110, 111 and reduced gait adaptability.59, 
60, 109 So far, however, the number of studies focusing on the restoration of steady gait 
remains quite limited providing evidence for an impaired59, 60 as well as non-impaired55 
capacity to restore gait after a step modification. In the current study we examine the 
capacity of persons post stroke to restore steady gait after a step modification induced 
by obstacle crossing. To this end, twenty persons after stroke and twenty paired healthy 
controls of similar age were instructed to avoid an obstacle that was dropped 
unexpectedly in front of one foot while walking on a treadmill. We compared success 
rates of obstacle avoidance and the capacity to re-establish steady gait during the 
post-crossing steps between stroke and control groups. In line with previous studies,55, 
56 we expected lower success rates in persons post stroke than in controls. Given 
reduced propulsion-generating capacity and postural stability when standing on their 
paretic leg,112, 113 we further expected a diminished capacity to restore steady gait in 
persons post stroke, reflected in more persistent deviations in post-crossing step length, 
step time, and hip kinematics.
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Methods
Participants
For the experimental group, twenty community walkers were invited (Functional 
Ambulation Categories47 5) in the chronic phase (at least six months) after stroke. 
Participants had to be able to walk comfortably on the treadmill without handrail support at 
2 km/h or faster. The following clinical characteristics were scored at inclusion: balance 
(Berg Balance Scale71), lower-extremity muscle strength (Motricity Index69) and lower- 
extremity motor selectivity (Fugl-Meyer Assessment70). For the control group we invited 
twenty healthy participants of similar age without gait limitations. The study protocol 
was approved by the medical ethics committee of the Arnhem-Nijmegen region. 
Participants gave their written informed consent before participating in the study.
Experimental setup and procedure 
The persons post stroke walked on a treadmill at 2 or 3 km/h, whichever was closest to 
their preferred treadmill walking speed; controls walked at the same speed (2 or 3 km/h) 
as the paired post-stroke person of similar age. All participants wore their own daily 
shoes and a safety harness to prevent them from falling. An electromagnet held an 
obstacle (length, width and height: 40 × 30 × 1.5 cm, respectively) to a bar at the front 
side of the treadmill just above the treadmill belt72, 73 (Figure 4.1a). 
We synchronously recorded bilateral sagittal hip excursions with goniometers (Biometrics 
SG150 and SG110/A, Biometrics Ltd, Ladysmith; VA 22501, USA) at a sampling rate of 1000 
Hz, and the positions of reflective markers attached to each foot and to the front edge of 
the obstacle with a 6-camera 3D motion analysis system (Vicon Motion Systems; Vicon-UK, 
Oxford, United Kingdom) at a sampling rate of 100 Hz.37, 64 Marker position recordings were 
processed online using custom-made software allowing for obstacle release between 
mid-stance and mid-swing of the paretic leg of post-stroke participants and the left leg of 
controls.37, 64, 73 The timing of release was randomly distributed over trials and uniformly 
across participants. The obstacle was always released in front of the paretic leg of 
post-stroke participants and the left leg of controls. Participants were instructed to 
maintain a distance of about 10 cm from the foot to the (unreleased) obstacle at the 
moment of foot strike (Figure 4.1a) and to avoid the obstacle when released without 
stepping aside with the paretic (or left) leg, whereas the other foot could be placed freely. 
Participants could thus apply one of two different strategies:75 1) shortening of the 
ongoing paretic/left stride to make an additional step in front of the obstacle before 
crossing it (short step strategy; SSS) or 2) lengthening of the ongoing paretic/left stride to 
directly cross the obstacle (long step strategy; LSS; see Figure 4.1b). It has been reported 
that the strategy choice strongly depends on the timing of obstacle release.75, 76 By 
experimentally manipulating this timing, we intended to elicit both SSS and LSS responses.
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Figure 4.1   Schematic diagram of (a) the experimental setup and (b) the definition 
of steps and strides in each of the avoiding strategies (short step 
strategy, SSS; long step strategy, LSS). A step is defined by the foot 
contact of one leg and the preceding foot contact of the contralateral 
leg, whereas a stride is defined by the foot contact of one leg and the 
preceding foot contact of the same leg.
SSSstep 1step 3
step 2
stride 1 
stride 2
stride 3
crossing stridestride 4 short step
step 1step 3
step 2
stride 1
stride 2
stride 3
 
crossing stridestride 4
LSSnon-paretic 
(or right) foot
non-paretic 
(or right) foot
paretic 
(or left) foot
paretic 
(or left) foot
crossing step
crossing step
b
a
visco-elastic brake ceiling-mounted rail
camera
safety harness
treadmill
computer-triggered
electromagnet
obstacle
markers
10 cm
62
CHAPTER 4
At the beginning of the session, the participants got ample time to familiarize to 
unsupported treadmill walking (at least 5 minutes). Then, a so-called unperturbed 
walking trial was performed during which participants’ normal gait pattern was 
registered for two minutes. Subsequently, participants performed five obstacle-cross-
ing trials to get familiarized with obstacle negotiation, followed by thirty experimental 
obstacle-crossing trials. Recordings started when the obstacle was attached to the 
magnet and stopped 10 seconds following obstacle release. 
Data processing 
For each trial, it was determined whether the obstacle was avoided successfully. Contact 
of the foot with the obstacle or paretic/left steps beside the obstacle was classified as 
failure.37 Mean success rates were quantified, stratified for LSS and SSS. 
Steps and strides were defined on the basis of foot strike instances (Figure 4.1b), derived 
from foot marker positions in the vertical and sagittal planes. Step lengths (length) and 
step durations (duration) were obtained from the sagittal marker positions, after 
transformation to a reference frame moving with the belt.114 Bilateral hip angles were 
low-pass filtered (4th order, bi-directional Butterworth at 10 Hz) and time-normalized to 
the stride. Hip flexion angle at foot strike (at start of the stride; hipfl) and maximum hip 
extension (hipext) angle were computed for each leg at every stride. From the 
unperturbed trial, step duration, step length, hip flexion, and hip extension (length
unper
, 
duration
unper
, hipfl
unper
 and hipext
unper
, respectively) were averaged over 30 strides, starting 
at stride 50. We included both unsuccessful and successful trials as long as a step 
modification was involved in the crossing maneuver (i.e., we only excluded trials if the 
crossing stride length remained within the control stride length ±1.96 ∙ SD, totaling 10.5 
±5.2 and 4.9 ±4.8 trials for post-stroke persons and controls, respectively). From each 
trial, length(n)
,
 duration(n), hipfl(n), and hipext(n) were computed for all n post-crossing 
steps (for length and duration) and strides (for hipfl, hipext). Specifically, step (stride) n=1 
was defined as the first step (stride) with the non-paretic/right leg after obstacle 
crossing (see Figure 4.1b). Subsequent steps (strides) were with alternating legs. Thus, 
odd step (stride) numbers refer to steps (strides) with the non-paretic/right leg, while 
even numbers refer to steps (strides) with the paretic/left leg. 
Subsequently, all post-crossing variables X(n) were normalized to their unperturbed 
counterparts X
unper
, according to X*(n) = 100 ∙ X(n)/X
unper
[%], where X(n) represents each of 
the variables of interest of the obstacle-crossing trials (i.e., length(n), duration(n), hipfl(n), 
and hipext(n)) while X
unper
 represents their averaged counterparts of the unperturbed 
trial (i.e., length
unper
, duration
unper
, hipfl
unper
 and hipext
unper
). These data were then stratified 
depending on the employed obstacle-crossing strategy (i.e., either SSS or LSS) for each 
trial per participant. 
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Statistical analyses 
For each X*(n) series, a two-way repeated-measures analyses of variance (ANOVA) with 
Group as a between-subjects factor (two levels: persons post stroke and healthy 
controls) and Step (Stride) as a within-subjects factor (n=11 levels; at least n=11 
post-crossing steps (strides) were available for all participants) was conducted, separately 
for SSS and LSS. The alpha-level in the ANOVAs was set to 0.025 to correct for dual 
testing of dependent variables (i.e., separately for SSS and LSS). If sphericity was violated, 
Greenhouse-Geisser correction was applied (adjusted degrees of freedom are reported). 
Effect sizes are reported as η
p
2. For significant Step(Stride) by Group interactions, 11 post 
hoc two-tailed independent-samples t-tests with Bonferroni correction were conducted. 
For significant main effects of Step(Stride), post hoc contrast tests were performed. 
Results
Participants
Table 4.1 lists group characteristics. Nineteen post-stroke participants used an ankle-foot 
orthosis for a stroke-related drop foot. They had relatively mild balance problems and 
demonstrated mild to moderate paresis of the affected leg (Table 4.1). In one patient a 
trip occurred and this trial was excluded from further analysis. On average, 25.1 ±4.8 and 
19.5 ±5.2 trials were included for controls and post-stroke persons, respectively. Four 
participants (three persons post stroke and one control) showed a strong preference for 
LSS, regardless of variations in the timing of obstacle release. Because these participants 
did not apply SSS in any of the trials, the statistical analyses of SSS were performed for 
17 persons post stroke and 19 controls. Mean ± standard deviation success rates were 
64.2 ±25.7% and 29.1 ±34.4% in the stroke group and 98.2 ±4.0% and 97.7 ±6.3% in the 
controls for LSS and SSS, respectively (p-values < .001 for group differences). 
Normalized step length (length*) and step duration (duration*)
In general, the first post-crossing step length and step duration deviated more from 
steady gait in persons post stroke (i.e., the non-paretic step) than in controls (i.e., the 
right step; Figure 4.2). For LSS, this observation was confirmed by significant Group × 
Step interactions for duration* and length* (F(3.05,115.96) = 24.39, p < .001, η
p
2 = .39 and 
F(1.97,74.71) = 10.50, p < .001, η
p
2 = .22, respectively). Post hoc t-tests revealed 13.9% and 
21.5% lower values in persons post stroke compared to controls for n=1, for duration* 
and length*, respectively (t(38) = 5.89, p < .001 and t(38) = 3.75, p = .001). For duration* the 
same held for n=3 (t(38) = 3.87, p < .001). For SSS, significant Group × Step interactions 
were only observed for duration* (F(3.57,121.35) = 29.28, p < .001, η
p
2 =.46), with 8.3% and 
4.4% lower values for n=1 and n=3, respectively, for persons post stroke compared to 
controls (t(34) = 6.60, p < .001 and t(34) = 3.51, p = .001). For length* in SSS, the Group × 
Step interaction tended towards significance (F(2.43,82.55) = 3.07, p = .04, η
p
2 = .08).
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Table 4.I  Characteristics of the participants
Stroke
(n=20)
Control
(n=20)
p-value
Mean age, years (SD) 53.9 (11.0) 54.6 (12.0) .837
Sex, male/female, n 15/5 17/3 .435
Mean body weight, kg (SD) 81.33 (16.9) 77.9 (12.1) .460
Mean body height, m (SD) 1.74 (0.09) 1.77 (0.07) .299
Median lower extremity Motricity Index, % (range)a 64 (27-77) -
Median lower extremity FMA, % (range)a 66 (21-86) -
Median Berg Balance Scale (range)b 52.5 (41-55) -
Mean step length, cm (SD)c
Paretic/left leg 40.4 (3.8) 45.8 (5.7) .001
Non-paretic/right leg 35.4 (4.7) 44.3 (4.7) < .001
Mean step time, s (SD)c
Paretic/left leg 0.73 (0.10) 0.79 (0.09) .055
Non-paretic/right leg 0.63 (0.07) 0.79 (0.09) < .001
Mean hip flexion angle at foot strike, deg (SD) c
Paretic/left leg 7.5 (2.8) 10.2 (1.8) .001
Non-paretic/right leg 10.5 (2.9) 10.4 (2.5) .954
Mean peak hip extension angle, deg (SD) c
Paretic/left leg 10.8 (3.3) 15.5 (3.4) < .001
Non-paretic/right leg 14.2 (3.4) 15.6 (3.5) .187
Mean obstacle avoidance success rate, % (SD)
LSS 64.2 (25.7) 98.2 (4.0) < .001
SSS 29.1 (34.4) 97.7 (6.3) < .001
Mean number of trials in analysis per participant, n (SD)
LSS 13.4 (5.7) 14.1 (5.3)  .668
SSS 6.1 (4.9) 11.0 (5.8)  .006
Self selected walking speed overground, m/s (SD) 1.0 (0.2) 1.4 (0.1) < .001
a Scores of the paretic leg; b Range of the Berg Balance Scale: 0-56; c Outcomes that were computed from 
step (stride) 50-80 of a trial of unperturbed treadmill walking. 
P-values < .05 indicate significant between-group differences. 
LSS: long step strategy; SSS: short step strategy.
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Normalized hip flexion (hipfl*) and hip extension (hipext*) excursions 
Average kinematic profiles for the groups are provided in Figure 4.3. Figure 4.4 shows 
that hipfl* and hipext* deviated from unperturbed gait, in particular for n=2 (i.e., the first 
stride with the paretic/left leg; Figure 4.1b). For hipfl*, this was not different between the 
groups; for hipext* the deviation was greater in persons post stroke than in controls. 
 
Specifically for LSS, a significant main effect of Stride was observed for hipfl* (F(2.53,95.93) 
= 39.49, p < .001, η
p
2 = .51) and a significant Group × Stride interaction was observed for 
hipext* (F(3.20,121.51) = 10.91, p < .001, η
p
2 = .22). Post hoc tests revealed that hipfl* was 
significantly larger for n=2 than for all other strides (F(1,38) = 81.77, p < .001, η
p
2 = .68). 
Hipext* for n=2 was 41.8% smaller in persons post stroke than in controls (t(38) = 4.24, 
p < .001). 
Figure 4.2   Mean normalized step lengths and step times for the crossing step 
(i.e., step n=0) and 11 subsequent post-crossing steps for LSS and SSS.
Values were normalized to unperturbed counterparts. Significant differences between groups for a given 
step n are indicated with asterisks. Note that even steps were with the paretic/left leg, whereas odd steps 
were with the non-paretic/right leg (see Figure 4.1). Post-crossing steps (i.e., n ≥ 1) were included in the 
statistical analysis.
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For SSS, a similar pattern of results was found for hipfl* (main effect of Stride: F(3.31,112.37) = 
9.65, p < .001, η
p
2 = .22), with overall larger values for n=2 (F(1,34) = 19.55, p < .001, η
p
2 = .37). 
The Group × Stride interaction for hipext* was absent (F(2.73,92.83) = 1.08, p = .36, η
p
2 = .03).
 
Figure 4.3   Time normalized hip angle courses of the paretic leg (stroke group; 
grey lines) or left leg (control group; black lines), averaged over all 
participants within the groups.
The crossing stride and 2 subsequent strides are depicted for the short step strategy (SSS; upper panel) 
and long step strategy (LSS; lower panel). Unperturbed reference joint angle courses are given with dotted 
lines. Note that the crossing stride and strides 2 and 4 are subsequent strides that started with the paretic/
left leg. The non-paretic/right leg is not depicted. Time instants of paretic/left foot strike (fs) are indicated 
with vertical dashed lines. Instants of hip flexion at the start of stride 2 and peak hip extension during 
stride 2 are indicated with arrows.
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Discussion
The goal of this study was to investigate gait adaptability of persons post stroke using a 
treadmill-based obstacle-avoidance paradigm with time-critical obstacle presentations 
to elicit step modifications. Notwithstanding the observation that persons post stroke 
were able to adjust gait to a certain extent, their gait adaptability was strongly reduced 
compared to controls. First, persons post stroke demonstrated lower obstacle avoidance 
success rates (Table 4.1), particularly in SSS, which is considered the favorable strategy 
for the more difficult obstacle presentations (i.e., late in the gait cycle). In these 
time-critical situations, persons post stroke were more often unable to shorten the 
Figure 4.4   Mean normalized hip flexion angle at foot strike (hipfl*) and peak hip 
extension excursion (hipext*) for the crossing stride (i.e., stride n=0) 
and 11 subsequent strides for LSS and SSS.
Values were normalized to unperturbed counterparts. Significant differences between groups for a given 
stride n are indicated with asterisks. Note that even strides were started with the paretic/left leg, whereas 
odd strides were started with the non-paretic/right leg (see Figure 4.1). Post-crossing strides (i.e., n ≥ 1) 
were included in the statistical analysis.
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ongoing stride, resulting in obstacle contacts with the toe. Failures in LSS were mostly 
due to insufficient lengthening of the stride resulting in obstacle contacts with the 
heel.115 Second, post-stroke persons required more post-crossing steps to return to 
steady gait. Post-crossing group differences were most pronounced for the LSS obstacle 
crossing strategy because of the larger crossing step involved (length*(0); Figure 4.2). 
Whereas the first post-crossing step in controls already largely matched unperturbed 
gait (length*(1) and duration*(1) close to 100%; see Figure 4.2), the first post-crossing step 
in persons post stroke was shorter in length and duration, even in individuals with 
relatively preserved balance capacities according to clinical evaluation. These findings 
largely corroborate earlier work of den Otter and colleagues,55 who reported an impaired 
restoration of walking cadence in the first post-crossing stride in those who were 
severely affected by stroke. However, their mildly affected participants did not display 
restoration difficulties after a step modification, even though their clinical scores were 
comparable with the present study (e.g., their Brunnstrom stages 5-6 match fairly well 
with our average Fugl-Meyer Score of 66%). This discrepancy between studies may be 
explained by the use of handrail support during treadmill walking, which was prohibited 
in the current study but allowed by den Otter and colleagues.55 Handrail support may 
have facilitated the return to steady gait after a step modification. 
For the first post-crossing step, the non-paretic step length of persons post stroke was 
shortened to a greater extent than the right control step of the healthy controls (LSS, 
length*(1); Figure 4.2). Moreover, the non-paretic step durations were shorter for persons 
post stroke up to the third post-crossing step (LSS and SSS, duration*(1) and duration*(3); 
Figure 4.2). We propose two explanations for these group differences in post-crossing 
step parameters: (1) an asymmetry in propulsion generating capacity between sides in 
persons post stroke, and (2) a reduction of postural stability during single-support on 
the paretic leg in persons post stroke.
We start with the former explanation by addressing concomitant changes in post- 
crossing hip kinematics (Figure 4.4). The increased hip flexion angles in both groups at 
the start of the first post-crossing stride with the paretic (left) leg (n=2) roughly reflect 
how far the foot is placed in front of the trunk at foot strike behind the obstacle, most 
compellingly so for LSS (Figure 4.4). The increased forward foot placement relative to 
the trunk strongly reduces the forward momentum over the leading paretic leg (i.e., in 
the subsequent paretic stance phase). Both legs have hence to deliver more mechanical 
work to progress the trunk over the paretic stance limb.55, 79 Given the asymmetry in 
propulsion generating capacity between body sides in persons post stroke,112 in 
particular the weaker paretic leg may be unable to generate the relatively increased 
propulsion required to progress the trunk forward to maintain speed.79 Thus, the trunk 
does not displace far enough forward over the supporting foot during paretic 
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single-limb support with consequently, smaller peak hip extension excursions of the 
paretic leg (LSS, hipext*(2); Figure 4.4) and smaller first post-crossing non-paretic step 
lengths (LSS, length*(1); Figure 4.2) for persons post stroke than for controls.
Besides asymmetric propulsion generating capacity, persons post stroke also show 
postural-stability related asymmetries in stance and swing durations,113 with shorter 
non-paretic than paretic step durations (Table 4.1). Post-crossing non-paretic step 
durations were shortened to an even greater extent, as evidenced by significantly lower 
duration* values for n=1 and n=3 for both LSS and SSS (Figure 4.2), suggesting that 
persons post stroke shorten paretic single-support stance duration during the first 
post-crossing steps. We note that for both groups and for both crossing strategies, the 
crossing step was larger than the step lengths observed for unperturbed gait (i.e., 
length*(0) > 100%; Figure 4.2), thereby challenging balance after landing. This may be 
particularly harmful for persons post stroke, as the weaker paretic leg manifests 
post-obstacle landing. Persons post stroke functionally adjusted their gait to this 
challenging situation by adopting shorter non-paretic step duration, thereby reducing 
paretic single-support stance duration.
We conclude that persons post stroke have an impaired gait adaptability compared to 
controls walking at the same gait speed. This is evidenced by a reduced capacity to 
cross obstacles (see Table 4.1) as well as by a reduced capacity to restore steady gait 
after a step modification. We attributed the latter finding to a reduced propulsion 
generating capacity with the paretic leg relative to the non-paretic leg as well as to 
postural imbalance during single-support on the paretic leg. 
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Abstract
Objective: The aim of this study was to evaluate whether community-dwelling chronic 
stroke patients wearing an ankle-foot orthosis would benefit from changing to 
functional electrical stimulation of the peroneal nerve.
Methods: In 26 community-dwelling chronic (> 6 months post-onset) patients after 
stroke, their ankle-foot orthosis was replaced by a surface-based functional electrical 
stimulation device (NESS L300®). Comfortable walking speed over 10 meter was 
measured at baseline with the ankle-foot orthosis and after 2 and 8 weeks with both 
ankle-foot orthosis and functional electrical stimulation. The level of physical activity 
was assessed with a pedometer, and patients’ satisfaction was assessed with a 
questionnaire at baseline and at week 8 regarding ankle-foot orthosis and functional 
electrical stimulation, respectively. 
Results: Ankle-foot orthosis and functional electrical stimulation were equally effective 
with regard to walking speed and activity level. The participants were more satisfied 
with functional electrical stimulation than with their ankle-foot orthosis regarding the 
effort and stability of walking, quality of the gait pattern, walking distance, comfort of 
wearing and appearance of the device. 
Conclusion: The patients judged functional electrical stimulation superior to their 
ankle-foot orthosis, but measurements of walking speed and physical activity could not 
objectify the experienced benefits of functional electrical stimulation. Other outcome 
measures focusing on the stability and effort of ambulation may objectify the perceived 
benefits of functional electrical stimulation in community-dwelling chronic stroke 
patients.
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Introduction
The standard of care for stroke patients with a paresis of the ankle dorsiflexor muscles (a 
so-called drop foot) is the prescription of an ankle-foot orthosis (AFO). Although an AFO 
provides a stable support of the ankle joint, its disadvantage is that it limits normal ankle 
mobility and reduces the adjustments of the foot and ankle to the walking surface.
Functional electrical stimulation (FES) of the peroneal nerve is an alternative to an AFO. 
Muscles that dorsiflex and evert the ankle are activated during the swing phase of gait. 
As early as 1961, Liberson et al5 reported the use of peroneal FES, but, for a long time 
afterwards, its use in clinical settings was limited due to technical and ergonomic 
problems. With recent technological advances, a renewed interest has grown in the 
application of peroneal FES in patients with stroke. The question now arises as to whether, 
in clinical practice, peroneal FES is beneficial to patients who regularly use an AFO.
To justify the replacement of an AFO, FES should be at least as effective as an AFO. There 
is convincing evidence for beneficial effects of FES on the gait speed in stroke patients 
with a drop foot.7, 8, 25, 27, 30, 35, 116 However, most of these studies investigated the effects of 
FES compared with walking without any ankle device, whereas stroke patients with a 
drop foot are usually provided with an AFO or raised orthopaedic footwear. 
The number of studies comparing FES with an AFO is limited and the results are not 
conclusive as to whether FES has additional value over an AFO with regard to walking 
speed.25, 32, 38, 40, 117 Two studies found positive effects,25, 38 but in one of these studies, FES 
was not strictly compared with an AFO, as a number of patients used orthopaedic 
footwear or no device at all.25 In the other study, not only stroke patients, but also 
patients with other central neurological diseases were included.38 Furthermore, both 
Kottink et al25 and Waters et al38 investigated the effects of an implanted FES device. 
Such studies typically select patients who have responded well to transcutaneous 
stimulation. As a result, these studies suffer from selection bias concerning the question 
as to whether peroneal FES should generally be preferred over an AFO in chronic 
patients after stroke. 
A second consideration in interpreting the literature on FES concerns the outcome 
measures. The effects of FES are usually expressed in terms of walking speed. Indeed, in 
the evaluation of gait, walking speed is a valuable outcome measure, in which many 
other gait parameters are captured.47, 48 Another measure that has been used is the level 
of daily physical activity, but the results with regard to the effects of FES are inconclusive.25, 
118 There may be other outcomes, such as patients’ preference and satisfaction, which 
are relevant in the clinical decision as to whether to replace an AFO with peroneal FES.119 
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Although some investigators have already described that patients were generally 
satisfied about a peroneal FES device,7, 9, 118, 120 this has never been contrasted with AFO use. 
Hence, the aim of this study was to determine whether patients with chronic stroke 
who regularly use an AFO would benefit from changing to transcutaneous peroneal 
FES. In a within-subjects design, we compared a transcutaneous FES device with a 
custom-made AFO with regard to walking speed, activity level, and patients’ satisfaction. 
We included community walkers only, because these patients are most likely to benefit 
from, and make extensive use of, the FES device in daily life. 
Methods
Participants
Twenty-six patients with chronic stroke who were referred to an academic hospital 
participated in this study. All patients suffered from a drop foot due to a stroke at least 6 
months prior to recruitment. As an inclusion criterion, they had to regularly use a 
(polypropylene) AFO, with which they did not experience any problems. An additional 
inclusion criterion was independent walking ability without a walking aid for more than 
10 min. Exclusion criteria related to the paretic body side were: a passive range of ankle 
motion less than 30 degrees, inability to load the heel while standing with an extended 
knee, severe hypertonia of the calf (Modified Ashworth Scale scores 4 and 5), inability to 
stimulate the superficial or deep peroneal nerves, and skin lesions at the electrode sites. 
Other exclusion criteria were: pregnancy, psychological disorders (depression or 
psychosis), and a demand-type pacemaker. The study protocol was approved by the 
medical ethics committee of the Arnhem-Nijmegen region. Participants gave their 
written informed consent before participation in the study.
Protocol and outcome measures
At inclusion, clinical assessments were conducted with regard to gait (Functional 
Ambulation Categories47), balance (Berg Balance Scale98), lower extremity hypertonia 
(Modified Ashworth Scale121), muscle strength (Motricity Index47), and motor selectivity 
(Fugl-Meyer Assessment122). Furthermore, sensation of the lower limb was evaluated by 
means of the Quantitative Vibration Threshold.123 Vibration was administered at the 
lateral malleolus and the first metatarsophalangeal joint of the paretic leg with a semi-
quantitative tuning fork (Rydel Seiffer, Neurologicals®, Arno Barthelmes & Co, GmbH, 
Tuttingen, Germany). The lowest level of vibration that was perceived by the patient 
was recorded. 
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At baseline (t
0
), comfortable walking speed with the AFO was assessed (Figure 5.1). The 
participants performed 8 walking trials on a wooden walkway. Length, width and height 
of the walkway were 10, 1.25 and 0.15 m, respectively. Mean speed for each participant 
was computed over the 8 trials. In the same session, the FES device (NESS L300®) was 
adjusted to the patient. The NESS L300® is a transcutaneous, 2-channel system, 
stimulating the peroneal nerve and the anterior tibial muscle (pulse rate 30 Hz; phase 
duration 200 ms). A 2-week period of adaptation to this device followed, in which the 
participant increased the use of FES up to 6 h a day. After the 2-week adaptation period 
(t
1
), the comfortable walking speed was assessed both with the AFO and with the FES 
device. Subsequently, in weeks 3 to 8 of the study protocol, the patients followed a 
schedule to increase the daily use of FES to ’whole day long‘ , although they were still 
required to use the AFO for 1 h a day (in order not to ’unlearn’ how to walk with the AFO). 
At week 8 of the study (t
2
), comfortable walking speed was assessed again with the AFO 
and with FES. 
In the week preceding the baseline gait assessment (t
0
), the patient completed a 
questionnaire assessing the individual use of, and satisfaction with, the AFO. To this aim, 
a purpose-designed questionnaire was used, consisting of 9 aspects regarding the 
orthosis, which had to be evaluated on a 5-point scale (from very unsatisfied to very 
Figure 5.1   Time line of the study, indicating the assessments of patients’ 
satisfaction, physical activity and walking speed at baseline (t
0
),  
at week 2 (t
1
) and at the final week of the study period (t
2
).  
AFO: ankle-foot orthosis; FES: functional electrical stimulation.
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satisfied). The questionnaire was completed at home with no input from either the 
researchers or the clinicians involved with the study. During the same week, the patient 
also monitored his or her level of physical activity. The number of steps taken per day 
was counted by means of a pedometer (Yamax Digiwalker SW-650, Yamax USA, Inc, San 
Antonio, USA) and averaged over 7 days. 
In the final week of the study period (t
2
), the patient completed the same questionnaire 
assessing the individual use of and satisfaction with the NESS L300®. During this week, 
the patient again monitored his or her level of physical activity, but now with FES, in 
order to complete the second assessment. 
Statistical analysis
An analysis of variance (ANOVA) with repeated-measures was performed to compare 
walking speed between FES and AFO. Device (2 levels, AFO and FES) and time (2 levels, 
t
1
 and t
2
) were used as within-subjects factors. Differences in the number of steps taken 
per day between the AFO and FES were tested with a paired t-test. For each of the items 
of the questionnaire, a non-parametric test for 2 related samples was conducted to 
identify differences in satisfaction between the AFO and FES. The alpha level was set 
at .05.
Results 
Participants
The characteristics of the patients are shown in Table 5.1. All patients had a Functional 
Ambulation Categories score of 5 (independent ability to walk over uneven terrain) and 
were used to walking with an AFO. The AFO was a custom-made polypropylene brace, 
which limited plantar flexion but allowed dorsiflexion mobility at the ankle in all patients 
except for 2 patients, who wore an AFO merely providing an external dorsiflexion 
moment about the ankle. Two patients dropped out of the study. Reasons for drop-out 
were discomfort from the electrical stimulation (n=1) and allergic skin reaction at the 
electrode sites (n=1). 
Walking speed
Walking speed was not different between the AFO and FES (mean ± standard deviation 
= 1.00 ±0.05 m/s and 1.02 ±0.05 m/s for AFO; 0.98 ±0.05 m/s and 1.03 ±0.05 m/s for FES, 
at t
1
 and t
2
, respectively) as indicated by the absence of a significant main effect of 
device (F(1,23) = 0.068; p = .796) or time × device interaction effect (F(1,23) = 1.049; p = 
.316). A significant main effect of time indicated that walking speed at t
2 
was, on average, 
0.04 m/s higher than at t
1 
(F(1,23) = 6.30; p = .02) 
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Physical activity level
There was no significant difference in the number of steps per day between the AFO 
and FES (with 5541 ±2900 and 5733 ±2516 steps, respectively; t(23) = 0.609; p = .548). 
Satisfaction
Table 5.2 summarizes the patients’ satisfaction with the AFO at baseline and with FES at 
the end of the study. The participants experienced benefits of FES over their conventional 
walking device with regard to comfort, appearance of the device, quality of the gait 
pattern, walking distance, effort of walking, and stability during gait (all p-values < .05). 
For all these items, the median score for FES was 4, whereas the median score for the 
Table 5.I  Characteristics of the participants
Variable
Subjects, n 26 (2)b
Age, years, mean (range) 52.8 (21-68)
Time post stroke, months, mean (range) 38 (7-105)
Gender, male/female, n 21 (2)b / 5
Body weight, kg, mean (range) 84 (57-131)
Body height, m, mean (range) 1.77 (1.53-1.89)
Hemisphere of stroke, left/right, n 15 (1) / 11 (1)b
Type of stroke, infarction/haemorrhage, n 19 (2)b / 7
Modified Ashworth Score (0-5)a, median (range)
Knee flexors/extensors 0 (0-4) / 0 (0-2)
Ankle plantar flexors/dorsiflexors 0.5 (0-3) / 0 (0-1)
Motricity Index (0-100), median (range)a 64 (27-83)
Fugl-Meyer Assessment (% functional recovery), median (range)a 66 (21-93)
Quantitative Vibration Thresholda  
(0 = no sensation; 8 = normal), median (range)
First metatarsophalangeal joint 4.5 (0-8)
Lateral malleolus 5 (1-8)
Berg Balance Scale (0-56), median (range) 53 (41-56)
Baseline comfortable walking speed with AFO, m/s, mean (SD) 1.02 (0.05)
aScores of the paretic body side; 
bNumber of drop-outs (between brackets) are included in the total numbers;
 AFO = ankle-foot orthosis; SD = standard deviation
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AFO was 3, except for the stability during gait that was 3.5. Participants were not 
significantly more satisfied about FES compared with AFO regarding getting the device 
on and off, ease of use, and going up and down the stairs (median scores of 4 on all 
items with FES and 3-3.5 with AFO), although all scores tended to be higher for FES. 
Problems experienced with functional electrical stimulation
One patient dropped out of the study due to allergic reactions to the electrodes. An 
additional 3 participants experienced skin irritations under the electrodes for short 
periods of time. Other minor problems that were encountered using FES were: 
discomfort of the device below the knee (n=7), tendovaginitis of the peroneal muscles 
at the level of the lateral malleolus (n=1) and muscle soreness (n=5). These problems 
were transient and did not prevent the patients from completing the study.
Discussion
The aim of the present study was to investigate whether community-dwelling patients 
with chronic stroke who were regularly using an AFO would benefit from changing to 
transcutaneous peroneal FES. The results showed that patients judged FES superior to 
their AFO, without concomitant differences in walking speed or level of daily activity. 
The patients judged FES superior to some key features of walking ability, which may 
indeed not translate to a higher walking speed. The participants experienced more 
Table 5.2  Median scores (ranges) of patients’ satisfaction with walking device
Baseline (AFO) Week 8 (FES)
Ease of getting on and off 3.5 (2-5) 4.0 (2-5)
Comfort to wear 3.0 (2-4) 4.0 (2-5)*
Ease of use 3.0 (2-5) 4.0 (2-5)
Appearance 3.0 (1-4) 4.0 (3-5)*
Quality of the gait pattern 3.0 (2-4) 4.0 (2-5)*
Walking distance 3.0 (2-4) 4.0 (2-5)*
Effort of walking 3.0 (2-4) 4.0 (2-5)*
Stability during gait 3.5 (2-5) 4.0 (2-5)*
Going up/down the stairs 3.0 (2-5) 4.0 (2-5) 
*Significantly better scores with functional electrical stimulation (FES) than with the ankle-foot orthosis (AFO).
Satisfaction was scored on a 5-point scale (1 = very unsatisfied; 2 = unsatisfied; 3 = neutral; 4 = satisfied; 
5 = very satisfied). 
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stability of gait with FES, which may be particularly relevant during activities such as 
walking over uneven terrain or on inclines. A second aspect of gait on which the patients 
experienced a benefit of FES was the effort of walking, as patients reported that walking 
with FES was “less fatiguing”. Several studies indeed demonstrated a reduction of 
energy expenditure with FES,6-8, 27, 35 although this was never compared with an AFO. In 
addition, our findings are in line with those from previous studies investigating patients’ 
satisfaction.7, 9 In these studies, patients were also satisfied about the stability and the 
effort of walking with FES, but the present study is the first to demonstrate that patients 
were more satisfied with FES than with their AFO. 
The increase in stability and reduction in effort experienced may be explained by 
several properties of the NESS L300®. First, in contrast to most AFOs, this FES device does 
not limit ankle mobility, permitting easier balance reactions and plantar flexion 
movements during loading and push-off. Furthermore, peroneal FES may improve the 
stereotyped movement pattern of the paretic leg by reduction of spasticity11, 12, 31, 124-126 or 
triggering of the flexion reflex.10, 127-129 The stability as well as the effort of gait may 
benefit from such an improved movement pattern. 
With respect to walking speed, no differences were observed between the AFO and 
FES. The small increase in walking speed at t
2 
compared with t
1
 was probably due to a 
slightly decreased walking ability shortly after the application of the FES device. Gait 
speed was restored to baseline level at t
2
 (see Table 5.1). A separate ANOVA of the 3 AFO 
measurements at t
0
, t
1
 and t
2 
showed that there was no significant time effect on walking 
with the AFO, indicating that there was no influence of FES on walking with the AFO. 
These findings are in agreement with previous studies, in which no differences were 
found between AFO and FES.32, 40, 117 In contrast, other studies found a significantly 
higher speed when walking with FES.25, 38 This discrepancy may be explained by the 
study populations. The participants of the current study had a mean comfortable 
walking speed of 1.02 m/s at baseline, whereas the patients in the studies of Kottink et 
al25 and Waters et al38 walked at a mean speed of 0.70 and 0.58 m/s, respectively. An 
already high baseline walking speed, as in the patients of our study, may yield a ceiling 
effect.25, 30 From this perspective, it is even more interesting that our patients experienced 
clear benefits from FES. The difference between our results and the results of previous 
studies25, 38 may also be related to the fact that, in those studies, an implanted FES 
system was used, whereas the patients in our study used a transcutaneous device. 
Transcutaneous and implanted FES have not yet been compared directly, so it cannot 
be excluded that effects with respect to walking speed may differ between these types 
of devices. More importantly, as mentioned in the introduction, studies investigating 
the effects of implanted devices are bound to suffer from (positive) selection bias 
considering the general comparison between peroneal FES and AFO.
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As for the level of physical activity, no change was found in the number of steps per day 
between the devices. The finding that physical activity did not increase with FES is in 
line with the observations of Kottink et al.25 It suggests that the walking distance reflects 
a person’s functional aims, and that in patients with chronic conditions these have 
become adjusted to their walking ability over time. It may, therefore, be that an 8-week 
study protocol is too short for true behavioural changes. In contrast, Laufer et al116 did 
find improvements in self-reported physical functioning in activities of daily living and 
participation in community life after 8 weeks of using FES. The baseline level of physical 
functioning, however, was probably much lower in their patients than in ours, as 
indicated by the mean walking speed (0.65 m/s). Furthermore, our study sample was 
already quite active with ~5600 steps per day compared to the average of only ~2800 
steps per day in individuals with chronic stroke.130 So it may well be that due to a ceiling 
effect our participants did not increase their activity level. 
As a disadvantage of transcutaneous FES, skin problems are mentioned in the literature. 
In this study, 4 participants (15%) developed skin problems, one of whom dropped out 
of the study for this reason. Both higher and lower incidences of skin problems with FES 
have been reported in the literature.6, 7, 9 The larger numbers may be related to prolonged 
use of FES, but other factors may also be involved, such as the conductive substance 
used in the electrodes or genetic differences in skin types. 
This study has some limitations. We used a purpose-designed questionnaire to assess 
patients’ satisfaction, which has face validity but which has not been formally validated. 
Furthermore, besides gait speed, no other gait variables were included to objectify 
possible benefits of FES. Particularly in the case of good walking ability, future studies 
should include other outcome measures, e.g. related to gait endurance or the ability to 
negotiate uneven surfaces. 
In conclusion, this study aimed to compare the efficacy of transcutaneous peroneal FES 
with a conventional AFO in order to support clinicians in their decision whether to 
replace an AFO with FES in community-dwelling patients with chronic stroke who suffer 
from a drop foot. The patients judged FES to be superior to their AFO, but measurements 
of walking speed and level of physical activity could not objectify the perceived benefits 
of FES. The patients experienced greater stability of gait with FES, which may be related 
to a feeling of safety during transfers, walking on inclines or over uneven terrain. FES 
was also judged superior with respect to the effort of gait. 
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Abstract 
Background. Walking ability of people with a drop foot in the chronic phase after stroke 
is better with functional electrical stimulation (FES) of the peroneal nerve than without 
an orthotic device. However, the literature is not conclusive on whether peroneal FES 
also is better than an ankle-foot orthosis (AFO) in this regard. 
Objective. This study aimed to identify potential benefits of peroneal FES over an AFO 
with respect to the ability to negotiate a sudden obstacle. 
Design. The study design was a within-subject comparison between FES and AFO using 
repeated measures. 
Methods. Twenty-four community-dwelling people with stroke (mean age = 52.6 years, 
SD = 12.7) who regularly used a polypropylene AFO were fitted with a transcutaneous 
FES device. The participants’ obstacle avoidance ability was tested after 2 and 8 weeks. 
They had to avoid 30 obstacles that were suddenly dropped on a treadmill in front of 
the affected leg while walking with either FES or an AFO. The obstacle avoidance 
success rates were determined. 
Results. Success rates were higher with FES than with an AFO, especially after adjustment 
for individual leg muscle strength. Participants with relatively low muscle strength 
(Motricity Index score < 64) were most likely to benefit from FES regarding obstacle 
avoidance ability. 
Limitation. Further work is needed to determine whether the results may be generalized 
to other groups of people with stroke. 
Conclusions. Peroneal FES seems to be superior to an AFO with regard to the obstacle 
avoidance ability in community-dwelling people with stroke. The observed gains in 
obstacle avoidance ability appear to be clinically most relevant in the people with 
relatively low leg muscle strength.
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Introduction
People with a drop foot due to stroke usually are provided with an ankle-foot orthosis 
(AFO), a polypropylene posterior splint that keeps the ankle in a neutral position during 
the swing phase of gait. However, the use of functional electrical stimulation (FES) of the 
peroneal nerve is growing as an alternative treatment option. With peroneal FES, the 
muscles that dorsiflex and evert the ankle joint are activated during the swing and early 
stance phases of gait. Ankle mobility is left free with FES, which permits residual plantar 
flexion (push-off) during the late stance phase as well as balance-correcting movements, 
particularly during the mid-stance phase. Both the activation of the dorsiflexor muscles, 
consistent with the normal gait pattern in people who are healthy, and the free ankle 
mobility may be responsible for potential benefits of peroneal FES over an AFO.
With the recent development of advanced and user-friendly peroneal FES devices, the 
number of studies on the effects of FES has increased rapidly. When walking with 
peroneal FES, people with a drop foot due to stroke have been reported to feel more 
confident, to perceive better stability of gait, and to experience less fatigue compared 
with walking with either no device or with an AFO.7, 9, 36 The potential added value of FES 
over an AFO, however, has not yet been convincingly demonstrated by quantitative 
measurements, for example, for comfortable walking speed.25, 32, 36, 38, 40, 117 Although 
comfortable walking speed is an important and frequently used parameter in the 
evaluation of the quality of gait,131, 132 it may not reflect all potential benefits of FES as 
perceived by the patients. In addition, in the population of community ambulators, gait 
speed may not be the limiting factor with regard to independent and safe walking and, 
therefore, may not reflect the main problem of these people. The finding that commu-
nity-dwelling people with stroke perceived an improvement in gait stability with 
peroneal FES without an improvement in comfortable gait speed36 may be related to 
the experience of safer and more flexible ambulation skills in complex every-day life 
situations such as walking on uneven terrain or inclines. Walking under these challenging 
circumstances depends heavily on the ability to adjust the gait pattern to environmental 
demands, such as loose tiles in the pavement or an obstacle that has to be negotiated. 
These adjustments, which involve a delicate interplay between whole-body stability 
and motor control of the legs, have been found to be substantially impaired even in 
well-recovered survivors of stroke.55-59, 61, 78 Stroke-related deficits appear to be most 
pronounced when there is little time to implement stepping adjustments.55, 57, 58 The 
most frequently used experimental paradigms to challenge and study gait adaptability 
in people with stroke are obstacle avoidance tasks.53 Obstacle avoidance is considered 
to be an appropriate test of the potential beneficial effects of peroneal FES in commu-
nity-dwelling people with stroke because it represents a very important aspect of safe 
and independent ambulation in daily life. 
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A few previous studies have used a timed obstacle course to investigate the effects of 
peroneal FES in people with stroke.7, 15, 40 In two of these studies,7, 15 the obstacle course 
was completed faster with FES than without an orthosis, in both short-term and 
long-term evaluations. However, people with a drop foot due to stroke usually are 
provided with an AFO. Therefore, walking with peroneal FES should be contrasted to an 
AFO rather than to walking without any orthotic device. Sheffler and co-workers40 did 
not find better performance with FES compared with an AFO on an obstacle course. In 
that study, however, the outcome assessments were conducted after only 1 day of 
training with FES, which is probably too early to demonstrate measurable effects on 
complex walking ability. 
We selected active survivors of a stroke who are able to walk outdoors as the target 
population of our study because we expected that this population would be most 
interested in and responsive to the potential benefits of peroneal FES. Hence, the 
present study aimed to identify whether community-dwelling people in the chronic 
phase after stroke who use an AFO for a drop foot would benefit more from peroneal 
FES than from their AFO during the avoidance of a sudden obstacle. To this aim, we 
applied an experimental paradigm in which participants walked on a treadmill and had 
to avoid obstacles that were suddenly released in front of their affected leg, leaving little 
time to respond. This paradigm allows participants to be tested at the limits of their 
abilities under standardized and well-controlled conditions, rendering it highly sensitive 
to identify changes in stroke-related deficits in obstacle avoidance abilities. As previous 
studies have suggested that, in addition to its foot elevation function, peroneal FES may 
facilitate active hip and knee flexion of the paretic leg,12, 46 we expected that participants 
would be better able to avoid sudden obstacles with FES than with their AFO.
 
Methods
Participants
The data presented in this report and those reported in a previous article36 were 
obtained within the same study protocol. The participants were 26 people who had a 
drop foot due to a stroke at least 6 months prior to recruitment. They all had to regularly 
use an AFO that was prescribed by their physician and with which they did not 
experience any problems. In addition, all participants had to be able to walk 
independently without a walking aid for more than 10 minutes on even and uneven 
surfaces (Functional Ambulation Categories 547) to perform the obstacle avoidance task. 
Exclusion criteria related to the paretic body side were insufficient ankle mobility 
(defined as ankle passive range of motion of less than 30 degrees or inability to reach a 
plantigrade foot position when standing with an extended knee), severe hypertonia of 
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the calf muscles (Modified Ashworth Scale score of 4 or 5), inability to stimulate the 
superficial or deep peroneal nerves, and skin lesions at the electrode sites. Other 
exclusion criteria were pregnancy, psychological disorders (depression or psychosis), 
and a demand-type pacemaker. 
In order to characterize the population of the current study and to support the 
identification of potential good responders in our study, the following characteristics of 
the patients were scored at inclusion: 10-m comfortable gait speed, balance (Berg 
Balance Scale71), muscle tone of the knee extensors and flexors and the ankle plantar 
flexors and dorsal flexors (Modified Ashworth Scale68), lower-extremity muscle strength 
(Motricity Index69), and lower-extremity motor selectivity (Fugl-Meyer Assessment70). 
Furthermore, sensation of the lower limb was evaluated by means of the Quantitative 
Vibration Threshold administered with a semiquantitative tuning fork (Rydel Seiffer, 
Neurologicals®, Arno Barthelmes & Co, GmbH, Tuttingen, Germany).123 The lowest levels 
of vibration that were perceived at the lateral malleolus and the first metatarsophalan-
geal joint of the paretic leg were recorded. Participants gave their written informed 
consent before participation in the study.
Study protocol
At baseline, a transcutaneous FES device (NESS L300®, Bioness Inc, Valencia, California) 
was fitted to each participant (Figure 6.1). The NESS L300® is a single-channel neuropro-
sthesis consisting of three parts that communicate wirelessly: a control unit, a stimulation 
unit and a footswitch. Two electrodes integrated in the stimulation unit electrically 
stimulate the common peroneal nerve and the anterior tibial muscle (pulse rate = 30 Hz; 
phase duration = 200 µs). A force-sensitive footswitch that is worn in the shoe ensures 
that the electrical stimulation is delivered during the swing and early stance phases of 
gait. During a 2-week adaptation period, participants increased their daily use of the 
device up to 6 hours a day, followed by a 6-week period of whole-day use. However, 
during the entire 8-week study protocol, the participants kept using their AFO for 1 hour 
a day to prevent an unlearning effect. A practice session of the obstacle avoidance test 
was performed at baseline with the AFO. This session was not included in the statistical 
analysis. Obstacle avoidance ability was tested at week 2 and week 8 of the study 
protocol, with the AFO and with peroneal FES, in an order that was randomised across 
the participants. Testing sessions lasted 2 hours each, including rest periods.
Experimental setup of the obstacle avoidance measurement
The participants walked on a treadmill at 2 or 3 km/h, depending on their individual 
walking ability, but for each participant, walking speed was kept constant over all tests. 
To prevent falling, the participants wore a safety harness attached to a ceiling-mounted 
rail. An obstacle (length = 40 cm, width = 30 cm, and height = 1.5 cm) was held by an 
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electromagnet just above the treadmill and could be released by a trigger from the 
computer (Figure 6.2). 
Three reflective markers were placed bilaterally at the most anterior, posterior and 
lateral parts of the shoe, and one additional marker was placed on the front edge of the 
obstacle. Kinematic data of both feet and the obstacle were collected with a 6-camera, 
3-dimensional motion analysis system (Vicon Motion Systems, Vicon-UK, Oxford, United 
Kingdom) at a sampling rate of 100 Hz. The obstacle always fell in front of the affected 
foot. The participant had to respond to the obstacle within the same stride as its release 
in order not to touch it. Marker data of that foot were processed online to determine the 
instant of foot strike, on the basis of which the obstacle was released in 1 of 3 phases of 
the gait cycle: mid-stance, late stance to early swing, and mid-swing. Releasing the 
obstacle in a later phase of the step cycle reduced the time available to successfully 
implement the stepping adjustment (available response time [ART]) and, consequently, 
increased the level of difficulty of the trial. The 3 phases of obstacle release corresponded 
to ARTs of 450 to 600, 300 to 450, and 150 to 300 ms, respectively, where ART was 
quantified as the time between obstacle release and the moment that the toe would 
have crossed the front edge of the obstacle in case of an unaltered walking pattern.73
Figure 6.1   Time line of the study protocol.
Assessments that were included in the analysis of variance (ANOVA) are within the dotted line. OA = 
obstacle avoidance task; AFO = ankle-foot orthosis; FES = functional electrical stimulation.
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Each trial consisted of the presentation of one obstacle. At the beginning of each 
session, the participants performed 5 practice trials to familiarize themselves with the 
experimental setup. The total number of experimental trials was set at 30 for each of the 
2 device conditions (AFO and FES). The instants of obstacle release were randomly 
distributed over the trials. The participants were instructed to maintain a constant 
distance of about 10 cm from the toe of the affected foot to the hanging obstacle at the 
moment of foot strike. In addition, they were requested to either lengthen or shorten 
their stride in order to avoid the obstacle when it was dropped on the treadmill. Contact 
of the foot with the obstacle, loss of balance, and steps beside the obstacle with the 
paretic foot were classified as failures. Two assessors judged the success of the avoidance 
maneuver. In the case of any uncertainty, the marker position data and video recordings 
of the respective trial were consulted to determine whether the foot had contacted the 
obstacle.
Figure 6.2   Experimental setup of the obstacle avoidance measurement.
visco-elastic brake ceiling-mounted rail
camera
safety harness
treadmill
computer-triggered
electromagnet
obstacle
markers
10 cm
90
CHAPTER 6
Data processing and statistical analysis 
Within-subject averaged success rates were calculated for each of the ART categories 
(450 - 600, 300 - 450 and 150 - 300 ms) and for each device condition (AFO and FES). To 
determine whether the participants’ obstacle avoidance ability differed between 
walking with an AFO and with FES, the success rates were subjected to an analysis of 
variance (ANOVA) for repeated measures. Time (2 levels: week 2 and week 8), device (2 
levels: AFO and FES) and ART (3 levels) were used as within-subject factors. To stabilize 
the variance in the success rates, the data were subjected to angular transformation 
before conducting the ANOVA. 
To investigate whether the expected benefits of FES with regard to obstacle avoidance 
ability depended on clinical characteristics of the participants, bivariate non-parametric 
(Spearman) correlations were calculated between the increase in success rates with FES 
(compared with AFO) at week 8 and each of the following characteristics: Modified 
Ashworth Scale score (for ankle plantar flexors), lower-extremity Motricity Index score, 
lower-extremity Fugl-Meyer Assessment score, Berg Balance Scale scores, and 
comfortable walking speed with the AFO. Subsequently, the analysis of obstacle 
avoidance ability with AFO and FES was adjusted for the clinical characteristics that 
demonstrated significant correlations by adding them to the statistical model as 
covariates (i.e., yielding a repeated-measures analysis of covariance). We used SPSS 
version 15.0 (SPSS Inc, Chicago, Illinois) for all statistical analyses. The level of significance 
was set at p ≤ .05.
Results
Participants
The characteristics of the participants are shown in Table 6.1. They had a median 
Motricity Index ankle score of 14, which corresponds to the ability to perform some 
active dorsiflexion, but not over the entire range of motion. In all but 2 participants, the 
AFO was a customized polypropylene brace of various designs, limiting plantar flexion 
but allowing at least 15 degrees of dorsiflexion mobility at the ankle. Two participants 
wore a simple spring-type AFO that merely provided an external dorsiflexion moment 
about the ankle. Two participants dropped out of the study: one participant stopped 
due to severe discomfort during the electrical stimulation prior to week 2, and the other 
participant developed allergic skin reactions (dermatologically confirmed) at the 
electrode sites in week 3 of the study protocol. The data of the 24 participants who 
completed the study were used in the statistical analyses.
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Table 6.1  Characteristics of the participants (n=24)
Characteristic Values
Age, years, mean (SD) 52.6 (12.7)
Time post stroke, months, mean (SD) 35.9 (30.8)
Sex, male/female, n 19 / 5
Body weight, kg, mean (SD) 81.4 (16.0)
Body height, m, mean (SD) 1.76 (0.08)
Hemisphere of stroke, left/right, n 14 / 10
Type of stroke, infarction/haemorrhage, n 17 / 7
Modified Ashworth Scale (0-5)a, median (range)
Knee flexors/extensors 0 (0-4) /0 (0-2)
Ankle plantar flexors/dorsiflexors 0.5 (0-3)/0 (0-1)
Lower-extremity Motricity Index (0-100)a, median (range) 64 (37-83)
Ankle dorsiflexion (0-33) 14 (0-25)
Lower-extremity FMAa,b, median (range) 70 (39-93)
Quantitative Vibration Thresholda 
(0 = no sensation, 8 = normal), median (range)
First metatarsophalangeal joint 5 (0-8)
Lateral malleolus 5 (1-8)
Berg Balance Scale (0-56), median (range) 53 (45-56)
Baseline comfortable walking speed with AFO, m/s, mean (SD) 1.02 (0.22)
aScores of the paretic body side; bFugl-Meyer Assessment (percentage of full recovery). 
AFO: ankle-foot orthosis; SD: standard deviation.
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Obstacle avoidance success rates
Table 6.2 shows the obstacle avoidance success rates; the results of an ANOVA model 
without interaction effects are presented after reconversion from the angular transformation. 
As expected, reducing the ART increased the level of difficulty, which was indicated by 
a significant main effect of ART on obstacle avoidance success rates (F(2,46) = 97.03, 
p < .001, η
p
2 = .81). The repeated-measures ANOVA yielded a significant main effect of 
device (F(1,23) = 4.53, p = .04, η
p
2 = .16), with better success rates (percentage) when the 
participants walked with FES (mean (95% confidence interval) = 52.6 (35.6 - 70.4)%) than 
with their AFO (44.7 (22.7 - 63.8)%). Furthermore, overall success rates were better at 
week 8 (53.8 (35.0 - 73.5)%) than at week 2 (43.5 (28.3 - 60.5)%), as demonstrated by a 
significant main effect of time (F(1,23) = 7.92, p = .01, η
p
2 = .26). There was no significant 
interaction effect of device by time (F(1,23) = 0.04, p = .85, η
p
2 = .002), nor any other 
significant interaction effect. 
We observed a wide range of individual differences in success rates between FES and 
AFO at week 8 (−14% to 22%), which indicated that there were good responders and 
nonresponders to peroneal FES. The only clinical characteristic that was statistically 
significantly associated with the difference in success rates between FES and AFO was 
the lower-extremity Motricity Index score (Spearman rank correlation = −.40, p = .05). 
Participants with a lower Motricity Index were more likely to benefit from FES than 
participants with a higher Motricity Index score (Figure 6.3). 
Table 6.2   Estimated mean (95% Confidence Interval [CI]) obstacle avoidance 
success rates (%) (n=24) using a 3-way analysis of variance for each of 
the Device, Time and Available Response Time (ART) categories.
Variable Category Mean (95% CI) P a
Device AFO 44.7 (27.7-63.8) .04
FES 52.6 (35.6-70.4)
Time week 2 43.5 (28.3-60.5) .01
week 8 53.8 (35.0-73.5)
ART 450-600 ms 93.4 (77.0-100.0) < .001b
300-450 ms 54.0 (31.3-78.2)
150-300 ms 8.0 (2.9-15.7)
AFO: ankle-foot orthosis; FES: functional electrical stimulation.
a P values are presented for the differences between categories
b Post hoc tests revealed significant differences among all ART categories (p < .001).
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When the initial repeated-measures ANOVA was adjusted for Motricity Index score, it 
yielded a significant interaction effect of device × Motricity Index score (F(1,22) = 7.38, 
p = .01), indicating that participants with the lowest Motricity Index score (< 64) 
demonstrated the largest improvements in success rates with FES compared with the 
AFO.
Discussion 
The present study aimed to identify whether, in a group of community-dwelling people 
in the chronic phase after stroke, peroneal FES was superior to an AFO regarding 
time-critical obstacle avoidance performance. The included participants had relatively 
good balance skills and high walking speeds as a consequence of the inclusion criterion 
that they had to be able to walk independently without a walking aid for more than 10 
minutes on all surfaces. These people demonstrated significantly higher success rates 
with FES than with their AFO, although the overall increase in success rate was small. A 
lower Motricity Index score, however, was associated with greater benefits of FES; 
therefore, the gains in obstacle avoidance ability with FES might be clinically relevant, 
particularly in this patient group. 
Figure 6.3   Association between Motricity Index and individual differences in 
success rates between functional electrical stimulation (FES) and 
ankle-foot orthosis (AFO) at week 8 of the study protocol, with positive 
values indicating higher scores with FES.
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The present findings of an improved obstacle avoidance ability with peroneal FES are in 
agreement with previous studies that demonstrated significantly shorter times to 
complete an obstacle course over ground with FES compared with using no orthotic 
device.7, 15 Yet, this is the first study to show that the obstacle avoidance ability with 
peroneal FES also was better compared with using an AFO, the standard of care for 
people with a drop foot due to stroke. This observation is in contrast with the results of 
Sheffler and coworkers,40 who found neither of these orthotic devices superior with 
regard to the time to complete an obstacle course. This discrepancy, however, may well 
be explained by differences in the duration of FES training. Previous studies have 
identified increasing benefits of FES after prolonged use.7, 15, 27, 35, 133 Hence, an 8-week 
period of FES use, as in the present study, is more likely to yield beneficial effects than a 
1-day training session as in the study by Sheffler et al.40 Another explanation for the 
discrepancy in the results between this study and that of Sheffler et al40 may be the 
difference in the type of obstacle avoidance task used, because stroke-related motor 
deficits become more pronounced under time pressure. Thus, the time-critical setup of 
the present study, which tested the participants at the limits of their ability, may be 
more sensitive to change than a timed obstacle course. 
On average, the observed improvement in success rates with FES, compared with an 
AFO, was relatively small, raising the question of whether this result is clinically important. 
There was, however, large between-subject variability indicating that FES worked very 
well for some participants, but not for others. Therefore, we suggest that, although the 
improvements with FES were statistically significant for the group at large, in clinical 
practice, FES may only outweigh an AFO for a particular subset of people. This 
observation is in agreement with previous studies showing the existence of good 
responders and nonresponders to peroneal FES.27, 38 Yet, the identification of predictors 
of good response to FES has received little attention, and the literature provides no 
consensus with regard to this issue.8, 14 In the present study, we found that low leg 
muscle strength is a possible indicator of a good response to peroneal FES concerning 
obstacle avoidance ability. Participants with low Motricity Index scores (< 64) showed 
greater benefits than those with higher Motricity Index scores, a finding that was not 
caused by ceiling effects in the participants in the ’higher band‘. Indeed, the obstacle 
avoidance success rates averaged for the 3 participants with the highest Motricity Index 
scores were 68% with FES and 71% with AFO at week 8, whereas success rates in elderly 
people who are healthy usually are between 89.6% and 99.5%.55, 62, 63 In the 8 participants 
with the lowest Motricity Index scores, the mean difference in success rates between 
FES and AFO at week 8 was 9% (Figure 6.3). In a group of elderly people who were 
healthy,54 similar improvements in average success scores were observed after a fall 
prevention exercise program, which coincided with a substantial reduction in fall 
incidence. In this perspective, the observed benefits of FES in the participants in the 
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’lower band‘ may well be clinically relevant. However, only comparison of fall incidences 
in daily life between ambulation with FES and with an AFO may convincingly answer 
the question of whether the superiority of FES over an AFO for obstacle avoidance 
ability is truly clinically relevant.
Consistent with our finding of greater benefits of FES in people with low Motricity Index 
scores, the participant who dropped out of the study in week 3 of the protocol (not 
represented in the results) had a Motricity Index score of 27 and appeared to be a very 
good responder to FES. A detailed description of this case has been published 
previously.46 The participant dropped out due to an allergic reaction of the skin to the 
electrodes and was later successfully provided with an implanted FES device. This case 
illustrates that, irrespective of the functional response, there will always be a small 
subset of people who will not benefit from surface FES because of skin problems. 
Implantable FES devices may help to solve this problem. 
In addition to the beneficial effects of FES on the obstacle avoidance success rates, there 
was an overall improvement in avoidance ability over time with both devices. This 
finding is in agreement with other studies16, 17, 118 that showed carryover effects of FES to 
walking without FES. It cannot completely be ruled out, however, that these ’therapeutic‘ 
effects have been influenced by task-specific learning, although we purposely included 
a practice session to minimize the contribution of task-specific learning to the later 
assessments. It might still be possible that the participants just became more familiar 
with the task over time. The only way to convincingly demonstrate therapeutic effects 
of FES would be to conduct a randomized controlled trial (RCT).
The improved obstacle avoidance ability with FES may be related to what FES users 
reported as “a better gait stability” in daily life. In a previous publication,36 the perception 
of gait stability with FES was reported for the same participants who were included in 
the present study. Ten out of 11 participants who perceived a better gait stability also 
showed improvements of obstacle avoidance ability with FES. This result suggests that 
there might be a relationship between improvements in obstacle avoidance ability and 
improvements in perceived gait stability with FES. It confirms previous reports of better 
perceived gait stability during walking on uneven surfaces and inclines when using 
peroneal FES.7, 9, 29, 118 One of these studies also related participants’ perception to 
quantitative measurements29 and reported that general satisfaction with FES (including 
perceived effort of gait, feeling of confidence of walking on uneven surfaces, and quality 
of life) was associated with the effort of walking on uneven terrain. It is possible that an 
improved ability to quickly adapt the ongoing gait pattern with FES, as demonstrated in 
the present study, may underlie such a decreased effort of walking on uneven surfaces. 
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Better obstacle avoidance ability has previously been reported to be associated with a 
lower fall risk in elderly people who were healthy.134 Although similar evidence of the 
construct validity of this test is not available for people in the chronic phase after stroke, 
the present results suggest that peroneal FES may enhance the safety of ambulation in 
community-dwelling people with stroke. This notion is supported by Hausdorff and 
Ring,7 who found fewer falls in patients walking with peroneal FES compared with 
walking without an orthotic device. In addition, improved symmetry and reduced 
variability of gait have been found as a result of FES.32 Both gait variables have been 
related to a reduced risk of falling.135, 136 However, at this time, there is no direct evidence 
that peroneal nerve FES is superior to an AFO in reducing fall incidence. 
This study has some limitations. First, the applied within-subject design was optimal, 
given the limited number of participants, but an RCT would need to be conducted to 
further demonstrate the additional value of peroneal FES over an AFO. Second, this 
study compared FES with AFOs, the current standard of care in many countries, which 
limits the generalizability to other, more specialized, types of AFOs. Third, the current 
study focused on obstacle avoidance ability with the affected leg. It would be interesting 
to investigate obstacle avoidance with the unaffected leg as well. However, as FES is not 
active during the major part of the stance phase, we expect it to have less pronounced 
effects in this situation. Furthermore, the present protocol was already very strenuous 
for our participants, and adding another condition would have been too strenuous for 
most of them. Fourth, although blinding patients to the use of FES is not possible in 
practice, the fact that they were aware of the test conditions was a limitation and might 
have influenced their performance. Lastly, the present study included only community 
ambulators with relatively good balance and walking abilities because we expected 
these people to profit most from peroneal FES, which limits generalizability to people 
with lesser ambulation capacity. 
Future studies on the added value of FES over AFOs with regard to obstacle avoidance 
ability should be conducted with larger samples of people with stroke, including indoor 
and limited outdoor ambulators, to investigate whether the results of this study can be 
generalized to other types of patients. In addition, the value of low leg muscle strength 
as a predictor of good response to peroneal FES should be confirmed in other groups of 
people with stroke. In larger samples, it may also be possible to identify other (and 
combinations of) characteristics of people with stroke that are associated with a good 
response to peroneal FES. Furthermore, additional research, outside the controlled 
setting of the laboratory, on the effects of FES with regard to community ambulation is 
recommended. To investigate the effects of peroneal FES on fall reduction in people in 
the chronic phase after stroke, an RCT with prospective monitoring of falls would be 
needed.
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Conclusion
The present study demonstrated that in community-dwelling people in the chronic 
phase after stroke who use an AFO for a drop foot, obstacle avoidance ability can be 
improved by replacing the AFO by peroneal FES. In addition, within our group of 
relatively good walkers, lower-leg muscle strength was associated with greater benefits 
from FES with regard to obstacle avoidance ability. Specifically, in people with low leg 
muscle strength (Motricity Index score < 64) due to stroke, the observed gains in 
obstacle avoidance ability appear to be clinically relevant. 
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CHAPTER 7
Abstract
In recent years, the use of functional electrical stimulation (FES) of the peroneal nerve 
has increased as an alternative for an ankle-foot orthosis (AFO) to treat stroke-related 
drop foot. We present a chronic stroke patient demonstrating an almost normal gait 
pattern with peroneal FES as a neuroprosthesis. A 60-year-old survivor of a right 
hemisphere infarction 21 months ago, who regularly used a polypropylene AFO, was 
provided with a surface-based peroneal FES device for severe drop foot. In a second 
instance, he received an implanted FES system because of skin problems with the 
surface stimulator. With both FES devices, the patient achieved an adequate foot 
elevation. Moreover, his hip and knee flexion angles during walking increased to normal 
values and his ankle push-off power increased. His gait pattern became almost 
symmetrical and less variable than with the AFO. Furthermore, his ability to avoid a 
sudden obstacle improved to normal values with FES. Our patient showed benefits 
from peroneal FES beyond what can be attributed to improved foot lift alone. With 
regard to the potential working mechanisms underlying this response to FES, 
biomechanical benefits related to improved ankle push-off are suggested as the main 
mechanism. 
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Introduction
In stroke patients who suffer from a drop foot, an AFO is usually provided to lift the foot 
during the swing phase and early stance phase of gait in order to prevent the toes from 
touching the ground and to facilitate heel loading. As an alternative treatment, FES of 
the peroneal nerve as a form of neuroprosthesis is gradually becoming more feasible 
due to advanced and commercially available systems. Peroneal FES activates the 
muscles that dorsiflex and evert the ankle joint as well as the toe extensors and may 
lead to significant improvement in the gait pattern7 and gait speed8, 25 compared to 
walking without aids. Although FES has several theoretical advantages over an AFO and 
patients’ preferences often support the use of FES, there is as yet no conclusive evidence 
for the superiority of peroneal FES over an AFO with respect to walking abilities.36, 119 The 
aim of the present report is to demonstrate the potential superiority of peroneal FES 
over an AFO. To this end, we present a stroke patient who was used to walking with a 
polypropylene AFO and who showed functional benefits from FES that went beyond 
what can be attributed to improved foot elevation alone (open access videos on http://
www.neurorehab.nl/APMR_english.htm). Secondly, we aim to discuss the potential 
mechanisms underlying the observed functional improvements. 
List of abbreviations
AFO ankle-foot orthosis
COV coefficient of variation
FES functional electrical stimulation
V
plfl
maximal ankle plantar flexion velocity (at push-off )
T
swing
asym asymmetry in swing time duration between left and right limb
M
plfl
maximal ankle plantar flexion torque (at push-off )
Case Description
Patient and methods
A 60-year-old farmer presented himself at the outpatient clinic of our university hospital 
21 months after a right hemispheric infarction. Characteristics of the participant are 
provided in Table 7.1. The Motricity Index69 of his left lower limb was 27% with a 0 score 
for the ankle dorsiflexors. The strength of his calf muscles was scored Medical Research 
Council137 grade 4. Because of his ankle dorsiflexor paralysis, the patient used an AFO, 
which was a custom made polypropylene (2.5-mm thickness) posterior splint, trimmed 
behind the malleoli of the ankle. The AFO was rigid into plantar flexion, but allowed 
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about 15o of ankle dorsiflexion. The patient was hardly able to walk without this AFO 
due to foot drag during the swing phase of gait, which he was not able to compensate 
by active hip and knee flexion. 
At baseline (t0), his gait ability with AFO was assessed, after which he received a 
surface-based peroneal FES device (NESS L300®, Bioness, Inc, Valencia, California). The 
L300 stimulated the peroneal nerve and the anterior tibial muscle using 2 electrodes 
embedded into a lightweight orthosis placed just below the knee (symmetrical bipolar 
Table 7.1  Characteristics of the participant at baseline
Variable Patient’s outcome
Age, years 59
Time post stroke, months 21
Sex male
Body weight, kg 101
Body height, m 1.78
Hemisphere of stroke right
Type of stroke infarction
Modified Ashworth Score (0-5)*      
Knee flexors/extensors* 0/0
Ankle plantar flexors/dorsiflexors* 0/0
Lower-extremity Motricity Index (0-100) * 27
Ankle score (0-33)* 0
Lower-extremity Fugl-Meyer Assessment (0-34)* 6
Calf muscle strength (Medical Research Council 0-5)* 4
Quantitative Vibration Threshold* (0 = no sensation; 8 = normal)
(0= no sensation; 8= normal)
First metatarsophalangeal joint* < 2
Lateral malleolus* 2
Berg Balance Scale (0-56) 41
Passive range of motion at ankle, deg*
Dorsiflexion (knee extended/flexed)/plantar flexion* (0/10)/35
Varus/valgus* 30/15
*Scores at the paretic body side
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42 mA current; pulse rate 30 Hz; phase duration 200 µs) during the swing phase and the 
subsequent loading response. Stimulation onset and offset were based on detection of 
heel-off and heel-on by an insole footswitch that communicated wirelessly with the 
stimulator that was attached to the orthosis. 
In the following 2 weeks, the patient increased the use of FES up to 6 hours a day. 
Subsequently, the gait assessment was repeated with both the AFO and FES (t1 
[measurements after 2 wk]). In the third week, the patient developed an allergic skin 
reaction to the electrodes, which was dermatologically confirmed. Because no 
alternative electrodes were available at that time, the patient had to terminate the use 
of the surface stimulator shortly after he had started. One year later, this patient was the 
first person to be implanted with the ActiGait® (Neurodan A/S, Aalborg SV, Denmark) 
peroneal stimulator in The Netherlands. With this system, the common peroneal nerve 
was directly stimulated through 4 distinct electrode arrays embedded in a cuff, which 
was surgically placed around the nerve about 4 cm above the knee joint (asymmetrical 
bipolar 1.2 mA current; pulse rate 20 Hz; phase duration 247, 236, 210 and 0 µs for channel 
1 to 4). The stimulation settings of the 4 channels were individually adjusted such that a 
balanced eversion and dorsiflexion were evoked during the swing phase and early 
stance phase of gait. Stimulation onset was timed simultaneously with heel-off, and the 
offset of stimulation was timed using a ramp-down period of 0.5 sec following heel 
strike. Heel contacts were detected by an insole footswitch that communicated 
wirelessly with the control unit that was worn on a waist belt. The control unit was 
hard-wired externally to a transmitter coil (antenna), positioned on the skin over a 
receiver and stimulator, which was implanted subcutaneously on the lateral side of the 
proximal thigh. The stimulator was hard-wired subcutaneously to the cuff electrode. 
After he had used this system all day long for 6 months, a third gait assessment was 
conducted with his AFO and with the implanted stimulator (t2 [measurements after 1.5 
y]). In addition, in spite of the difficulties the patient experienced when he walked 
without an orthosis, the assessment of comfortable walking was also performed 
without any device at this occasion. 
During each gait assessment, 70 gait cycles of treadmill walking at a comfortable speed 
of 0.56 m/s were analyzed. Flexion-extension movements of the hip, knee and ankle 
joints were measured with goniometers (Biometrics SG150 and SG110/A; Biometrics Ltd, 
Ladysmith; VA 22501, USA) at a sampling rate of 1000 Hz, and maximal flexion and 
extension joint angles during the step cycle were determined. The coefficient of 
variation for the hip (COVhip), knee (COVknee) and ankle (COVankle) joint angles and maximal 
ankle plantar flexion velocity (V
plfl
) were computed after low-pass filtering (6 Hz; zero lag, 
4th order Butterworth filter) of the joint angle signals. The COV was calculated as the 
root mean square of the standard deviation at each time interval divided by the mean 
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magnitude of joint angle over the stride.138 V
plfl
 was determined from the differentiated 
ankle angle signal as the maximum value within 200 ms before toe off. With a 6-camera 
3D motion analysis system (Vicon Motion Systems, Vicon-UK, Oxford, United Kingdom), 
foot marker data were collected at a sampling rate of 100 Hz to determine heel strike 
and toe off. The asymmetry in swing time between left and right limb was defined as 
(Eq. 7.1),139 
Tswingasym = 
Tswing,left – Tswing,right (s)
max(Tswing,left , Tswing,right) (s)
 (7.1)
where T
swing, left
 stands for swing time (from toe off to heel strike) of the left (paretic) leg 
and T
swing, right
 stands for swing time of the right (nonparetic) leg. Subsequently, to assess 
advanced gait skills, the ability to avoid sudden obstacles during walking was tested on 
a treadmill. Thirty obstacles were dropped in front of the paretic foot during each test 
(for detailed description of the methods see Weerdesteyn et al62, 73). Avoidance success 
rates were determined as the proportion of trials without foot contact to the obstacle. 
Without any device, walking ability was too poor to perform the obstacle avoidance 
trials. Finally, comfortable gait speed was measured during overground walking on a 
10-m walkway, both with FES and AFO. In addition, at t2, ground reaction forces were 
measured for 1 step with each leg during 3 overground trials by means of 2 force plates 
(Custom designed force platforms; Advanced Mechanical Technology, Inc, Watertown, 
USA) positioned in the middle of the walkway. Kinematic data were recorded from 16 
reflective markers, which were placed on the lower limbs according to the lower-body 
model (Vicon). These data were analyzed using the PlugInGait model in Vicon 
Workstation to obtain the joint torques of the lower limb.
Results
The outcomes of the gait assessments are summarized in Table 7.2. With surface-based 
FES (t1), maximal hip and knee flexion angles during the gait cycle increased by 6.3° and 
20.4°, respectively, compared with the AFO, while maximal hip and knee extension 
angles were similar. COV
hip
 and COV
knee
 decreased by 11.4% and 14.4%, respectively. V
plfl
 
increased by 46.3 o/s with FES compared to AFO. Finally, movement symmetry increased 
with FES, as indicated by a 23.8% decrease in T
swing
asym. 
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At t2, the gait pattern with AFO had deteriorated compared to t0 and t1, as indicated most 
clearly by decreased stance phase hip extension and swing phase knee flexion and 
increased movement variability. With implanted FES, similar improvements as with 
surface-based FES were observed for hip and knee flexion angles, COV
hip
 and COV
knee
, 
T
swing
asym and for V
plfl
. Walking ability without any device was measured, although only 10 
gait cycles on the treadmill could be performed. The movement pattern was characterized 
by large variability and asymmetry, but could not be compared with previous assessments 
because measurements without a device were lacking at those instants.
The increased joint excursions and decreased joint motion variability with FES are 
illustrated in Figure 7.1. In addition, this figure shows that with FES the joint angles at the 
paretic side closely resembled those at the nonparetic side, whereas with the AFO the 
joint excursions showed substantial differences between the lower limbs with a time 
shift in the start of the swing phase. These results demonstrate that with FES, the 
movement pattern became more symmetrical and that particularly, the ranges of 
motion at the ankle, knee and hip were almost normalized.140 
Figure 7.2   Plantar flexion torque at the affected ankle, averaged over 3 trials in 
each of the conditions. Abbreviation: NO, no orthosis..
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Kinetic data were only obtained at t2. Profiles of ankle torques with FES, AFO, and 
without device are provided in Figure 7.2. Consistent with the data for V
plfl
, maximal 
ankle plantar flexion torques at push-off (M
plfl
) were larger with FES than with AFO or 
without device (1.50, 0.93 and 1.15 Nm/kg, respectively) (Table 7.2). 
The obstacle avoidance success scores were better with surface-based and implanted 
FES (68% and 90% success, respectively) than with the AFO (0% - 17%) (see Table 7.2). In 
contrast, the comfortable walking speed did not differ between AFO and FES (1.04 m/s 
with both devices). 
Discussion 
In our patient, knee and hip movements almost normalized when he walked with FES, 
which was reflected by increased knee and hip flexion angles, decreased knee and hip 
motion variability, and increased movement symmetry (see Table 7.2). Remarkably, the 
active ankle push-off benefited from FES. In addition, the ability to avoid sudden 
obstacles during walking improved with FES. These results indicate that peroneal FES 
not only elevates the foot, but may improve the entire gait pattern after stroke, even 
when walking is affected by severe hemiparesis.
In order to evaluate whether this potential of peroneal FES has been addressed 
previously, a literature search was conducted. Gait speed appeared to be used most 
frequently as an outcome measure. However, gait speed does not provide information 
about the quality of the walking pattern. Indeed, our patient had an almost normal gait 
speed,141 yet a very asymmetric and inefficient gait pattern at baseline (see t0 in Table 
7.2). The effects of peroneal FES on knee and hip motion angles during gait have only 
been reported in 2 pre-experimental studies41, 45 showing inconclusive results. Hence, 
the possibility of more extended effects of FES on the hemiparetic walking pattern has 
received little attention. Some mechanisms have been suggested that might explain 
the extended effects of FES that we observed. First, peroneal FES might reduce 
lower-limb spasticity.11, 12 However, in our patient, this mechanism is not likely because 
the modified Ashworth scores at baseline (see Table 7.1) indicated no signs of spasticity. 
Particularly in spinal cord injured patients, it has been observed that peroneal FES may 
facilitate the lower-limb flexion reflex.10 In our patient, maximal knee and hip flexion 
increased with FES (see Table 7.2), which might indeed be indicative of such flexion 
reflex facilitation. An additional observation in our patient might support this notion. 
When he was sitting on a chair, he was not able to flex his paretic hip to lift his leg from 
the ground, whereas with FES he was able to do so. On the other hand, the movement 
sequence for swing initiation as observed in all conditions was similar to the sequence 
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in normal gait and started with knee flexion, followed by hip flexion and finally ankle 
dorsiflexion.140 When the flexion reflex would have been triggered in a stationary 
position, the onset of hip, knee and ankle movements would have typically occurred 
simultaneously, which renders this possibility less likely. Nevertheless, because we did 
not record muscle activations and because gait is influenced by passive mechanical 
constraints as well, preservation of the normal movement sequence does not preclude 
the possibility of a facilitated flexion reflex. Another mechanism that has been 
mentioned in the literature is that, in contrast to most AFOs, FES allows the use of 
residual active ankle plantar flexion at push-off.32 Such increased plantar flexion power 
increases knee flexion during pre-swing and, thus, facilitates the swing phase of gait.13 
Indeed, the increased V
plfl
 (see Table 7.2) indicated that with FES our patient had faster 
plantar flexion movements at push-off. The increase in M
plfl
 at t2 showed that with FES 
also the ankle plantar flexion torques increased to normal values (see Table 7.2), which 
confirms that the increased ankle plantar flexion velocity reflected an active propulsion. 
However, the precise mechanism underlying the improved ankle push-off with FES in 
our patient is not clear. It might be related to less dependency on a compensatory 
movement strategy that he had developed to overcome impaired swing phase 
initiation. Both with the AFO and without a device, he showed excessive hip exorotation 
during the stance phase, which may have enabled him to use the inertia of the trunk to 
initiate the subsequent swing of the leg (see videos on http://www.neurorehab.nl/
APMR_english.htm). This increased hip exorotation might explain the decreased hip 
extension and ankle dorsiflexion during the stance phase as observed with and without 
AFO at t2 (see Table 7.2). With FES, there was improved hip extension (without 
exorotation) and increased ankle dorsiflexion during the stance phase, which may have 
contributed to an increase in push-off ankle torque due to more passive stretch of the 
calf muscle. The larger ankle plantar flexion velocity may have further added to the 
increased push-off power with FES.
With respect to the functional benefits related to FES in our patient, we expected him 
to have better walking abilities with peroneal FES on regular, but even more so, on 
irregular terrain. The large improvement in obstacle avoidance success rates confirmed 
that his advanced gait skill had indeed substantially improved with FES. Such 
improvements might also have led to safer ambulation during daily life. Indeed, our 
patient reported to fall about once a week with his AFO, whereas he reported no more 
falls with FES. With FES, he experienced an improvement of balance and went out for a 
walk, which he was reluctant to do with his AFO. With respect to comfortable walking 
speed, we observed no difference between AFO and FES, whereas previous work on the 
L300® and the ActiGait® systems reported increased speeds (34%7 and 19%142, 
respectively) for walking with FES in the long term compared with walking without FES 
at baseline. The difference with the present study can most likely be attributed to the 
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almost normal initial walking speed of our patient, which probably prevented any 
FES-induced improvement. Previous studies did not evaluate the effects of the L300 or 
ActiGait on the quality of the gait pattern in terms of kinematics. 
In order to convincingly demonstrate the potential superiority of FES over an AFO in our 
patient, the finding of a deterioration of gait with the AFO at t2 needs to be further 
clarified. In the year that the patient waited for implantation, he retired from his 
profession and reduced his activity level. At a gait assessment 2 weeks before 
implantation, the gait pattern already showed deteriorations similar to those observed 
at t2, with absent hip extension, decreased knee flexion angles, and increased movement 
variability. This indicated that the deterioration of gait at t2 was not related to the 6 
months of FES use, but was most likely due to the decrease in physical activity before 
the implantation of FES. Whether a similar deterioration was also present in his gait 
pattern without any device could not be evaluated because of the lack of walking 
assessments without any device at t0 and t1.
Conclusions
The presented case study shows that peroneal FES may have important effects on the 
entire hemiparetic gait pattern beyond what can be attributed to improved foot lift 
alone. The effects of FES on knee and hip motion angles as well as on gait symmetry, 
gait variability and obstacle avoidance skills call for further research including these 
outcome measures and the most commonly used walking speed. Furthermore, 
fundamental studies are needed on the neural and biomechanical mechanisms that 
may underlie the observed extended effects of peroneal FES.119 Finally, because the 
extended effects of FES in our patient may not be generalized to other patients, future 
research should try to identify the subject characteristics that are predictive of such a 
beneficial response in patients with hemiparesis due to stroke.
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Summary
Many people in the chronic phase after stroke experience gait deficits that limit their 
community ambulation. A common gait deficit after stroke is the inability to elevate the 
foot during the swing and loading phase, the so-called ‘drop foot’. The standard of care 
to improve gait in persons with stroke-related drop foot is to prescribe an ankle-foot 
orthosis (AFO), but nowadays functional electrical stimulation (FES) of the peroneal 
nerve is growing as an alternative treatment option.
In Chapter 1 a systematic literature search established the evidence of the orthotic effect of 
peroneal FES on walking speed in persons post stroke compared to walking without any 
device. In addition, this search identified two shortcomings of the current literature on this 
topic. Firstly, walking with FES is most commonly compared to walking without any device, 
whereas it is particularly relevant for clinical decision making to compare between walking 
with FES and with AFO. Until the start of this project, there was no conclusive evidence on 
the superiority of peroneal FES compared to AFO. Secondly, the most common outcome 
measure in the evaluation of the effects of FES is walking speed. Yet, FES users report 
perceived benefits of FES in terms of gait confidence and the risk of tripping. In addition, 
benefits of FES have shown to be particularly relevant for complex gait, like walking on 
uneven surfaces. These profits of FES may not be reflected by measurements of walking 
speed. Safety of walking might be even more important than walking speed in people post 
stroke, as indicated by high fall rates in this population, even in well-recovered community-
dwelling people. In this perspective, it is clinically relevant to compare FES and AFO for their 
effects on the safety of gait. Safe community walking requires continuous adaptation of gait 
to the changing environment. Thus, reduced adaptability of gait contributes to an increased 
risk of falls in daily life. Because the presumed effects of peroneal FES may go beyond the 
realization of active foot lift by improving the entire movement pattern of the paretic leg, it 
was hypothesized that FES might also improve the adaptability of gait and, thus, contribute 
to the safety of walking in community-dwelling people post stroke. 
Hence, the primary aim of this thesis was to evaluate the effects of peroneal FES 
compared to AFO with regard to gait adaptability in persons with stroke-related drop 
foot. To this aim, it was considered important to have knowledge about the adaptability 
of gait in persons post stroke. Indeed, insight in underlying gait deficits will support the 
understanding of the presumed benefits of peroneal FES for gait adaptability. Previous 
research has suggested a reduced gait adaptability after stroke, however, the underlying 
deficits in motor control have remained largely unaddressed. Therefore, the secondary 
aim of this thesis was to gain insight in online gait adaptations and underlying motor 
control after stroke. This topic was addressed first in Part I. Thereafter, the effects of 
peroneal FES compared to AFO are evaluated with regard to gait adaptability in Part II.
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Part I: Online gait adaptations and underlying motor control after stroke
In Part I the online adaptability of gait to environmental changes was compared 
between community-dwelling persons in the chronic phase after stroke (> 6 months 
post stroke) and healthy controls. To this aim, an obstacle avoidance paradigm on a 
treadmill was used. While walking on the treadmill, an obstacle was suddenly released 
in front of the paretic foot of the participants with stroke and in front of the left foot of 
the control subjects. The participants were instructed to adapt the length of the 
ongoing stride in order to avoid the obstacle. The following research questions were 
answered using this paradigm:
1. (a) Is the capacity to adapt gait to sudden environmental changes reduced in persons 
post stroke compared with healthy controls? (b) Which deficits in neuromuscular control 
underlie the expected disability in persons post stroke?
In Chapter 2 the hypotheses were tested that (a) the online gait adaptability is reduced 
in persons post stroke and (b) delayed and weak muscle responses contribute to this 
presumed reduction of gait adaptability. To this end, obstacle avoidance capacity was 
compared between an experimental group that consisted of 25 persons post stroke 
(Functional Ambulation Categories score 5; aged 51 ±13 years) and a control group 
consisting of 25 persons of similar age without any neurological or orthopedic disorder. 
All participants performed 30 obstacle avoidance trials on the treadmill. The obstacle 
avoidance success rates were determined. Furthermore, the electromyographic (EMG) 
activity of biceps femoris, rectus femoris, tibialis anterior and gastrocnemius medialis 
muscles were recorded bilaterally with concomitant knee and hip kinematics in the 
sagittal planes. Finally, spatial characteristics of the avoiding stride were computed. The 
results showed clearly decreased success rates of obstacle avoidance in the stroke 
group compared to the controls, most prominently when the time to respond to the 
obstacle decreased. Furthermore, delayed and decreased muscle responses were 
identified as one of the possible mechanisms underlying the reduced gait adaptability 
in persons post stroke. These deviant muscle responses were particularly observed in 
the prime movers: the biceps femoris muscle of the paretic leg and the rectus femoris 
muscle of the non-paretic leg. Coherent with the deviant EMG responses, knee and hip 
angle courses deflected less from unperturbed walking compared to the control group. 
Spatial characteristics of the avoiding stride showed that the participants post stroke 
landed closer to, and more often in contact with, the obstacle. The findings confirmed 
our hypothesis that the online gait adaptability is reduced, even in persons who are only 
‘mildly’ affected by stroke, particularly when there is little time to execute the stride 
adjustment. The delayed muscle responses of the prime movers in people with stroke 
suggest that they use different neural pathways for online step adjustments, which 
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might involve cognitive control. This notion raised the question whether the control of 
gait adaptations in persons post stroke is associated with increased attentional demands.
2. Are gait adaptations associated with higher attentional demands in persons post stroke 
than in healthy controls?
Chapter 3 tested the hypothesis that the attentional demands of online gait adaptations 
are higher in persons post stroke than in healthy controls. A subset of eight patients 
(aged 57 ±15 years) and eight healthy controls (aged 54 ±15 years) from the subjects in 
Chapter 2 participated. In addition to the obstacle avoidance paradigm, the participants 
performed a secondary cognitive task (i.e., an auditory Stroop task). Eighteen obstacle 
avoidance trials on the treadmill were performed in each of two conditions: with and 
without the concurrent cognitive task. Dual-task costs were assessed both on the 
obstacle avoidance and on the cognitive task. The outcomes on the motor task were 
the obstacle avoidance success rates and muscle reaction times of the biceps femoris 
and rectus femoris bilaterally. On the cognitive task, the outcome was a composite 
score of accuracy and reaction time. The results showed no differences between the 
groups for dual-task costs on the motor task: in both groups, the addition of the 
cognitive task resulted in similar deterioration of muscle reaction times and unchanged 
success scores. However, the composite Stroop score while crossing the obstacles 
deteriorated more in the stroke group than in the controls compared with the responses 
just before and after obstacle crossing. In conclusion, dual-task costs on onset latencies 
and Stroop performance were observed in both people with stroke and healthy 
subjects, demonstrating that avoiding obstacles imposes attentional demands on both 
groups. However, the higher dual-task costs on the Stroop task confirm the hypothesis 
that the attentional demands of online gait adaptations are higher in persons post 
stroke than in healthy controls. Participants post stroke dealt with the increased 
attentional demands by prioritizing the motor task over the cognitive task, as suggested 
by the absence of stroke-related dual-task costs on the obstacle avoidance task. This 
so-called ‘posture-first strategy’ can be considered a safe strategy in challenging 
situations as the current obstacle avoidance paradigm. Still, in daily life, the increased 
dual-task interference as observed in the cognitive task performance may place people 
with stroke at risk when their gait is challenged and concurrent tasks demand attention. 
3. Is the capacity to restore steady gait after a step modification reduced in persons post 
stroke compared with healthy controls?
In Chapter 4 the hypothesis was tested that persons post stroke demonstrate more 
persistent deviations in step characteristics after crossing an obstacle. To this end, the 
restoration of gait after crossing the obstacle was compared between 20 persons post 
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stroke (aged 54.1 ±11 years) and 20 healthy controls of similar age, who all performed 30 
obstacle avoidance trials on the treadmill. Outcomes were success rates of obstacle 
avoidance as well as post-crossing step length, step duration, hip flexion angle at foot 
strike, and peak hip extension of the steps measured within 10 s following obstacle 
release. The results showed lower success rates in the persons post stroke than in the 
controls. Furthermore, first post-crossing step length and duration of the participants 
post stroke (i.e., the non-paretic step) deviated more from steady gait than those of 
controls (i.e., the right step), with lower values for persons post stroke. For peak hip 
extension in the first post-crossing stride with the paretic/left leg, the same pattern was 
found, with lower values in the participants post stroke than in the controls. These 
findings may be explained by the large crossing stride over the obstacle with increased 
hip flexion angles at foot strike, similarly in both groups. The increased hip flexion angles 
roughly reflect how far the foot is placed in front of the trunk at foot strike behind the 
obstacle. Consequent to the increased hip flexion at foot strike, increased propulsion is 
required to progress the trunk forward over the lead foot. The weaker paretic leg may 
be unable to generate the required increased propulsion, culminating in insufficient 
forward displacement of the trunk over the supporting foot during paretic single-limb 
support behind the obstacle. Consequently, paretic hip extension and non-paretic step 
length decreased. Furthermore, the first post-crossing step durations with the 
non-paretic leg were shortened in persons post stroke, probably as a result of shortening 
of the duration of the single-support phase on the paretic leg. Usually, persons post 
stroke functionally adjust their gait to postural imbalance by reduction of the 
single-support phase of the paretic leg. Further shortening of this phase following 
obstacle crossing may, therefore, be interpreted as a symptom of postural imbalance 
induced by the large crossing stride. In conclusion, persons post stroke have reduced 
gait adaptability, as evidenced by lower success rates of obstacle avoidance as well as by 
an impaired capacity to restore steady gait after crossing an obstacle. The persistent 
deviations in step characteristics after obstacle crossing can be attributed to asymmetric 
propulsion generating capacity as well as to postural imbalance during the single- 
support phase of the paretic leg.
 
Part II: The effects of peroneal FES compared with an AFO on gait adaptability 
in persons with stroke-related drop foot
In Part II the potential surplus value of peroneal FES over an AFO for the treatment of 
stroke-related drop foot was investigated. To this aim, 26 community-dwelling persons 
in the chronic phase of stroke (Functional Ambulation Categories score 5; aged 53 ± 13 
years) participated in a study using a within-subjects design; 24 participants completed 
the study. All participants suffered from a drop foot for which they used an AFO. During 
an 8-week study protocol, the participants were provided with a surface-based peroneal 
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FES device (NESS L300®). Measurements of gait capacity were performed at baseline, 
regarding walking with AFO, and at week 2 and 8 of the protocol, regarding walking 
with AFO as well as with FES. The following research questions were addressed:
4. Is transcutaneous stimulation of the common peroneal nerve superior to an ankle-foot 
orthosis regarding patients’ satisfaction and walking performance in persons post stroke 
with a drop foot?
In Chapter 5 the hypothesis was tested that community-dwelling persons with chronic 
stroke wearing an AFO would benefit from a transfer to peroneal FES. To this end, the 
10-meter comfortable walking speed was recorded at baseline with the AFO and at 
week 2 and 8 of the protocol with AFO and FES. Furthermore, the level of physical 
activity was assessed with a pedometer that was worn for one week at home. The 
participants’ satisfaction was assessed with a custom-made questionnaire. Both the 
level of physical activity and participants’ satisfaction were assessed at baseline with the 
AFO and at week 8 with FES. The results showed that the participants judged FES 
superior to their AFO regarding the effort and stability of walking, the quality of the gait 
pattern, the walking distance, the comfort to wear and the appearance of the device. 
The quantitative measurements of comfortable walking speed and activity level did not 
discriminate between FES and AFO. It was concluded that common measures of 
ambulation, such as walking speed and activity level, were insensitive to the perceived 
benefits of FES compared to AFO. 
5. Is transcutaneous stimulation of the common peroneal nerve superior to an ankle-foot 
orthosis regarding gait adaptability?
Chapter 6 tested the hypothesis that the capacity to avoid a sudden obstacle is better 
with FES than with AFO in persons with stroke-related drop foot. To this aim, the 
participants performed 30 trials of obstacle avoidance (see Part I) in either of two 
conditions (AFO and FES), both at week 2 and 8 of the study protocol. The primary 
outcome was the obstacle avoidance success rate. Success rates were higher with FES 
than with AFO, which confirmed the hypothesis for the group at large. Yet, the observed 
benefits of FES with regard to obstacle avoidance success rates were rather small, and 
the between-subject variability was large. Post hoc analysis revealed that particularly 
participants with relatively low muscle strength (Motricity Index < 64%) of the affected 
leg benefitted most from FES in terms of gait adaptability. Thus, the surplus value of FES 
over AFO may be clinically relevant in only a particular subset of people with stroke 
suffering from drop foot. Further work is needed to determine whether the results may 
be generalized to other groups of people with stroke and it remains to be elucidated 
which underlying determinants are most critical for the surplus value of FES. 
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6. (a) What aspects of functional superiority of peroneal FES over AFO can be distinguished 
in the case of an excellent responder? (b) Can the gait pattern with FES in such an 
excellent responder shed light on the potential working mechanisms underlying this 
superiority?
Chapter 7 reports the functional effects of peroneal FES in one of the participants of 
the study who was an extraordinarily good responder. This participant was hardly able 
to walk without any device and was used to wearing an AFO for severe drop foot. His 
AFO was first replaced by a surface-based peroneal FES device (NESS L300®). In second 
instance, he received an implantable FES system (Actigait®) to overcome the problem of 
skin irritation with the surface-based device. With both FES devices, an improvement of 
the entire gait pattern was observed that went beyond an improvement of foot lift. Hip 
and knee flexion angles and ankle push-off power during walking improved to normal 
values. The gait pattern with FES was almost symmetrical and less variable than with the 
AFO. Furthermore, his capacity to avoid a sudden obstacle improved to normal values 
with FES. Regarding the working mechanism underlying the response to FES in this 
patient, an improved ankle push-off was suggested as the main mechanism. Besides, a 
triggering of a lower-limb flexion reflex may have played a role.
General Discussion
First, the potentials of the obstacle avoidance paradigm for assessment and rehabilitation 
of the stroke population are discussed. Then, the clinical implications of the superiority 
of peroneal FES over AFO regarding gait adaptability are evaluated and, subsequently, 
the working mechanisms underlying this superiority are explored. Finally, perspectives 
for future research are addressed. 
The obstacle avoidance paradigm in persons post stroke
The obstacle avoidance paradigm aims to quantify the capacity of an individual to 
adapt gait to environmental constraints. Part I of this thesis explored the potentials of 
this paradigm to quantify the adaptability of gait in persons post stroke. Most previous 
studies that tested complex walking skills in persons post stroke have used an 
overground walking obstacle avoidance paradigm.15, 40, 56 Such paradigms allow persons 
to slow down and, thus, reflect what people would naturally do to compensate, 
opposed to what people are capable of. The obstacle avoidance paradigm applied in 
this thesis challenges the participants at the very limits of their abilities. Thus, their 
maximum capacity to perform online step adaptations is tested. An additional 
advantage of the applied treadmill procedure is that the level of difficulty can be 
controlled and tuned to the gait cycle by computerized triggering of the obstacle 
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release: the later the obstacle falls on the treadmill, the less time one has to respond and 
the more difficult it is to adapt the ongoing stride to the obstacle.
Better obstacle avoidance ability in the treadmill paradigm has previously been reported 
to coincide with a lower fall risk in healthy elderly.54 Although similar evidence of its 
construct validity is not available for people in the chronic phase after stroke, it is likely 
that this test is also valid for community-dwelling people post stroke. Further research 
is recommended, including prospective monitoring of fall incidents in daily life, to 
convincingly answer the question whether an improvement of the gait adaptability is 
truly relevant for the safety of daily life walking in people post stroke.
The results of Part I of the current thesis demonstrated that the capacity to online adapt 
gait is clearly reduced in persons post stroke, even in persons who seem to be well 
recovered from stroke and walk at an almost normal walking speed. Thus, the obstacle 
avoidance paradigm on the treadmill demonstrated to be sensitive for gait deficits that 
remained unnoticed by clinical tests of walking performance in this population. In 
addition, it was demonstrated to be sensitive to an improvement of post-stroke gait 
adaptability with peroneal FES compared to AFO, unlike more common clinical outcome 
measures such as gait speed and physical activity level (assessed with a pedometer). 
Therefore, this paradigm is recommended for future research to evaluate the effects of 
interventions on the adaptability of gait in persons with stroke.
The reduced gait adaptability in persons post stroke, as revealed in part I, suggests that 
the safety of their daily life ambulation is compromised. From a clinical perspective, 
interventions that aim to increase the gait adaptability might, therefore, be promising 
tools to enhance the safety of community ambulation after stroke. In therapeutic 
settings, time-constraint step modifications, including post-crossing restoration of gait, 
may be implemented. Previous research has demonstrated preliminary evidence for the 
clinical effectiveness of obstacle training for the improvement of walking ability post 
stroke.84, 143-145 Future research should confirm whether gait adaptability can be improved 
by such training and, if so, whether the effects translate to safer community ambulation. 
Specific training for gait adaptability can be combined with orthotic interventions, like 
FES or an AFO, to optimize the safety of gait. 
Clinical implications of increased gait adaptability with peroneal FES
The present work demonstrated superiority of peroneal FES over AFO regarding gait 
adaptability (Chapter 6), suggesting that peroneal FES may enhance the safety of gait 
(compared to AFO) as well. This would be coherent with the participants’ perception of 
improved stability of gait using FES. The presumed improvement of safety of gait with 
peroneal FES is a relevant point of consideration in the process of clinical decision 
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making. In patients who are only mildly affected by stroke and who have an almost 
normal gait speed, safety of gait might be even more relevant than walking speed or 
the level of physical activity. Regarding these two latter aspects of walking, this thesis 
provided evidence of equal effectiveness of peroneal FES and AFO in relatively well 
recovered persons with stroke (Chapter 5). Yet, there was superiority of FES over AFO 
with regard to gait adaptability, even though differences between the devices were 
small. It was concluded that potential benefits of FES might be clinically relevant only in 
a subset of people after stroke. Identification of a good response to FES is of great 
interest for the prescription of an orthotic device in individual cases. The current thesis 
made a start with the identification of persons with relatively poor muscle strength (Leg 
Motricity Index < 64%) who were found to have the greatest likelihood to be good 
responders to FES in terms of obstacle avoidance ability. Consistent with this finding, 
the participant who responded very well to FES (single-subject study of Chapter 7) had 
the lowest muscle strength (Leg Motricity Index score 27%) of all subjects included in 
this thesis. Interestingly, this person had no sign of lower-limb spasticity. Future research 
should further substantiate the notion that the combination of poor muscle strength and 
low spasticity is favorable for a beneficial response to peroneal FES.
Our conclusion on the superiority of FES over AFO regarding gait adaptability is restricted 
to the stroke population with relatively good walking ability (in terms of gait independence 
and speed) and balance (reflected by high scores on the Berg Balance Scale). At the start 
of the FES studies, it was decided to include community walkers in the chronic phase, 
because it was assumed that particularly in these persons the feasibility (e.g. device 
handling) and (cost-)effectiveness of peroneal FES would justify its clinical implementation. 
As a consequence, it remains unknown whether the conclusions also hold for persons 
who show lower levels of gait independence or speed, or who are in the sub-acute phase 
after stroke. Further research is recommended to investigate whether the findings in this 
thesis may be generalized to other subpopulations after stroke. 
Mechanisms underlying increased obstacle avoidance ability with 
peroneal FES 
 Knowledge of the working mechanisms of peroneal FES regarding the adaptability of 
gait may support the development and adequate prescription of FES devices. Although 
the current work demonstrates that gait adaptability increases with peroneal FES 
compared to AFO, it remains unknown to which working mechanisms the beneficial 
effects of FES can be attributed. 
Neuromuscular control of obstacle avoidance with FES and AFO
Three mechanisms have been suggested that may contribute to a presumed improvement 
of the entire lower limb movement pattern during the swing phase of gait with FES 
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compared to AFO (Chapters 1 and 7): a reduction of spasticity, facilitation of the flexion 
reflex and an increase in ankle plantar flexion power at push-off. These mechanisms 
relate to the orthotic effects of FES. In addition, modification of corticospinal connectivity 
due to long-term FES use may improve the entire synergistic movement pattern of the 
lower limb. Better neuromuscular control of the entire lower limb with FES might 
increase the capacity to adapt gait to environmental challenges. Deficits in 
neuromuscular control were identified as an important factor contributing to the loss of 
gait adaptability after stroke (Chapter 2). Regarding the paretic leg, these deficits were 
particularly observed in the biceps femoris muscle (BF-avoid). Therefore, increased 
obstacle avoidance success rates with FES may coincide with improved neuromuscular 
control. A comparison of BF-avoid onset latencies and amplitudes between AFO and 
FES seems to be the most appropriate approach to evaluate whether an increase in 
success rate with FES coincides with improved control of BF-avoid. However, there is a 
major problem that hampers the analysis of muscle EMG recordings when surface-based 
FES is used. The onset and amplitude of selective muscle activations of all lower-limb 
muscles are obscured by EMG potentials that are evoked by the electrical stimulation 
itself (see Figure 8.1). 
Current artifact removal algorithms aim to acquire m-waves, free from stimulus artifacts 
during electrical stimulation in rest.146 However, when one aims to quantify selective 
muscle activity in response to the obstacle, it is necessary to remove all stimulation-
evoked potentials from the EMG, including the m-wave due to stimulation. Moreover, 
the EMG data in this thesis were recorded during gait and not during rest. 
Algorithms that fulfill the necessary requirements might be based on subtraction 
methods147 that deal with the non-linearity in the stimulus components, or alternatively, 
might cut all stimulus-evoked parts out of the EMG signal (i.e. about 30%). The 
development and validation of such algorithms was beyond the goals of the current 
thesis, but they are useful for future analyses of EMG that is recorded during gait with 
FES. For the analysis of the obstacle avoidance trials with FES in the present thesis, stim-
ulus-evoked potentials could not be eliminated from the EMG recordings, which 
prohibited the determination of onsets and amplitudes of lower-limb muscle responses 
to the obstacle during FES. 
Kinematic characteristics of obstacle avoidance with FES and AFO  
Although the actual muscle responses to the obstacle cannot be quantified during FES 
enhanced gait, it is possible to determine the resulting kinematic changes. In Chapter 2 
it was concluded that, in SSS, the controls shortened their stride more effectively than 
the persons post stroke. This was due to quick deceleration of the forward swing of the 
avoiding leg, resulting in lower maximum hip flexion angles and increased knee flexion 
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angles at initial contact in front of the obstacle. In LSS, the controls lengthened their 
stride more adequately than the persons post stroke in order to land after the obstacle. 
Increased swing phase knee flexion in the controls was suggested to contribute to 
successful lengthening of this stride. In the participants post stroke, obstacle avoidance 
success rates improved with FES compared to AFO. It is possible that the increased 
success rates with FES can be attributed to an improvement of knee and hip kinematics. 
Thus, an additional analysis was performed to test this hypothesis. The obstacle 
avoidance data retrieved at week 8 of the study protocol were compared between FES 
and AFO according to the methods described in Chapter 2 (Appendix I). A similar 
comparison was made for lower-limb kinematics during unperturbed treadmill walking 
Figure 8.1   Example of raw EMG recordings of one unperturbed stride (from foot 
strike to foot strike) of the avoiding (i.e. paretic) leg in one participant 
post stroke.
The EMG amplitudes of stimulation-evoked potentials with FES (right windows) exceed the amplitudes of 
the physiological potentials as shown with AFO (left windows). This was observed not only in the 
stimulated anterior tibial muscle (TA-avoid; upper windows) but also in other ipsilateral lower-limb 
muscles, e.g. biceps femoris muscle (BF-avoid; lower windows).
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at week 8 of the protocol (Appendix II). The results could not confirm the hypothesis; 
higher obstacle avoidance success rates with FES were not accompanied by 
improvements of hip and knee kinematics during the avoiding stride in SSS nor LSS 
(Appendix I). In contrast, knee flexion in LSS tended to increase more with AFO (mean ± 
standard deviation = +7.5 ±2.9o) than with FES (+3.9 ±2.8o). Similarly, the results for 
unperturbed walking demonstrated no differences in hip and knee kinematics between 
FES and AFO (Appendix II). Hence, it must be concluded that the improved obstacle 
avoidance success scores with FES cannot be attributed to improved movement control 
of the hip and knee. This notion is in accordance with previous research26, 41 that reported 
no improvements of the movement patterns of hip and knee with FES. Although this 
conclusion may hold for the population at large, FES has been reported to improve the 
entire hemiparetic gait pattern in several descriptive studies,5, 31, 34, 45 as well as in the 
single-case report of this thesis (Chapter 7). Apparently, we are still unable to identify 
the critical determinants of a more generalized beneficial response to peroneal FES after 
stroke. This is an important target for future research.
Other promising parameters of obstacle avoidance with FES and AFO 
While it is clear that better obstacle avoidance ability with FES cannot be attributed to 
an improved movement pattern of the hip and knee, it remains unclear which 
mechanisms do contribute to the beneficial effects of peroneal FES. It may be that other 
parameters are able to reveal the underlying working mechanisms. For example, foot 
clearance over the obstacle may profit from improved ankle dorsiflexion during the 
swing phase of gait. Indeed, previous research has demonstrated an increased ankle 
dorsiflexion with peroneal FES during the swing phase of gait,41 even compared to 
AFO.26 In contrast to this latter study, the increase of swing phase ankle dorsiflexion with 
FES was not significant in the present thesis (see Appendes I and II). Use of an implanted 
FES device may have contributed to the differences between the studies. Furthermore, 
it was shown in this thesis that restoration of gait after obstacle avoidance is reduced 
post stroke, particularly in the first post-crossing stance phase of the paretic leg (Chapter 
4). Improved pre-positioning of the foot for initial contact behind the obstacle may 
facilitate post-crossing dynamic balance and restoration of gait. So far, however, the 
number of studies focusing on prepositioning of ankle eversion with FES remains quite 
limited providing preliminary evidence for improved ankle eversion during the stance 
phase of gait with FES compared with no device.30 
Another interesting parameter is the dual-task cost. It was shown that while avoiding 
obstacles higher attentional demands are imposed on people with stroke than on 
controls (Chapter 3). However, FES users experience less mental load,24 which may reflect 
a decrease in the attentional demands of walking. If so, FES should facilitate gait 
adaptability particularly under dual-task conditions. Thus, further research is 
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recommended to study the beneficial effects of peroneal FES compared to AFO under 
both single- and dual-task conditions by adding an attention-demanding (non-motor) 
task to a complex gait task (such as obstacle avoidance). Studying both three-dimen-
sional ankle, knee and hip kinematics would be necessary to understand differences in 
leg motor control during and after step modifications.
 
Recommendations for future research
This project evaluated the effects of a surface-based peroneal FES system. Such FES 
systems are most commonly used in the clinical setting, allowing the possibility to try 
out the benefits of a device in individual patients. Although surface-based FES may also 
be suitable for long-term use, an implantable system might be considered as a more 
permanent solution because of more precise stimulation of the peroneal nerve, less 
skin burden, easier use, and better cosmetics. Existing implantable FES devices have two 
(e.g. STIMuSTEP®) or even four (e.g. ActiGait®) independent channels. With more than 
one channel, ankle eversion and dorsiflexion can be better balanced, which is often 
necessary due to individual anatomical differences in the topography of the common 
peroneal nerve. Implantable FES systems, thus, solve the problem of ankle eversion-
dorsiflexion imbalance due to inadequate muscle recruitment that is sometimes 
encountered with surface-based systems. The movement pattern in the swing phase of 
gait and, perhaps more importantly, also the loading response will profit from a more 
balanced eversion-dorsiflexion of the ankle. A within-subjects comparison between 
transcutaneous and implanted FES may confirm this notion, but has not yet been made. 
Such a comparison is an important goal for future research.
The present work investigated gait adaptability while stepping with the paretic leg. It 
was hypothesized that differences between FES and AFO would be most prominent 
during the swing phase of the paretic leg, because of the timing of the stimulation 
(mainly during the swing phase). Nevertheless, gait adaptability while stepping with the 
non-paretic leg is probably equally important for the safety of community walking. A 
reduced adaptability of stepping in people with stroke can also be expected with the 
non-paretic leg.55, 56, 58, 148 During stepping adjustments with the non-paretic leg, 
dynamic balance on the paretic stance leg is challenged. Stepping adjustments require 
adaptation of muscle activity in both the stance and stepping leg, and disruption of this 
coupled activity may explain reduced accuracy of the adjustments performed by either 
leg.55, 58 From this coordination perspective, one could argue that a unilateral stroke 
affects both sides of the body. Thus, it would be interesting to compare peroneal FES 
with AFO with regard to the capacity to adapt the non-paretic step to a sudden obstacle 
as well. Because the electrical stimulation is absent during the main part of the stance 
phase, FES may show disadvantages compared to AFO while stepping with the 
non-paretic leg, especially in persons with reduced ankle-foot stability during the 
127
SUMMARY AND GENERAL DISCUSSION
8
single-support phase of the paretic leg. On the other hand, it has been shown that 
dynamic balance improves with peroneal FES compared to AFO,26, 32 probably due to 
better pre-positioning of the foot for initial contact and improved loading response. 
How possible benefits and adverse effects of peroneal FES might affect the capacity to 
perform complex gait modification with the non-paretic leg in subgroups of patients 
with stroke is an important topic for further research. 
The present thesis has focused on the orthotic effects of peroneal FES. Next to these 
orthotic (or neuro-prosthetic) effects, FES may induce neuroplasticity resulting in an 
improvement of walking capacity without stimulation in the long term. Such effects 
would imply a therapeutic potential of FES besides orthotic effects. Plastic changes may 
occur in both peripheral and central structures of the neuromuscular control systems. 
For example, muscle fibers may be strengthened and the spinal recruitment of the 
peripheral motor neurons may be improved by long-term neurostimulation. In addition, 
corticospinal connectivity may be strengthened.18, 19 There is, however, no conclusive 
evidence yet of the therapeutic effects of peroneal FES. Some researchers reported 
such effects on walking speed,16, 17, 149 but others could not confirm these findings.27, 133 In 
the current study, success rates in obstacle avoidance were generally higher at week 8 
than at week 2 (Chapter 6), which might be attributed to therapeutic effects. On the 
other hand, these training effects may also be related to task-specific learning of the 
obstacle avoidance task.150 It is a challenge for the future to elucidate both the existence 
and underlying mechanisms of the putative therapeutic effects of functional electrical 
stimulation of the lower limb after stroke.
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Appendix I: Characteristics of obstacle avoidance
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Appendix II: Characteristics of unperturbed walking 
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Samenvatting
'Dit proefschrift heeft als onderwerp ‘de sturing van complexe looptaken’ bij mensen 
in de chronische fase na een beroerte. De bewegingssturing van plotselinge stap - 
aan passingen tijdens het lopen wordt onderzocht. Hiernaast worden in dit proefschrift 
de effecten van functionele elektrostimulatie op dit aanpassingsvermogen geëvalueerd. 
Veel mensen in de chronische fase na een beroerte hebben loopstoornissen die hen 
beperken in het zelfstandig lopen in het dagelijks leven. Een veel voorkomende stoornis 
die de loopvaardigheid na een beroerte beperkt is het onvermogen de voet tijdens het 
lopen voldoende te heffen, ook wel een ‘sleepvoet’ genoemd (drop foot in het Engels). 
Standaard krijgen mensen met een sleepvoet ten gevolge van een beroerte een spalk, 
een enkel-voetorthese (EVO), voorgeschreven om hun loopvaardigheid te verbeteren. 
Tegenwoordig wordt functionele elektrostimulatie (FES) van de peroneuszenuw echter 
steeds belangrijker als alternatieve behandeloptie. Bij deze vorm van FES worden de 
voetheffersspieren via de peroneuszenuw elektrisch geprikkeld om aan te spannen 
tijdens de zwaaifase van het lopen. Op deze manier voorkomt men dat de voet tijdens 
het lopen over de grond sleept.
In Hoofdstuk 1 laat een systematisch literatuuronderzoek zien dat FES van de peroneus - 
zenuw als orthese een gunstig effect heeft op de loopsnelheid bij mensen na een 
beroerte wanneer dat vergeleken wordt met lopen zonder orthese. Verder toonde het 
onderzoek twee tekortkomingen aan van de beschikbare literatuur op dit gebied. In de 
eerste plaats wordt het lopen met FES doorgaans vergeleken met lopen zonder orthese 
terwijl het, ter ondersteuning van beslissingen in de klinische praktijk, relevanter zou 
zijn FES te vergelijken met een EVO. Tot het moment dat dit project van start ging was 
er geen sluitend bewijs dat FES van de peroneuszenuw beter is dan een EVO. In de 
tweede plaats is het meest voorkomende criterium bij de evaluatie van FES de 
loopsnelheid. De FES-gebruikers hebben echter aangegeven dat ze de voordelen van 
FES vooral ervaren als een groter gevoel van zekerheid bij het lopen en een kleiner risico 
om te struikelen. Bovendien is ook aangetoond dat de voordelen van FES vooral relevant 
zijn voor moeilijker looptaken, zoals het lopen op oneffen terrein. Het zou kunnen zijn 
dat deze voordelen van FES zich niet laten vertalen in een verbetering van de 
loopsnelheid. De veiligheid van het lopen zou voor mensen na een beroerte wel eens 
belangrijker kunnen zijn dan de snelheid ervan. Het aantal valincidenten onder mensen 
na een beroerte is immers groot, zelfs indien zij goed hersteld zijn en in staat zelfstandig 
te wonen. Daarom is het van klinisch belang de effecten van FES en een EVO te 
vergelijken met betrekking tot de veiligheid van het lopen. Een veilige, zelfstandige 
loopvaardigheid vereist het vermogen om het lopen voortdurend aan te kunnen 
passen aan veranderingen in de omgeving. Een vermindering van deze complexe loop-
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vaardigheid draagt bij aan een verhoging van het valrisico in het dagelijks leven. Van 
FES wordt verondersteld dat dit het aanpassingsvermogen van het lopen verbetert. 
Deze veronderstelling berust op de hypothese dat FES niet alleen de voet heft, maar het 
bewegingspatroon van het gehele aangedane been verbetert. Op deze wijze zou FES 
kunnen bijdragen aan de veiligheid van het lopen van mensen met een zelfstandige 
loopfunctie na een beroerte.
Het belangrijkste doel van dit proefschrift is een vergelijking tussen FES en EVO wat 
betreft het effect op het aanpassingsvermogen van het lopen bij mensen met een 
sleepvoet ten gevolge van een beroerte. Met dit doel voor ogen is het belangrijk over 
kennis van het aanpassingsvermogen van het lopen bij mensen na een beroerte te 
beschikken. Inzicht in de stoornissen die aan het beperkte aanpassingsvermogen ten 
grondslag liggen zal immers ten goede komen aan het begrip van de veronderstelde 
voordelen van FES voor dit aanpassingsvermogen. Eerder onderzoek heeft laten zien 
dat het aanpassingsvermogen na een beroerte verminderd is; de onderliggende 
stoornissen in bewegingssturing zijn echter grotendeels onopgehelderd gebleven. 
Daarom is het tweede doel van dit proefschift inzicht te vergaren in het vermogen de 
stap aan te passen tijdens het lopen en in de onderliggende bewegingssturing bij 
mensen na een beroerte. Dit onderwerp wordt eerst behandeld in Deel I. Daarna, in 
Deel II, worden de effecten van FES vergeleken met die van een EVO, wat betreft het 
aanpassingsvermogen van het lopen.
Deel I: Stapaanpassingen tijdens het lopen en de onderliggende 
bewegingssturing na een beroerte 
In Deel I wordt het vermogen om de stap tijdens het lopen aan veranderingen in de 
omgeving aan te passen vergeleken tussen zelfstandig wonende mensen in de 
chronische fase (> 6 maanden) na een beroerte en gezonde proefpersonen. Hiertoe 
werd een obstakel-ontwijkparadigma op een loopband gebruikt. Terwijl de proef -
personen op een loopband liepen, viel er plotseling een obstakel voor de paretische 
voet van de deelnemers met een beroerte en voor de linkervoet van de gezonde 
proefpersonen. De proefpersonen werden geïnstrueerd het obstakel te vermijden door 
hun stap te verlengen of te verkorten. Met behulp van dit paradigma werden de 
volgende onderzoeksvragen beantwoord. 
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1. (a) Is het vermogen om het lopen aan plotselinge veranderingen in de omgeving aan te 
passen verminderd bij mensen na een beroerte vergeleken met gezonde proefpersonen? 
(b) Welke stoornissen in de neuromusculaire sturing liggen ten grondslag aan de 
verwachte beperking hierin bij mensen na een beroerte?
In Hoofdstuk 2 worden de volgende hypotheses getoetst: (a) het vermogen om de 
stap aan te passen tijdens het lopen is verminderd bij mensen na een beroerte en (b) 
vertraging en verzwakking van spieractivatie dragen bij aan de veronderstelde 
vermindering van het aanpassingsvermogen van het lopen. Hiertoe werd het vermogen 
om obstakels te ontwijken vergeleken tussen een experimentele groep, bestaande uit 
25 personen na een beroerte (51 ±13 jaar oud), en een controlegroep, bestaande uit 25 
personen van vergelijkbare leeftijd zonder neurologische of orthopedische aandoening. 
Alle deelnemers voerden de obstakel-ontwijktaak op de loopband uit waarbij 30 maal 
getracht moest worden een obstakel te ontwijken. Hierbij werd het percentage 
succesvol ontweken obstakels bepaald. Verder werd de elektromyografische (EMG-) 
activiteit van de m. biceps femoris, m. rectus femoris, m. tibialis anterior en 
m. gastrocnemius (mediale deel) beiderzijds gemeten, synchroon met de kinematica 
van knieën en heupen in het sagittale vlak. Ten slotte werden enkele spatiële parameters 
van de ontwijkstap bepaald. De resultaten lieten een duidelijk verminderde obstakel-
ontwijkprestatie zien voor de experimentele groep in vergelijking met de controlegroep. 
Dit verschil werd nog duidelijker wanneer de tijd die beschikbaar was om op het 
obstakel te reageren afnam. Verder werden vertraagde en verminderde spierreacties 
geconstateerd als factoren die mogelijk ten grondslag liggen aan het verminderde aan-
passingsvermogen van het lopen bij mensen na een beroerte. Deze afwijkende 
spierreacties werden vooral gezien bij de spieren die bij de gezonde proefpersonen als 
eerste reageerden: de m. biceps femoris van het paretische been en de m. rectus 
femoris van het niet-paretische been. In overeenstemming met de afwijkende 
EMG-reacties weken de profielen van knie- en heuphoeken bij mensen na een beroerte 
minder af van de profielen tijdens onverstoord lopen dan bij de gezonde proefpersonen. 
Spatiële parameters van de ontwijkstap lieten zien dat de personen na een beroerte 
dichterbij, en vaker bovenop, het obstakel landden. De bevindingen bevestigden de 
hypothese van een verminderd aanpassingsvermogen van het lopen bij mensen na 
een beroerte, zelfs bij mensen die hierdoor slechts ‘licht’ waren aangedaan. Het 
vermogen was vooral verminderd wanneer er weinig tijd beschikbaar was om de stap 
aan te passen. De vertraagde spierreacties bij mensen na een beroerte van juist die 
spieren die als eerste dienen te reageren doen vermoeden dat personen na een 
beroerte andere neurale circuits gebruiken voor de sturing van online stapaanpassin-
gen, waarbij meer cognitieve sturing betrokken zou kunnen zijn. Deze suggestie roept 
de vraag op of de sturing van stapaanpassingen tijdens het lopen meer aandacht vraagt 
van mensen na een beroerte dan van gezonde personen. 
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2. Vergen stapaanpassingen tijdens het lopen meer aandacht van personen na een 
beroerte dan van gezonde proefpersonen? 
In Hoofdstuk 3 wordt de hypothese getoetst dat stapaanpassingen tijdens het lopen 
meer aandacht vragen van mensen na een beroerte dan van gezonde proefpersonen. 
Er namen 8 patiënten (57 ±15 jaar oud) en 8 gezonde proefpersonen (54 ±15 jaar oud) 
deel die allen ook in de studie van Hoofdstuk 2 deelnamen. Tegelijk met de obstakel-
ontwijktaak voerden de proefpersonen een tweede, cognitieve taak uit (welke bestond 
uit een auditieve Stroop-taak). De proefpersonen trachtten 18 maal een obstakel op de 
loopband te ontwijken in elk van twee condities: mét of zónder de gelijktijdige 
cognitieve taak. De extra belasting die de dubbeltaak met zich meebracht werd 
beoordeeld voor de obstakel-ontwijktaak en de cognitieve taak. Voor de motorische 
taak waren de uitkomstmaten het percentage succesvol ontweken obstakels en de 
reactietijden van de m. biceps femoris en m. rectus femoris beiderzijds. Voor de 
cognitieve Stroop-taak was dit een samengestelde score van nauwkeurigheid en 
reactietijd. De resultaten lieten geen verschil tussen de groepen zien wat betreft de 
extra belasting van de dubbeltaak op de uitkomsten van de motorische taak: de 
toevoeging van de cognitieve taak resulteerde in vergelijkbare toename van de 
reactietijd en in gelijkblijvende succespercentages voor beide groepen. De 
samengestelde Stroop-score verslechterde echter meer bij de patiënten dan bij de 
gezonde proefpersonen op het moment dat het obstakel werd gepasseerd in 
vergelijking met de scores net voor en na passage van het obstakel. De onderzoeksre-
sultaten leiden tot de conclusie dat de dubbeltaak voor beide groepen een extra 
belasting met zich meebrengt op de reactietijden van de spieren en op de 
samengestelde Stroop-score. Dit toont aan dat het ontwijken van obstakels extra 
aandacht vergt van zowel mensen na een beroerte als van gezonde proefpersonen. Die 
extra aandacht is echter meer bij mensen na een beroerte dan bij gezonde mensen, 
zoals de grotere belasting op de samengestelde Stroop-score bij de patiënten dan bij 
de gezonde proefpersonen laat zien. Bij deze toename van aandacht voor het vermijden 
van een obstakel, geven mensen met een beroerte prioriteit aan de motorische taak 
boven de cognitieve taak, zoals blijkt uit de afwezigheid van extra, aan de beroerte 
gerelateerde, dubbeltaakbelasting op de uitkomsten van de obstakel-ontwijktaak. Deze 
strategie waarbij aan de handhaving van de lichaamspositie voorrang wordt gegeven 
(posture-first strategy in het Engels) kan als een veilige keuze worden beschouwd in 
uitdagende situaties zoals de huidige obstakel-ontwijktaak. De extra belasting die de 
dubbeltaak met zich meebrengt kan mensen met een beroerte echter in het dagelijks 
leven in gevaar brengen wanneer zij een ingewikkelde looptaak uitvoeren terwijl 
tegelijk andere taken hun aandacht vergen. 
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3. Is het vermogen om het normale looppatroon na een stapaanpassing te herstellen 
verminderd bij mensen na een beroerte in vergelijking met gezonde proefpersonen? 
In Hoofdstuk 4 wordt de hypothese getoetst dat mensen na een beroerte na passage 
van een obstakel langduriger afwijkingen in hun stappatroon vertonen. Hiertoe werd 
het herstel van het looppatroon na passage van een obstakel vergeleken tussen 20 
personen na een beroerte (54.1 ±11 jaar oud) en 20 gezonde proefpersonen van 
vergelijkbare leeftijd. Alle proefpersonen trachtten 30 maal een obstakel op de 
loopband te ontwijken. De uitkomstmaten waren het percentage succesvol ontweken 
obstakels en een aantal parameters van de stappen die in de eerste 10 seconden na 
passage van het obstakel gemaakt werden. Deze parameters waren: de staplengte en 
-duur, heup-flexiehoek op het moment dat de voet werd neergezet en de maximale 
heup-extensiehoek. De succespercentages waren lager voor de personen na een 
beroerte dan voor de gezonde proefpersonen. Verder verkortten de deelnemers met 
een beroerte de eerste stap na passage van het obstakel sterker dan de gezonde 
proefpersonen, zowel in lengte als duur. Deze stap was met het niet-paretische been 
voor de deelnemers met een beroerte en het rechterbeen voor de gezonde 
proefpersonen. Voor de strekking van de heup van het standbeen tijdens deze stap 
werd hetzelfde patroon gevonden: een sterkere reductie voor de paretische heup bij de 
deelnemers met een beroerte dan voor de linker heup bij de gezonde proefpersonen. 
De resultaten bevestigen de hypothese dat mensen na een beroerte een verminderd 
aanpassingsvermogen van het lopen hebben. Deze conclusie wordt ondersteund door 
zowel de lagere succespercentages als het verminderd vermogen om na passage van 
het obstakel het oude looppatroon te hervatten. Het feit dat mensen met een beroerte 
na passage van een obstakel langduriger afwijkingen in hun stappatroon vertonen dan 
gezonde proefpersonen kan worden toegeschreven aan het verminderd vermogen 
van de paretische heup om propulsie te leveren en aan problemen bij de balanshand-
having gedurende de monopedale fase op het paretische been na passage van het 
obstakel. 
Deel II: De effecten van FES van de peroneuszenuw vergeleken met een  
EVO wat betreft het aanpassingsvermogen van het lopen bij mensen met een 
sleepvoet ten gevolge van een beroerte. 
In Deel II werd de mogelijke meerwaarde van FES ten opzichte van een EVO in de 
behandeling van een sleepvoet na een beroerte onderzocht. Aan dit onderzoek, waarin 
de deelnemers met zichzelf werden vergeleken onder verschillende condities, namen 
26 zelfstandig wonende mensen in de chronische fase na een beroerte (leeftijd: 53 ±13 
jaar) deel; 24 van hen hebben de studie ook helemaal doorlopen. Alle deelnemers 
hadden een sleepvoet waarvoor zij een EVO gebruikten. Gedurende het studieprotocol 
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(8 weken) schakelden de deelnemers over op een FES-apparaat dat gebruik maakte van 
oppervlaktestimulatie (de NESS L300®): de elektrische prikkeling wordt hierbij via de 
huid aan de peroneuszenuw overgedragen. De loopvaardigheid werd gemeten bij 
aanvang wat betreft het lopen met een EVO, en op week 2 en 8 van het studieprotocol 
wat betreft zowel het lopen met een EVO als met FES. De volgende onderzoeksvragen 
werden behandeld:
4. Is oppervlaktestimulatie van de peroneuszenuw beter dan een EVO wat betreft de 
tevredenheid en de loopfunctie van mensen met een sleepvoet na een beroerte?
In Hoofdstuk 5 werd de hypothese getoetst dat zelfstandig wonende mensen met een 
relatief goede loopfunctie met een EVO in de chronische fase na een beroerte profijt 
hebben van een overstap naar FES. Hiertoe werd de 10-m comfortabele loopsnelheid 
gemeten bij aanvang met de EVO en op week 2 en 8 van het studieprotocol met zowel 
EVO als FES. Verder werd het activiteitenniveau in het dagelijks leven gemeten met 
behulp van een stappenteller die gedurende 1 week thuis werd gedragen. De 
tevredenheid van de deelnemers werd gemeten met een zelfgemaakte vragenlijst. 
Zowel het activiteitenniveau als de tevredenheid werden bij aanvang gemeten met de 
EVO en op week 8 met FES. De resultaten lieten zien dat de deelnemers een meerwaarde 
van FES ervoeren boven hun EVO wat betreft de inspanning en de stabiliteit van lopen, 
de kwaliteit van het looppatroon, de loopafstand, het draagcomfort en het uiterlijk van 
het apparaat. De kwantitatieve uitkomstmaten, de loopsnelheid en het activiteitenni-
veau, verschilden echter niet tussen FES en EVO. Op basis hiervan werd geconcludeerd 
dat meetinstrumenten die doorgaans gebruikt worden om de loopvaardigheid te 
meten, zoals de loopsnelheid en het activiteitenniveau, ongevoelig zijn voor de ervaren 
voordelen van FES vergeleken met een EVO bij mensen met een relatief goede 
loopfunctie. 
5. Is oppervlaktestimulatie van de peroneuszenuw beter dan een EVO wat betreft het aan-
passingsvermogen van het lopen?
Hoofdstuk 6 toetste de hypothese dat het vermogen om een plotseling obstakel te 
vermijden tijdens het lopen beter is met FES dan met een EVO bij mensen met een 
sleepvoet na een beroerte. Hiertoe trachtten de deelnemers 30 maal een obstakel op 
de loopband te ontwijken in elk van beide condities (met EVO en met FES) (zie Deel I). 
Ze deden dit zowel op week 2 als week 8 van het onderzoeksprotocol. De belangrijkste 
uitkomst was het percentage succesvol ontweken obstakels. De succespercentages 
waren significant hoger met FES dan met EVO, wat de hypothese voor de groep als 
geheel bevestigde. De succespercentages verschilden in getal echter weinig en 
bovendien was de variabiliteit tussen de proefpersonen groot. Post-hoc analyses lieten 
141
SAMENVATTING IN HET NEDERLANDS (SUMMARY IN DUTCH)
zien dat deelnemers met relatief geringe spierkracht in het aangedane been (Motricity 
Index < 64%) het meest profiteerden van FES wat betreft hun aanpassingsvermogen 
van het lopen. De meerwaarde van FES boven een EVO zou van klinisch belang kunnen 
zijn voor vooral deze groep mensen met een beroerte. Nader onderzoek is nodig om te 
beoordelen of de resultaten gegeneraliseerd kunnen worden naar andere groepen 
patiënten met een beroerte. Ook is vervolgonderzoek nodig naar de persoonskenmer-
ken die bepalen of iemand meer profijt van FES zal hebben dan van een EVO. 
6.  (a) Welke aspecten van functionele meerwaarde van FES van de peroneuszenuw boven 
een EVO kunnen worden onderscheiden bij iemand met een buitengewoon goede 
reactie op FES? (b) Kan het looppatroon met FES bij iemand met zo’n buitengewoon 
goede reactie op FES ons iets vertellen over de werkingsmechanismen die aan deze 
meerwaarde mogelijk ten grondslag liggen? 
Hoofdstuk 7 behandelt de functionele effecten van FES van de peroneuszenuw bij een 
van de deelnemers aan de studie die een uitzonderlijke goede reactie op FES vertoonde. 
Deze deelnemer was nauwelijks tot lopen in staat zonder enige voetvoorziening; in 
verband met zijn ernstige sleepvoet droeg hij gewoonlijk een EVO. Zijn EVO werd in 
eerste instantie vervangen door een apparaat voor oppervlakte-FES (NESS L300®). In 
tweede instantie werd bij hem een geïmplanteerd FES-systeem (Actigait®) aangebracht 
om een probleem van huidirritatie met het oppervlaktesysteem op te lossen. Met beide 
FES-systemen werd een verbetering van het gehele looppatroon waargenomen die 
verder ging dan een verbetering van alleen de voetheffing. Heup- en knie-flexiehoeken 
en de afzetkracht over de enkel tijdens lopen verbeterden tot normale waardes. Het 
looppatroon met FES was bijna symmetrisch en minder variabel dan met de EVO. Verder 
verbeterde zijn vermogen om een plotseling obstakel te vermijden tot normale waardes 
met FES. Wat betreft het werkingsmechanisme dat aan de werking van FES bij deze 
patiënt ten grondslag kan hebben gelegen, wordt een verbeterde afzet over de enkel 
als belangrijkste mechanisme gezien. Hiernaast zou ook een door FES uitgelokte 
flexiereflex van het been een rol kunnen hebben gespeeld. 
De Algemene Discussie in Hoofdstuk 8 bespreekt eerst de betekenis van het obstakel-
ontwijkparadigma voor het onderzoek van mensen na een beroerte, en vervolgens het 
perspectief van FES in de behandeling van een sleepvoet na een beroerte. De werkings-
mechanismen die ten grondslag kunnen liggen aan de gevonden meerwaarde van FES 
ten opzicht van de EVO voor het aanpassingsvermogen van het lopen worden verkend 
door middel van aanvullende analyses. Ten slotte worden de mogelijkheden voor ver-
volgonderzoek besproken. 
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Het obstakel-ontwijkparadigma biedt het looponderzoek een test die gevoelig is voor 
verbetering van het vermogen om de stap tijdens het lopen aan te passen. Deze 
complexe loopvaardigheid kan van belang kan zijn voor de veiligheid van lopen in het 
dagelijks leven. Het paradigma kan vooral voor relatief goede lopers van belang zijn 
omdat gangbare klinische testen van de loopsnelheid bij hen ongevoelig zijn voor een 
verbetering van de loopvaardigheid. Juist wat betreft dit aanpassingsvermogen van 
de stap is FES van meerwaarde gebleken boven een EVO. Door dit voordeel zou de 
veiligheid van lopen beter gewaarborgd kunnen zijn met FES dan met een EVO, wat 
overeenkomt met de verbetering van de stabiliteit van lopen met FES zoals dat door de 
deelnemers werd ervaren. De meerwaarde van FES voor het aanpassingsvermogen van 
het lopen zou kunnen berusten op een verbetering van de neuromusculaire sturing 
tijdens de stapaanpassing met FES. Dit zou de hypothese bevestigen dat FES het bewe-
gingspatroon van het gehele been verbetert, en niet alleen de voet heft. Onderzoek 
van de spieractiviteit, zoals in Hoofdstuk 2, is de meest voor de hand liggende manier 
om deze neuromusculaire sturing te onderzoeken. Dit onderzoek wordt echter 
bemoeilijkt doordat de elektromyografische (EMG-) signalen van alle spieren van het 
aangedane been vertekend zijn door potentialen die het gevolg zijn van de elektrosti-
mulatie. Onderzoek van de kinematica was echter wel mogelijk, maar aanvullende 
analyses van de kinematica die in het onderzoek verzameld zijn kon de hypothese niet 
bevestigen: het verbeterde aanpassingsvermogen van de stap met FES kan niet worden 
toegeschreven aan een verbetering van knie- en heupbeweging. Wel is het mogelijk 
dat een verbetering van de enkelbeweging bijdraagt aan de meerwaarde van FES bij 
het maken van plotselinge stapaanpassingen. Verder onderzoek van de enkelbeweging 
met behulp van kinematica in het 3-dimensionale vlak is echter nodig om dit te 
bevestigen. Ten slotte ervaren de gebruikers van FES een vermindering van mentale 
belasting van het lopen met FES. Het huidige project toonde aan dat mensen na een 
beroerte meer aandacht nodig hebben bij het ontwijken van obstakels dan gezonde 
mensen (hoofdstuk 3). Het zou kunnen zijn dat een vermindering van mentale belasting 
van het lopen met FES de gebruikers helpt bij deze aandacht vergende stapaanpassin-
gen. Vervolgonderzoek kan zich richten op de vraag of het lopen met FES inderdaad 
minder aandacht vergt dan met een EVO en of dit mechanisme bijdraagt aan het 
verbeterde aanpassingsvermogen van het lopen met FES. 
Naast de vraag naar de werkingsmechanismen van het verbeterde aanpassingsvermo-
gen van het lopen met FES zijn er meer aandachtsgebieden voor nader onderzoek in 
het huidige project naar voren gekomen. Zo werd het huidige project uitgevoerd met 
een uitwendig FES-systeem. Het is onbekend of de bevindingen ook gelden voor een 
geïmplanteerd FES-systeem. Verder werd met de gebruikte onderzoeksopzet het aan-
passingsvermogen van de stap met het paretische been onderzocht. Bij stapaanpas-
singen met het niet-paretische been bevindt het paretische been zich in de standfase 
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van het lopen, waarin FES veel beperkter stimuleert dan in de zwaaifase. Of de gevonden 
meerwaarde van FES boven een EVO desondanks ook geldt voor stapaanpassingen 
met het niet-paretische been dient nader onderzocht te worden. Ten slotte is het 
effect van FES als orthese in het huidige project onderzocht. Het is denkbaar dat er 
morfologische en functionele veranderingen in het lichaam plaatsvinden ten gevolge 
van langdurig gebruik van FES. Deze veranderingen worden ‘therapeutische effecten’ 
genoemd. Tot op heden is er geen sluitend wetenschappelijk bewijs voor deze effecten 
gevonden noch voor de aard van de veronderstelde veranderingen bij langdurig 
FES-gebruik.
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Mam, je bood me de kansen op onderwijs die je zelf niet had gehad en liet me 
bovendien zien dat je ook zonder die bagage mooie dingen kunt bereiken. Dank 
hiervoor, en natuurlijk voor het gezelschap dat je vaak was voor de kinderen als ik in 
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weggewerkt, en het lekkere eten dat je vaak voor ons gekookt hebt.
Dit project heeft mij in de gelegenheid gesteld me te ontwikkelen. Met veel nieuws-
gierigheid en plezier heb ik me kunnen verdiepen in de sturing van het bewegen bij 
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observaties en recht-voor-zijn-raap-formuleringen zorgden ze ook letterlijk voor een 
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dienst van de Noordse Balk. Parallel hieraan volgde zij de professional master ‘Management 
in de Zorg’ aan de AKTHA Hogeschool te Alkmaar en rondde deze opleiding in 2001 
cum laude af. Zij was van 1999 tot 2002 afdelingshoofd fysiotherapie in de Noordse Balk. 
In 2002 wisselde zij deze betrekking in voor de opleiding Bewegingswetenschappen 
aan de VU in Amsterdam. In 2005 ontving zij hier de ‘van Ingen Schenau award’. Met 
deze prijs heeft zij een extra onderzoeksstage gedaan in de Sint Maartenskliniek in 
Nijmegen. Een jaar later studeerde zij cum laude af om direct hierna bij dezelfde onder-
zoeksgroep in Nijmegen terug te keren, maar nu als junior-onderzoeker in het UMC St 
Radboud. Zij onderzocht daar de effecten van functionele elektrostimulatie op de 
loopfunctie bij mensen na een CVA. Dit proefschrift is het resultaat van dit project en 
momenteel werkt zij aan een vervolgstudie hierop. Roos is getrouwd met Egbert 
Kooiman en samen kregen zij drie kinderen: Marleen (1988), Aart (1990) en Bram (1994). 
In de afgelopen jaren zijn de kinderen een voor een gaan studeren en op kamers gaan 
wonen. Met het vertrek van Bram dit jaar als laatste zijn er ook op het persoonlijke vlak 
nu nieuwe tijden aangebroken.
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